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VI 
Adenylylation, also referred to as adenylation or AMPylation, is the process by which 
adenosine-5‘-monophosphate (AMP) is covalently attached to a protein, a nucleic acid, or a 
small molecule. It is a widespread post-translational modification employed by a large variety 
of enzymes to regulate multiple cellular functions. This modification, originally discovered in 
the 1960s, recently re-emerged as a modification used by bacterial effector proteins to 
regulate key host signaling events upon infection. The Type Three Secretion System effectors 
VopS and IbpA from Vibrio parahaemolyticus and Histophilus somni, respectively, harbor a 
FIC domain, which catalyzes adenylylation of Rho family GTPases. The covalent attachment 
of the bulky AMP moiety abrogates binding of downstream effectors resulting in actin 
cytoskeleton collapse and concomitant host cell death.  
The FIC domain is not only present in a pathogenic setting but is also found in proteins 
that play a role in intrinsic signaling processes where its deleterious adenylylation activity 
needs to be tightly regulated. 
In this study, I performed structural and biochemical analyses to unravel the structural 
determinants and mechanisms governing catalysis and regulation of Fic proteins as 
widespread signaling proteins.  
First, by solving various structures of FIC domain-containing proteins I could show that 
FIC utilizes conserved active site features to favorably orientate the ATP substrate relative to 
the target protein, allowing AMP transfer to occur. We suggest that the catalytic mechanism 
can be generalized and extrapolated to all adenylylation-competent Fic proteins. 
Second, I deciphered the structural mechanism controlling Fic-catalyzed adenylylation. 
An alpha helix characterized by a conserved [S/T]xxxE[G/N] motif tightly associates with the 
Fic active site and perturbs adenylylation-competent ATP binding. This alpha helix can be 
part of the Fic protein itself as an N- or a C-terminal extension, or can be provided by a 
separate antitoxin. Based on structural homology modeling, this regulation mechanism was 
found to be conserved from bacteria to higher eukaryotes. 
The structural insights on the protein-ATP substrate binding specificity accumulated in 
this study will prove useful for coming efforts on rational drug design. Furtheremore, 
knowledge of the universal catalytic and inhibitory mechanism of Fic mediated AMP transfer 
will now pave the way for further studies towards the physiological roles of Fic proteins and 
particularly the identification of their protein targets. 
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1.1 Post-translational modifications in cellular physiology and 
pathogenesis 
 
1.1.1 Post-translational modifications: expand the structural and functional diversity 
of proteins 
 
Post-translational modification (PTM) is a widespread mechanism used by prokaryotes 
and eukaryotes to increase the structural and functional diversity of the proteome in the cell. 
There are two routes of diversification of the proteome. While changes at the transcriptional 
and mRNA levels increase the size of the transcriptome relative to the genome1,2, the 
combination of different post-translational modifications increases the complexity of the 
proteome and thus enriches information stored in the genome.  
More than 300 PTMs have been discovered to date and they are often classified 
according to the mechanism used to alter the properties of a protein. Proteins can be modified 
by, the addition of functional groups (e.g., acetylation and glycosylation), the covalent 
attachment of other proteins (e.g., ubiquitination ans SUMOylation), changes of the chemical 
nature of amino acids (e.g., deamidation, eliminylation) or proteolytic cleavage (Fig. 1). This 
tremendous number of PTMs provides a highly dynamic and largely reversible regulatory 
network that controls diverse cellular processes such as protein-protein interaction, signaling 
processes3, protein degradation4, subcellular localization5, and regulation of gene expression6. 
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Figure 1: Diversity of post-translational modifications. This graph gives a non-exhaustive list of 
PTMs classified according to the nature of the modification occurring on the target protein. The 
reversibility of the modification is indicated. (Taken from Ribet et al.7) 
 
 
1.1.2 Post-translational modifications and pathogenesis 
 
A hallmark of bacteria pathogenesis is the capacity of bacteria to survive and proliferate 
within their hosts. To this end, bacteria utilize PTMs as a key strategy to mimic the action of 
eukaryotic enzymes and interfere with host signaling pathways. PTMs can either be mediated 
by surface-localized or secreted effectors that cross the host membrane or are directly injected 
into the host cell via type III or IV secretions systems (T3SS or T4SS, respectively). These 
bacterial effectors display a large collection of enzymatic activities to modify key signaling 
molecules or to organize new signaling networks (Fig. 2).  
Phosphorylation that consists in the tacking of a phosphate group to an amino acid is 
one of the most common PTMs utilized by bacteria to modify catalytic properties of host 
proteins. This reversible post-translational modification is mediated by the highly abundant 
protein kinases and is counter-balanced by dephosphorylation the removal of phosphate 
catalyzed by phosphatases. Yersinia species translocate several T3SS effectors into host cell 
that are required for survival and replication of the bacterium. Among these effectors are 
Introduction 
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YpkA and YopH which possess serine/threonine kinase and phosphatase activities, 
respectively, which enable tight control of the host actin cytoskeleton and are important to 
prevent macrophage-mediated phagocytosis8,9.  
Eliminylation is another modification that consists in the irreversible cleavage of a 
phosphate group. The phosphothreonine lyases OspF from Shigella flexneri and its homolog, 
SpvC of Salmonella typhimurium, mediate this unusual β-elimination reaction to dampen host 
immune response by irreversible inactivation of mitogen-activated protein kinases 
(MAPKs)10. 
MAPK kinases are also altered by effectors bearing acetylation activity. For example, 
VopA from Vibrio parahaemolyticus covalently modify active site lysine residue with an 
acetate moiety that obstructs the ATP binding site11. 
Glycosylation refers to the enzymatic process that attaches glycans to proteins. Toxins 
A and B, the major virulence factors of Clostridium difficile are the best characterized toxins 
that harbor glycosyltransferase activity. These toxins transfer a glucose molecule onto a 
specific threonine within the switch I region of Rho GTPases, locking them in a dominant-
negative conformation12,13. 
ADP ribosylation, that is the transfer of ADP ribose from Nicotinamide Adenine 
Dinucleotide (NAD) is also a widely spread post-translational modification triggered by 
bacteria to manipulate host cell processes. For instance, clostridial C2 and C3 toxins mediate 
the attachment of one or more ADP-ribose moieties to actin and Rho-like proteins, 
respectively, to control actin cytoskeleton dynamics14. 
Some bacterial effectors share sequence and structural similarity with the E3 ubiquitin 
ligase, the enzyme that terminates the ubiquitylation process in eukaryotes. By adding 
polyubiquitin chains to the plant Fen kinase, the T3SS effector AvrPtoB from Pseudomonas 
syringae targets this host protein to the 26S proteasome for degradation, thereby inhibiting 
plant immune response15. 
Upon bacterial infection some eukaryotic proteins have also been reported to be 
deamidated or polyaminated, i.e. covalently modified with polyamines, such as spermidine, 
spermine and putrescine, upon bacterial infection. The Bordetella dermonecrotizing toxin 
(DNT) bears both functions of polyamination and deamidation to modify and render host 
Rho GTPases constitutively active, resulting in massive formation of actin stress fibers and 
focal adhesions16. 
Several bacterial proteins harbor proteolytic activities. YopT, a T3SS effector of 
Yersinia enterocolitica specifically recognizes prenylated Rho GTPases and irreversibly 
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inactivates them by a proteolytic cleavage near their carboxy-termini, leading to their release 
from the membrane. This cleavage disrupts the actin cytoskeleton and thus entails an 
antiphagocytic effect17. 
Phosphocholination, an unusual modification that requires CDP-choline as substrate 
has newly emerged as a potent mechanism to modulate Rab1/Rab35 GTPase. The Legionella 
pneumophila effector AnkX transfers phosphocholine onto these GTPases to regulate host 
vesicle transport18. The discovery of this unexpected modification highlights the importance 
of detailed investigations on baterial effectors and their interactions with host cell to further 
reveal unrecognized enzyme activities and post-translational modifications that govern a 
variety of distinct cellular functions. 
Adenylylation is a recently discovered post-translational modification triggered by 
bacterial effectors to disrupt Rho GTPase signaling. The two virulence factors VopS from 
Vibrio parahaemoliticus and IbpA from Histophilus somni utilize ATP to covalently modify 
key residues of the Rho GTPases Cdc42, Rac1, and RhoA with an AMP moiety19,20. This 
leads to the collapse of the actin cytoskeleton and to cell death. Adenylylation will be 
discussed in detail in the following Chapters19,20. 
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Figure 2: Common post-translational modifications triggered by bacterial pathogens. For each PTM, 
the enzyme responsible for the modification is in green, the substrate written in blue, and the molecule 
transferred onto the target protein is given in red. X, the nature of the amino acids modified; X*: 
irreversibly dephosphorylated amino acid; Pi, inorganic phosphate; PPi, inorganic pyrophosphate; 
NAD, nicotinamide adenine dinucleotide; coA, coenzyme A; Ubi, ubiquitin; UBL, ubiquitin-like 
proteins.  (Adapted from Ribet et al.7). 
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1.2 Adenylylation 
 
Adenylylation, also referred as adenylation or AMPylation, is the process by which 
adenosine-5‘-monophosphate (AMP) is covalently attached to a protein, nucleic acid, or small 
molecule. This process involves nucleophilic attack of the α-phosphate of ATP by the target 
molecule leading to AMP transfer (Fig. 3). As phosphorylation, adenylylation results in a 
covalent modification with phosphorous-containing molecule to regulate multiple cellular 
functions. Depending on the nature of the attacking nucleophilic group, the AMP moiety can 
be attached via a stable phosphodiester (P-O) bond or via a transient phosphoramidate (P-N) 
or carboxylate-phosphate (CO-P) linkage21 (Fig. 3). 
Enzymes mediate adenylylation in order to achieve three main functions. As originally 
discovered in the 1960s, in the context of the Escherichia coli glutamine synthetase 
regulation22, adenylylation is used as a stable post-translational modification to control 
protein activity.  
The second function is to allow thermodynamically unfavorable enzymatic reaction to 
occur. In this case, transient adenylylation is used to activate an unreactive substrate by 
adding an efficient leaving group for subsequent nucleophilic attack23. In this case, the 
adenylylation reaction is transient, and involves the generation of less stable and thus more 
reactive carboxylate-phosphate anhydrides (CO-P) or phosphoramidate (P-N) bonds. This is 
in contrast to stable phosphodiester (O-P) bonds formed in the case of regulation of protein 
activity. 
Finally, adenylylation occurs as an intermediate step along the biosynthetic pathway of 
protein cofactors21. 
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Figure 3: Protein adenylylation and phosphorylation. These two related modifications can occur at 
various positions on protein, peptide or amino acid and regulate a wide range of cellular processes. In 
both reactions, a nucleophile (such as the hydroxyl moiety of tyrosine (1), the side-chain amino 
functions of histidine (2), or the carboxy group of an amino acid (3)) attacks a phosphorous group of 
ATP. In adenylylation the attack takes place on the α-phosphate, thereby releasing pyrophosphate and 
transferring AMP. Phosphorylation is mediated by nucleophilic attack on the γ-phosphate, leading to 
phosphate transfer and release of ADP. 
Whereas the phosphodiester bond created in the case of Tyrosine Tyr-AMP or Tyr-P is chemically 
stable under physiological conditions, His-AMP or His-P and RCOO-AMP or RCOO-P are unstable 
intermediates in enzymatic reactions.  
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1.2.1 Adenylylation is a stable post-translational protein modification 
 
1.2.1.1 Glutamine synthetase adenylyltransferase 
 
The ubiquitous glutamine synthetase (GS) is a key enzyme for nitrogen metabolism. It 
catalyses the ATP-dependent condensation of ammonia with glutamate to form glutamine22, 
that is the principal source of nitrogen for protein and nucleic acid synthesis. Because of its 
critical role in nitrogen metabolism, this enzyme is found in all kingdoms of life from 
primitive to higher organisms24. GS has an elaborate control mechanism including a complex 
bicyclic cascade that controls its adenylylation state. The regulatory cascade contains the 
adenylyl transferase (ATase), a signal transduction enzyme called PII, and an uridylyl 
transferase (UTase).  
The master regulator is the bifunctional enzyme, adenylyl transferase (ATase) that 
allows rapid fine-tuning of GS activity in response to drastically changing environments. 
ATase consists of two conserved nucleotidyltransferase (NT) domains separated by a central 
regulatory domain (R). The N-terminal adenylyl removase (AR) domain carries a 
deadenylylation activity and the C-terminal adenylyl transferase (AT) domain harbors an 
adenylylation activity. Both domains are able to interact with GS and regulate its function. 
When the level of nitrogen is high, glutamine binds to AT and activates its 
adenylylation activity towards GS. The adenylylation occurs on a conserved tyrosine located 
below the glutamate active site. Thus, the bulky AMP moiety presumably prevents the 
binding of the glutamate substrate, resulting in low GS activity. Conversely, under nitrogen-
limiting conditions, GS-AMP is deadenylylated via phosphorolysis by the AR domain of 
ATase, restoring GS activity. It is noteworthy that the adenylylation and deadenylylation 
reactions catalyzed by ATase are not the reverse of each other. De-adenylylation occurs via 
phosphorolysis that requires a nucleophilic attack of inorganic phosphate on the AMP 
phosphate, thereby producing ADP.  
The uridylyl transferase (UTase), a second bifunctional enzyme with 
nucleotidylylation/denucleotidylylation activity, provides another level of regulation. UTase 
directly senses the nitrogen level within the cell. When the nitrogen levels are low, UTase 
covalently attaches an UMP moiety onto the PII enzyme25,26. PII-UMP binds to the ATase 
regulatory domain (R) and stimulates its deadenylylation activity leading to GS-mediated 
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production of glutamine. Under conditions of nitrogen excess, UTase uses its 
phosphodiesterase activity to cleave the UMP from PII-UMP. The unmodified PII stimulates 
the adenylylation activity of ATase, decreasing the rate at which GS converts glutamate to 
glutamine (Fig. 4). 
 
 
 
 
 
 
 
 
Figure 4: The bicyclic regulatory cascade that controls glutamine synthetase activity. The signal 
transduction protein PII is interconverted between its unmodified and its uridylylated form by the 
hydrolase and transferase activities of the UTase. The adenylylation and deadenylylation activities of 
adenylyl transferase (ATase) are regulated by PII and PII-UMP, respectively. Adenylylation of 
glutamine synthetase (GS) inhibits its activity, whereas deadenylylation restores its function. (taken 
from Jaggi et al.27). 
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1.2.1.2 Adenylylation of antibiotics 
 
Bacteria have developed different resistance strategies to deal with the long way of 
antibiotic treatment. The most common route of resistance involves modification of 
antibiotica by acetylation, phosphorylation or adenylylation. The enzymes mediating these 
modifications are often plasmid encoded but can also be associated with transposable 
elements and are thus frequently transferred by conjugation. Adenylyltransferases (ANTs) 
that trigger adenylylation of antibiotics belong to the nucleotidyltransferase (NT) superfamily, 
and share structural and functional similarity with the DNA polymerase B and the poly(A) 
polymerase28. ANTs confer to the bacteria resistance against a variety of antibiotic classes, 
such as aminoglycosides or lincosamides. Based on X-ray crystallography structures, the 
catalytic mechanism has been proposed to be an in-line nucleophilic attack of the antibiotic 
hydroxyl group onto the α-phosphate of ATP leading to an AMP-modified antibiotic and 
pyrophosphate release28,29 (Fig. 5). These bacterial nucleotidyl-transferases are not specific 
for ATP and can also mediate guanylylation or uridylylation through GTP or UTP transfer, 
respectively30. 
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Figure 5: Mechanism of antibiotic adenylylation. Close-up view of the S. aureus Kanamycin 
adenylyl-transferase active site (PDB code 1KNY). The non-hydrolyzable ATP analog AMPCPP and 
kanamycin are shown in cyan and yellow, respectively. Residues forming interactions with the ligands 
are shown in full and the magnesium ion with a magenta ball. Hydrogen-bonding interactions are 
shown as dashed lines. The ligand-binding pocket is created by two monomers shown in grey and 
beige that wrap one another. The 4’ hydroxyl on the kanamycin is located at a distance of 4.8Å from 
the α-phosphate of the nucleotide and both substrates are in the proper orientation for a single in-line 
displacement mechanism. The enzyme has to undergo a small conformational change to decrease 
distance between the two reactants. E145 that is situated within hydrogen-bonding distance to this 
hydroxyl group acts as a general base and abstracts the proton of the hydroxyl group, leaving 
kanamycin susceptible for nucleophilic attack on the α-phosphate of ATP. K149, that is close to the 
α-phosphorous, and Mg2+ ion stabilize the pentacovalent transition state and the pyrophosphate 
leaving group, respectively. ATP is locked in the binding pocket by an extensive hydrogen-bonding 
network through its phosphate tail and the ribose. The absence of contacts between the adenine ring of 
ATP and the adenylyl transferase active site is consistent with the lack of specificity for the nucleotide 
substrate28. 
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1.2.2 Activation of unreactive substrate by adenylylation 
 
Adenylylation is often use as a transient modification that increases the reactivity of a 
molecule23. The high energy of AMPylated intermediate will drive subsequent non-
spontaneous reactions.  
 
1.2.2.1 Aminoacyl-tRNA synthetases 
 
Aminoacyl-tRNA synthetase uses a transient adenylylation in order to charge tRNA 
with its cognate amino acid. The synthetase binds simultaneously ATP and the amino acid 
and facilitates the nucleophilic attack of the amino acid carboxylate group onto the ATP α-
phosphorous. As a second step, the appropriate tRNA binds to the synthetase and a high-
energy bond between the 2'- or 3'-hydroxyl of the terminal adenosine of tRNA and the 
adenylylated amino acid is formed, displacing the AMP31 (Fig. 6). The aminoacyl-tRNA is 
then released from the enzyme and brings the correct amino acid to the ribosome. The latter 
will transfer the amino acid to the nascent polypeptide chain whose sequence is specified by 
the codons of the mRNA. 
Introduction 
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Figure 6: tRNA charging by aminoacyl-tRNA synthetases (aaRSs). aaRSs utilize a two-step 
mechanism to charge a specific tRNA with its cognate amino acid. (a) The first step involves a 
nucleophilc attack of the amino acid carboxyl group on the α-phosphate of ATP, generating an 
adenylylated amino-acid and pyrophosphate. 
(b) In step 2, the adenylylated amino acid carbonyl is attacked by the 3' OH of the tRNA CCA ending, 
displacing AMP. 
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1.2.2.2 E1 activating enzyme from the ubiquitin-conjugation pathway 
 
Another example of transient adenylylation is the E1 activating enzyme from the 
ubiquitin-conjugation pathway. Ubiquitylation, i.e. covalent attachment of ubiquitin or 
ubiquitin-like proteins (UBLs), is one of the major post-translational modifications used to 
regulate eukaryotic protein functions32. The effect of this modification on the fate of the 
targeted protein depends on the length of the ubiquitin molecules appended to the protein. 
Polyubiquitylated protein substrates are often targeted to the 26S proteasome for degradation 
but single ubiquitin monomers are also involved in non-proteolytic regulatory mechanisms, 
such as endocytosis, immune responses, DNA repair, or histone regulation33-36. 
Attachment of ubiquitin involves a multienzyme cascade with the first step mediated by 
the E1 enzyme (Fig. 7). E1 binds ATP/Mg2+ and the ubiquitin molecule and catalyse 
adenylylation of the C-terminal carboxylate group of ubiquitin to produce an ubiquitin-
adenylylate intermediate37. In a second step, a catalytic cysteine sulphydryl group from E1 
attacks the acyl-adenylylate to form an activated E1-ubiquitin thioester intermediate. 
Ubiquitin is then transferred to a cysteine residue in ubiquitin-conjugating enzyme E2 through 
a trans(thio)esterification reaction. In the final step of the ubiquitylation cascade, ubiquitin 
molecules become covalently attached to lysine residues in target proteins by the action of the 
E2 with the assistance of ubiquitin ligase E3 (Fig. 7). 
Concomitantly, other UBL–modification pathways, such as SUMOylation (attachment 
of SUMO molecule) or NEDDylation (attachment of Nedd8 molecule) require initial 
activation of carboxylate group by adenylylation38,39. 
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Adenylylation Ub  transfer
Ub  transfer
 
Figure 7: The Ubiquitylation pathway. Ubiquitylation requires a cascade of E1 ubiquitin-activating, 
E2 ubiquitin-conjugating and E3 ubiquitin ligase enzymes. First, E1 enzyme activates the ubiquitin 
molecules by adenylylation of the carboxy-terminal carboxylate of ubiquitin (Ub), forming Ub–AMP. 
The second step transfers ubiquitin to the E1 active site cysteine residue, with release of AMP. This 
step results in a thioester linkage between the C-terminal carboxyl group of ubiquitin and the E1 
cysteine sulfhydryl group (E1-Ub). Ubiquitin is then transferred from E1 to E2 via a trans(thio)-
esterification reaction (E2-Ub). Finally, E2, in conjunction with E3 covalently attached ubiquitin to 
the protein target. Typically, an isopeptide bond is formed between the ubiquitin C-terminal 
carboxylate and the ɛ-amino group of a Lys side chain of the substrate protein or the growing ubiquitin 
chain. (Adapted from Maupin-Furlow et al.33). 
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1.2.2.3 Glucose-1-phosphate adenylyltransferase 
 
Many organisms synthesize and store glycogen as energy reserves to cope with 
starvation conditions. The pathway for synthesis of storage polysaccharides requires initial 
activation of glucose units for subsequent transfer to the growing α-1,4-glucosidic chain. The 
first committed step is catalyzed by Glucose-1-phosphate adenylytransferase (also named 
ADP-glucose pyrophosphorylase) that mediates formation of ADP-glucose, the activated 
form of glucose, from substrates glucose-1-phosphate and ATP40 (Fig. 8). The reaction 
proceeds via attack by a phosphate oxygen of glucose-1-phosphate on the α-phosphorous of 
ATP, with release of the pyrophosphate moiety41. ADP-glucose is then used as a substrate by 
the glycogen synthase to synthesize α-1,4-polyglucan chains. Whereas, ADP-glucose 
represents the activated form of glucose in bacteria and plants, mammals and fungi possess 
glucose-1-phosphate uridylyltransferases that pre-activate glucose-1-phosphate molecules 
with UMP during carbohydrate metabolism42. 
 
 
 
 
Figure 8: Schematic of glucose activation by the Glucose-1-phosphate adenylyltransferase. Upon 
binding of the two substrates, namely glucose-1-phosphate and ATP, glucose-1-phosphate 
adenylyltransferase facilitates the nucleophilic attack of one phosphate oxygen from glucose-1-
phosphate onto the α-phosphorous of ATP. This reaction induces formation of ADP-glucose together 
with release of pyrophosphate. 
  
 
 
-
-
Glucose-­1-­phosphate
ATP -
-
ADP-­glucose
Glucose-­1-­phosphate  
adenylytransferase  
Pyrophosphate
Introduction 
 
 18 
1.2.3 Adenylylation step is common in the synthesis of organic cofactors 
 
Cofactors are non-protein chemical compounds that are bound to proteins, commonly 
enzymes, and assist biochemical reactions. Two types of cofactors exist in nature: inorganic 
cofactors such as metal ions and organic cofactors, which are often derived from vitamins. 
NAD+, FAD, and Coenzyme A are essential organic cofactors that require adenylyl-
transferases for their biosynthesis. 
Nicotinamide adenine dinucleotide (NAD+) that is derived from the niacin vitamin is a 
pivotal coenzyme that plays fundamental roles in cellular metabolism. It is involved in redox 
reactions, DNA repair, stress responses and serves as a substrate in ADP-ribosylation43,44. The 
critical step in NAD generation involves the Nicotinamide/nicotinic acid mononucleotide 
adenylyltransferase (NMNAT). The enzyme catalyzes the formation of the dinucleotide 
through condensation of ATP with nicotinamide mononucleotide (NMN)45 (Fig. 9a). 
The flavo-coenzyme flavin adenine dinucleotide (FAD) is another important redox 
cofactor46. Its synthesis requires a two-step mechanism. In eukaryotes, riboflavin, also known 
as vitamin B2, is first phosphorylated by means of riboflavin kinases (RFK) to yield flavin 
mononucleotide (FMN). FMN is further adenylylated by Flavin mononucleotide 
adenylyltransferase (FMNAT) to form FAD (Fig. 9b). In bacteria, synthesis is mediated by 
the bifunctional enzyme flavin adenine dinucleotide synthetase (FADS), which bears both 
phosphorylation and AMP transfer activities47. 
AMP transfer also occurs in the course of Coenzyme A (CoA) biosynthesis pathway. 
The pantothenate (vitamin B5) is converted in CoA in a five-step process. An intermediate 
formed en route is dephospho-CoA (dPCoA). dPCoA is formed by Phosphopantetheine 
adenylyltransferase (PPAT), in a adenylylation reaction that requires phosphopantetheine 
(Ppant) and ATP (Fig. 9c). dPCoA is further utilized by dPCoA kinase that produces the acyl 
group carrier, CoA48. 
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Figure 9: General reaction schemes for the adenylylation process of the vitamin-derived cofactors 
NAD+ (a), FAD (b), and Coenzyme A (c). Adenylylation is mediated by Nicotinamide/nicotinic acid 
mononucleotide adenylyltransferase (NMNAT), Flavin mononucleotide adenylyltransferase 
(FMNAT), and Phosphopantetheine adenylyltransferase (PPAT), respectively. NMN: Nicotinamide 
mononucleotide; NAD+: Nicotinamide adenine dinucleotide; FMN: Flavin mononucleotide; FAD: 
flavin adenine dinucleotide; Ppant: Phosphopantetheine; dPCoA: Dephospho-Coenzyme A. 
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These three different adenylyltransferases involved in cofactor synthesis share 
remarkable structural similarities. They belong to the large nucleotidyltransferase α/β 
phosphodiesterase superfamily, to which class I aminoacyl tRNA synthetases (aaRS) belong, 
and adopt the typical nucleotide binding Rosmann fold with a conserved signature (H/T)xGH 
motif important for ATP recognition and stabilization49-51. Superimposition of NMNAT and 
PPAT also reveals a common binding pocket for the chemically dissimilar substrates, NMN 
and phosphopantetheine, respectively, suggesting a conserved catalytic mechanism50 (Fig. 
10). The adenylylation process involves nucleophilic attack of a phosphate oxygen from the 
respective substrates on the α-phosphorous of the adenine nucleotide in an in-line 
displacement mechanism (Fig. 9 and Fig. 10). Since the phosphate group is a reasonable 
nucleophile and does not require pre-activation, residues from the enzyme active site are not 
engaged in the chemistry of the reaction by acid/base catalysis (Fig. 10) (in contrast to 
antibiotic adenylyl-transferases, see fig. 5). An equivalent mechanism was also reported for 
tRNA amino-acylation by class I glutaminyl tRNA synthetase (GlnRS)52 (Fig. 10C). 
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Figure 10: Close-up view of PPAT, NMNAT, GlnRS and FMNAT active sites. The similar nucleotide 
binding and the highly conserved H/TxGH sequence motif, involved in nucleotide recognition and 
stabilization suggest a common catalytic mechanism for enzymes of the nucleotidyltransferase 
α/β phosphodiesterase superfamily. 
(a) Zoom-in of the E. coli Phosphopantetheine adenylyltransferase (PPAT) active-site with its two 
substrates obtained after superimposition of structures of PPAT/ATP-Mn2+ complex (PDB code 
1GN8) with PPAT/4'-phosphopantetheine (Ppant) complex (PDB code 1QJC). ATP and Ppant 
substrates are shown in full and colored orange and grey, respectively. Mn2+ ion is represented with a 
ball (in magenta). Residues important for substrates recognition are depicted in full with H-bonds 
marked by stippled lines in grey. Arg91, Ser128, Ser130 and the divalent cation facilitate the adoption 
of an ideal geometry for the pyrophosphate leaving group. Lys42 and Thr10 are essential to orientate 
the attacking nucleophile for catalysis. His18 from the conserved T/HxGH motif serves as a proton 
donor and interacts with the α-phosphate group to stabilize the transition state. Thus, electrostatic 
support and locking the reaction partners in a productive conformation is all that is required for 
catalysis to happen. The phosphate of Ppant undergoes nucleophilic attack on ATP α-phosphorous in 
an in-line displacement mechanism51. 
(b) Close-up view of the Nicotinamide mononucleotide adenylyltransferase (NMNAT) active-site 
with its two substrates obtained after superimposition of structures of M. Jannaschii NMNAT/ATP 
complex (PDB code 1F9A) with human NMNAT/nicotinamide mononucleotide (NMN) complex 
(PDB code 1GZU). ATP and NMN are colored in orange and grey, respectively. Residues involved in 
ATP binding (His16, Arg121, Ser125, Thr127) are equivalent in PPAT (His18, Arg91, Ser128, 
Ser130) and the 2 substrates adopt an orientation similar as seen in (A), supporting the mechanism 
proposed for PPAT. 
(c) Zoom-in of the E. coli Glutaminyl-tRNA synthetase (GlnRS) active site. The respective positions 
of the ATP and glutamine substrates have been obtained after superposition of GlnRS/ATP (PDB code 
1GTR) with GlnRS/Glutamine (Gln) (PDB code 1O0B) structures. ATP and Gln are shown in orange 
and grey, respectively. The amino acid activation by adenylylation is mechanistically equivalent as in 
A and B with the second histidine from the T/HxGH motif stabilizing the pentacovalent transition 
state. However, in this situation, the carboxyl group of Gln is not ideally positioned in front of the 
pyrophosphate leaving group and catalysis requires slight conformational changes that is induced by 
transfer RNA binding53. 
(d) Active-site of the flavin mononucleotide adenylyltransferase (FMNAT) domain of T. maritima 
flavin adenine dinucleotide synthetase (FADS) in complex with AMP (PDB code 1T6Y). The AMP 
conformation, which resembles the one observed for the nucleotides in A, B and C, and the presence 
of the conserved T/HxGH are reminiscent of a similar catalytic mechanism. 
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Finally, adenylyltransferases intervene in the formation of the organic, non-vitamin 
molybdenum (Moco) and 3’-Phosphoadenosine-5’-phosphosulfate (PAPS) cofactors.  
Moco-containing enzymes catalyze important redox reactions in the global carbon, 
sulfur, and nitrogen cycles. It is synthesized by an ancient and conserved biosynthetic 
pathway that can be divided into five steps, one of which is adenylylation54. In E. coli, the 
enzyme mediating adenylylation is named MoeB and activates the C-terminal end of MoaD 
protein by forming an acyl-adenylate. Subsequently, a sulphurtransferase converts the MoaD 
acyl-adenylate to a thiocarboxylate that provides sulphur during Moco biosynthesis55. MoeB 
is structurally and functionally similar to E1 enzyme from the ubiquitylation pathway56,57 (see 
Chapter 1.2.2.2).  
The cofactor PAPS is the sulfate donor in sulfotransferase-catalyzed synthesis and is an 
important component of the biosynthesis pathway of sulfur-containing amino acids58. An 
intermediate formed during PAPS biosynthesis is adenosine-5′-phosphosulfate (APS), a 
derivative of adenosine monosphosphate that has a sulfate group attached to the 5’ phosphate. 
APS is formed by sulfate adenylyltransferase, also named ATP sulfurylase, in an 
adenylylation reaction that requires ATP and sulfate ion. APS is further phosphorylated at the 
ribose 3’ hydroxyl by APS kinases, to yield PAPS59. 
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1.2.4 Pathogen-mediated adenylylation 
 
Adenylylation has emerged recently as a post-translational modification hijacked by 
bacterial pathogens to subvert key host cellular processes upon infection. Legionella 
pneumophila is an opportunistic human pathogen and the causative agent of Legionnaires’ 
disease. A hallmark of Legionella pathogenesis is the capacity of the bacteria to form 
endoplamic reticulum-derived vacuoles, called Legionella-containing vacuoles (LCV), to 
avoid fusion with endocytic vesicles and lysosomes and to allow bacterial survival and 
proliferation60. To this end, L. pneumophila manipulates intracellular vesicular trafficking 
through secretion of effectors via the T4SS-related Dot/Icm (defect in organelle 
trafficking/intracellular multiplication) translocation machinery61. This effectors co-opt host 
factors, such as Sar1, Sec22b and Rab1 to establish the LCVs62. In this context, the versatile 
L. pneumophila factor DrrA (also known as SidM) is involved in the recruitment and 
manipulation of the small GTPase Rab1 (Fig. 11). DrrA contains three domains. Whereas the 
C-terminal lipid phosphatidylinositol-4-phosphate binding domain (P4M) mediates 
attachment to the LCVs membrane, the central guanine nucleotide exchange factor (GEF) and 
the N-terminal adenylyl transferase activities subvert Rab1 functions (Fig. 11). The N-
terminal domain displays high structural similarity with the glutamine synthetase adenylyl 
transferase, with which it shares also the same catalytic residues63 (Fig. 11c, see Chapter 
1.2.1.1). It efficiently transfers AMP to a conserved tyrosine in the switch II region of Rab1-
GTP (Tyr77 in Rab1b), thereby inhibiting GAP-stimulated GTP hydrolysis and trapping Rab1 
in an active state63. Interestingly, later during infection, L. pneumophila also injects SidD, an 
effector that possesses AMP hydrolase activity to counteract DrrA function64,65. Combination 
of effectors with opposite activities allows L.pneumophila to achieve an accurate spatio-
temporal control of the Rab1 signalling pathway. 
 
Likewise, bacterial effectors carrying a FIC domain catalyse adenylylation of host cell 
proteins. The Fic-mediated adenylylation will be extensively discussed in the following 
chapters. 
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Figure 11: Structure and function of DrrA. a) Tripartite domain architecture of DrrA with a N-
terminal adenylyltransferase (ATase), a central GTP-GDP exchange factor (GEF) and a C-terminal 
lipid phosphatidylinositol-4-phosphate binding domain (P4M). b) Mechanism of Rab1 modulation by 
DrrA. DrrA docks on the LCVs through its P4M domain (step 1) where it recruits Rab1, displaces it 
from GDI and activates it by stimulating GDP/GTP exchange (step 2). Rab1 is then adenylylated by 
DrrA (step 3) preventing its inactivation by GAPs (step4). (yellow star, phosphatidylinositol-4-
phosphate ; grey arc, LCV membrane ; GDI, guanine nucleotide dissociation inhibitor). c) Comparison 
of crystal structures of a DrrA fragment (PDB code 3NKU) and a fragment of the C-terminal 
adenylytransferase domain of GS-AT (PDB code 3K7D), which highlights high structural similarity. 
(Adapted from Goody et al.66). 
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1.3 FIC domain: a new paradigm for adenylylation 
 
1.3.1 General introduction 
 
FIC stands for filamentation induced by cAMP and was initially identified as a 
regulatory factor of cell division. Utsumi et al, discovered that a specific mutation (G55R) in 
the fic gene perturbed normal cell division and led to a filamentation phenotype when bacteria 
were grown at 43°C in presence of 1.5mM67-73 (Fig. 12). Additional investigation on this fic 
mutant also suggested that the regulatory mechanism might involve folate metabolism by the 
synthesis of p-aminobenzoic acid (PABA) or folate70. 
 
 
 
Figure 12: E. coli Fic mutant G55R shows impaires cell division when incubated in high cAMP 
concentration resulting in filamentous cells. (Adapted from Komano et al.70) 
 
 
 
The enzymatic activity of FIC domains was only recently revealed with the work on the 
T3SS effector proteins VopS from Vibrio parahaemolyticus. This gram-negative halophilic 
bacterium, found in estuarine waters worldwide74, is a causative agent of seafood-borne 
human gastroenteritis and can lead to death in immune-compromised or burdened patients75. 
These bacteria use a type III secretion system (T3SS) to deliver bacterial effector proteins into 
the host cell cytosol where they disrupt the signaling network76 and induce autophagy, cell 
rounding and subsequent cell lysis77. In this context, VopS was implicated in the severe 
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rounding of cells by the inactivation of the Rho family guanosine triphosphatases (GTPases) 
members, Rac1, RhoA, and Cdc4278. Using pull-down experiments in combination with mass 
spectrometry analysis, Yarbrough et al20, deciphered the mechanism of VopS-mediated 
GTPases inactivation. They observed that upon incubation with VopS, a specific threonine 
(T35 in Rac1 and Cdc42 and T37 in RhoA) in the switch I loop of the GTPases was 
covalently modified with an AMP moiety. Furthermore, they attributed AMP transferase 
activity to the FIC domain since mutation of the conserved histidine residue in the FIC active 
site motif (HxFx[D/E]GNGRxxR) rescued the rounded phenotype (Fig. 13). Owing to the 
critical role of the switch I region in downstream protein binding, the bulky AMP group 
disrupts the GTPase signaling cascade resulting in cell death20.  
 
 
 
Figure 13: Human HeLa cells transfected with VopS round up. This phenotype, typical of actin 
cytoskeleton collapse, results from inactivation of Rho GTPase signaling. Mutant of the Fic active-site 
histidine displays normal cell shape, proving that the activity resides in the FIC domain. (Adapted 
from Yarbrough et al20) 
 
 
 
A parallel research on the Histophilus somni IbpA protein shed light on a similar Fic-
catalyzed adenylylation and disruption of GTPase signaling. H. somni is a gram negative 
pathogen that causes a variety of syndromes in cattle and other ruminants, including 
pneumonia, septicemia, myocarditis, and abortion79-82. 
One of the virulence factors of H. somni is IbpA (immunoglobulin-binding protein A), a 
fibrillar surface antigen that contains two FIC domains at its C-terminus. The expression of 
the FIC domains in HeLa cells but also in the most physiologically relevant primary bovine 
alveolar type 2 (BAT2) cells led to a cell rounding and retraction phenotype83. As in the case 
of VopS, this phenotype originates from the blockade of GTPase signaling by Fic-mediated 
adenylylation of the Rho GTPases19. 
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Interestingly, the modification was traced down to a tyrosine in the switch I region of 
Rho GTPases (Y32 in Rac1 and Cdc42 and Y34 in RhoA). It remains to be elucidated 
whether the variation in the type of amino acid that is modified has further implications in the 
regulation of Rho GTPase signaling events84. 
The same group also demonstrated that the huntingtin yeast-interacting protein E 
(HypE), the only human FIC-domain containing protein, can also adenylylate Rho GTPases 
in vitro19. It is unclear whether HypE inactivates GTPases in vivo and the physiological 
substrates remain to be identified. A yeast two-hybrid screening identified HypE as a binder 
of the huntingtin protein85. It is therefore tempting to speculate that HypE might play a role in 
the Huntington’s disease by direct covalent modification of the huntingtin protein or through 
an indirect mechanism by targeting huntingtin-interacting partners. 
 
The FIC domain is an evolutionary conserved domain that is ubiquitous in bacteria but 
also found in eukaryotes, archae and viruses but, noteworthy, not in plants and yeast. At the 
time of writing, more than 4500 sequences are present in the Pfam protein database86 with the 
vast majority harboring the consensus HxFx[D/E]GNGRxxR motif (Fig. 14). For all residues 
of the motif except for the first glycine and first arginine, single point mutant have been 
generated in various Fic proteins that showed reduced adenylylation activity19,20,87,88. 
Therefore, integrity of the FIC motif is essential for catalysis. Fic proteins with degenerated 
active centers are likely to carry other or no enzymatic functions. The effector protein AnkX 
of Legionella Pneumophila provides a striking example of a Fic protein harboring a motif 
divergent from the consensus and exhibiting a related function. Its Fic motif 
(HxFxDANGRxxV) allows CDP-choline substrate binding and enables the Fic protein to 
dysregulate Rab1 GTPase by phosphocholination18. 
 
H.sapiens|Q9BVA6                             H F  GNGR  R                     A  P D    T  LL ILAMNLHPVEFAAL HYKLVYI I S . MNL MQAGYPPITIRKE
M.musculus|Q8BIX9                            H F  GNGR  R                     A  P D    T  LL ILAMNLHPVEFAAL HYKLVYI I S . MNL MQAGYPPITIRKE
C.elegans|Q23544                             H F  GNGR  R                     A  P D    T  LL IMTLTIDPIERAAI HYKLVLV T A . LNL MRSGFPPVILPVE
M.tuberculosis|A5WTK8                        H F  GNGR  R                     R  P E    S  EF LLVGEGDLAGQVAY YDYVNYA R T . FDL SERGSGLDWGKTD
V.parahaemolyticus|Q87P32                     H F  GNGR  R                     L  G D    M  LY ELENPVADKDLGKH FAGVIGY T G M AIA RNDSFNPLAMNA.
N.meningitidis|E0N845                        H F  GNGR  R                     A  P D    T  IL LLSGDLDPLIIMAA HYQFEAI T G . NSL IEKGLLDLPILYL
H.somni_Fic1|Q06277                          H F  GNGR  R                     V  P E    M  VV ILKQNVEPSVLAGL YQRLIAY A A . VNK LDAGYPPFTKFSS
M.maripaludis|A6VJ92                         H F  GNGR  R                     I  P D    T  LF LLDKFIHPIIKGII HFLIGYI N A S YWY KNDYWLFEYMAI.
H.volcanii|D4GR67                            H F  GNGR  R                     I  P D    L  LL ALGPRYAPLVDLAL HYQFETI Q G . VML YKWELLPGPYLYP
WSSV|A2TEX9                                  H F  GNGR  R                     F  P D    T  LL LLNDQIKIIKACAY MYNFLTL N A . YSF KGNGIVPHFSPIT
Lactococcus_phage|Q9AZ49                     H F  GNGR  R                     S  P D    T  IL LARDDIPTYEKAFI HFYFENT Y G F CSY RKLDYLSAVGVS.
 
Figure 14: Sequence alignment of selected proteins that define the diversity of these Fic proteins. 
Sequences are accompanied with their respective uniprot number and are colored in the following: 
magenta, eukaryotes; black, bacteria; cyan, archae; blue, viruses. WSSV stands for White spot 
syndrome virus. The consensus HxFx[D/E]GNGRxxR is highlighted with red triangles. 
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1.3.2 FIC domain: an α-helical fold topology 
 
The FIC domain-containing Fic proteins are classified together with a second family of 
proteins, Doc (death on curing), in the Pfam protein database86 and form the Fic/Doc protein 
family (Pfam: PF02661) or later named the fido superfamily89. Among the proteins present in 
the database, few have known three-dimension architectures (Fig. 15). Four structures solved 
by structural genomics efforts (PDB codes 2G03, 2F6S, 3EQX, and 3CUC) present the highly 
conserved FIC active site motif (HxFx[D/E]GNGRxxR) and a common α-helical fold 
topology composed of eight helices87,88,90 (Fig 15 and 16). The α-helical fold consists of a 
four-helix bundle (α2-α5), representing the FIC core domain as defined by Pfam86 that is 
decorated by one preceding helix (α1) and two additional helices (α6 and α7) stacking almost 
perpendicular to the bundle. The active site motif is located in the loop between helix α4 and 
α5. An additional helix (α’) is visible in the four structures and adopts the same position with 
respect to the FIC active center. Interestingly, α’ helix is found permuted and can be either 
found N-terminally (3EQX and 3CUC) or C-terminally (2G03 and 2F6S) to the FIC active 
site and completes the Fic fold (Fig. 15). Finally a β-hairpin loop structure located between 
helices α2 and α3 seems to be a common feature shared by Fic proteins. 
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Figure 15: Overall topology of Fic and Doc proteins with known crystal structures. a) Fic 
Helicobacter pylori (PDB code 2F6S), b) Fic Neisseria meningitidis (PDB code 2G03), c) Doc of 
prophage P1 in complex with Phd (in green) (PDB code 3DD7), d) Fic Shewanella oneidensis (PDB 
code 3EQX), e) Fic Bacteriodes thetaiotaomicron. Color code is the following: red, core of Fic 
domain as defined by Pfam86; yellow, HxFxxGNGRxxR signature motif; green, permuted helix α’; 
magenta, remainder of structure. The same color code illustrates all Fic proteins throughout the 
manuscript. All Fic proteins harbor a β-hairpin structure implicated in target recognition (see chapter 
1.3.4) that is absent in Doc. Helices α1 and α’ are replaced by Phd in Doc/Phd structure. 
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  1       10              20                       30                                      
 1 NmFic|2G03   ..RIEVGTTAGLQQIHRYLFG......GLYDF...............AGQIRE..DN.ISK..............................
VopS_Fic|3LET ..GKDLLNMDNLKELHARLVP......NV...................ERD.Y..RG.PNIS.............................
IbpA_Fic|3N3U ..QGKPLTVQMIENLNHGLRP......DEGEG...............RLLYKK..E...................................
BtFic|3CUC   ..KERPLTESFIRELNRTILV......QDYWKNAKTPDGQDIRMQIKVGEYKS..RP.NSVL.............................
SoFic|3EQX   ..SNRPLCVTTALEICSTIKS......VQ...................MDVRK..VPGTSLTNQA..........................
HpFic|2F6S   ..TIEVGTIKGLQEIHRFLFE......GLYEF...............AGKIRD..KN.IAK..............................
 2 Doc|3DD7     ...MRHISPEELIALHDANIS......RYGGL...............P.GMSD......................................
 3 AvrB|2NUD    SRGGITSFEELWGRATEWRLSKLQRGEPLYSA...............FASERTSDTD.AVTPLVKPYKSVLARVVDHEDAHDEIMQDNLFG
                                                                                           
                                                                   40         50           
 1 NmFic|2G03                                                                                  L           ...........................................................GG.....FRFAN.AMYLKEA VKIEQMP....
VopS_Fic|3LET                                                                                L           ............................................................G.....GTLPS.SIGGEGM KQHIEGFLK..
IbpA_Fic|3N3U                                                                                L           ............................................................NLTKENAVFSS.PEAAKIQ AETVDFINRAK
BtFic|3CUC                                                                                  M           .......................................................TATGEV.....FSYAS.PEETPAF TSLVDWYNLEA
SoFic|3EQX                                                                                  L           ......................................................TG..EVI.....YTPPAGESVIRDL SNWEAFLHN..
HpFic|2F6S                                                                                  L           ...........................................................GN.....FRFAN.CLYLDLI PRIESMP....
 2 Doc|3DD7     ........................................................................PGRAEAIIGRVQARV....
 3 AvrB|2NUD    DLNVKVYRQTAYLHGNVIPLNTFRVATDTEYLRDRVAHLRTELGAKALKQHLQRYN..PDR.....IDHTN.ASYLPIIKDHLNDLYRQAI
                                                                                           
       60        70        80        90       100                                           
 1 NmFic|2G03                          HPF EGNGR  R                                                        ......ERTFEEIIAKYVEMNIA   L     ST IWLDLVLKKNLKKV
VopS_Fic|3LET                        HGF DGNGR  R                                                        .EN..PVADKDLGKHLFAGVIGY   T     MG MLYAIAELRNDSFN
IbpA_Fic|3N3U                        HPF EGNGR  R                                                        NE...GIEPSVVGALVYQRLIAY   A     MA VIVNKILLDAGYPA
BtFic|3CUC                          HPF DGNGR  R                                                        DKG..ILTPVELAALLHYRYIRI   E     IA LLVNFVLHRYGYPM
SoFic|3EQX                          HPF DGNGR  R                                                        .QD..DVDPLIKMAMAHYQFEAI   I     TG VLNILYLIDQQLLS
HpFic|2F6S                          HPF EGNGR  R                                                        ......QNNFNQIVEKYVEMNIA   L     AT IWLDLLLKKELKKI
 2 Doc|3DD7     AY.EEITDLFEVSATYLVATARGHIFNDANKRTALNSALLFLRRNGVQV                                           
 3 AvrB|2NUD    SSDLSQAELISLIARTHWWAASAMPDQRGSAAKAEFAARAIASAHGIEL                                           
  
   
  
 
Figure 16: Structure-based multiple sequence alignment of the fido structures represented in Figures 
15 and 17. The sequences were aligned using Expresso91 and rendered using ESPript92. Fic-domain 
containing proteins, Doc and AvrB sequences are colored (magenta, blue, and orange, respectively) 
and labeled with PDB ID. The proteins were classified in 3 groups for similarity calculations using the 
BLOSUM62 Matrix93 (group 1: Fic proteins, group2: Doc, group3: AvrB). In red characters are 
displayed highly similar residues within a group and yellow boxes reflect high global similarity 
between the different groups. Only the sequence part corresponding to the conserved FIC core domain 
(α2-α5 and β-hairpin) is shown. Red triangles highlight the residues defining the Fic active site 
(HxFx[D/E]GNGRxxR). The highly conserved Fic motif is degenerated in Doc and quasi absent in 
AvrB. AvrB displays a large extension between β1 and β2 strands that contacts the RIN4 target. 
 
1.3.3 Fic is evolutionary related to Doc and AvrB 
 
As mentioned above, Fic proteins are grouped with Doc related proteins in the same 
superfamily. In the E. coli phage P1 the Doc protein and the small PhD protein form a toxin-
antitoxin module that serves as a postsegregational killing system (PSK) to insure stable 
inheritance of plasmid in the bacterial population. In the absence of the PhD antitoxin, Doc 
induces cell growth arrest by inhibition of translation via interaction with the ribosome94,95. 
The structure of Doc in complex with a C-terminal fragment of Phd (PDB code 3DD7) 
reveals the same overall α-helical topology (α2-α7) but with helices α1 and α’ missing (Fig. 
15). Interestingly, in the complex structure, Phd antitoxin is found at the place of the two 
missing α-helices, and was suggested to complete the Fic core through fold 
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complementation95. Comparison of Doc with the Fic proteins reveals a divergent active site 
motif (HxFxDANKRxxL) (Fig. 16). The histidine that has a catalytic role in the Fic proteins 
is also essential for Doc toxicity95, pointing towards a conserved catalytic site in both 
families. However, besides the fact that, no adenylylation activity has been associated with 
Doc, the presence of a degenerated active site motif might indicate that Doc family proteins 
have adopted new enzymatic function. Given the similar topology and functional active site 
location, Fic and Doc are likely to have a common origin and have developed distinct 
functional properties later during evolution. 
 
In addition to Doc, structural comparison of Fic proteins with existing structures in the 
PDB data bank reveals similarities with the T3SS effector protein avirulence protein B 
(AvrB) from Pseudomonas syringae. P. syringae is a gram-negative bacterial pathogen of 
plants that uses a T3SS to deliver proteins into host cell to hijack cellular functions. 
Functional studies in the model host plant Arabidopsis thaliana have revealed a defense 
response triggered by AvrB. Upon translocation of AvrB the plant cells organizes a defense 
mechanism that relies on the recognition of the pathogen factor by the plant resistance gene 
product RIN4 (RPM1 interacting protein). This detection further leads to RPM1 activation 
resulting in effector-triggered immunity (ETI)96,97. The delivery of AvrB induces 
phosphorylation of RIN4 at threonine 166 that is a prerequisite for the RPM1-mediated 
resistance97-100. The mechanism of AvrB-dependent phosphorylation of RIN4 is unclear but 
two structures of AvrB in complex with either a RIN4 peptide or ADP suggest a kinase 
activity for AvrB98.  Indeed, ADP, the end-product of the phosphorylation reaction, as well as 
the phosphorylated threonine of RIN4 are oriented towards the putative AvrB active site and 
face each other (Fig. 17A). 
However, no kinase activity for AvrB has been detected in vitro and the ADP moiety 
rather seems to be a substrate for the activation of AvrB via phosphorylation by the 
Arabidopsis kinases RIPK (RPM1-induced protein kinase) and MPK4 (mitogen activated 
protein kinase 4)98-100. Moreover, RIPK and MPK4 can directly phosphorylate RIN4 in an 
AvrB-dependent manner in-vivo arguing for an indirect phosphorylation process triggered by 
AvrB99,100. Thus, more structural and functional data are needed to elucidate the exact 
function of AvrB in the RIN4-dependent RPM1 activation. 
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Figure 17: Structural elements important for target recognition illustrated by AvrB and IbpA. a) 
Structure of AvrB in complex with ADP and a RIN4 peptide obtained after superposition of structures 
of AvrB/ADP (PDB code 2NUN) and AvrB/RIN4 peptide (PDB code 2NUD). The upper lobe 
involved in RIN4 recognition and RIN4 are displayed in grey and blue, respectively. b) Close-up view 
of the AvrB active-site. The sequence-independent main chain-main chain hydrogen bonds are marked 
by stippled lines in grey. Side-chains have been omitted for clarity reason. The RIN4 Threonine 166, 
which is phosphorylated upon P. syringae infection, intrudes in the AvrB active site and is located 
close to ADP, supporting a kinase activity for AvrB. c) Structure of IbpA in complex with Cdc42 
(PDB code 3N3V). Tyrosine 32 of Cdc42 is found adenylylated in the structure. The arm domain 
important for Cdc42 binding is shown in grey with Cdc42 in blue. d) Close-up view of IbpA active-
site. Like AvrB, sequence-independent anti-parallel β-strand interactions are formed between Fic and 
target to position the target tyrosine in the Fic active site for catalysis. Additionally, side-chains of the 
β-hairpin residues Leu3668 and Lys3670 form a clamp that locks the tyrosine side-chain in the correct 
orientation for modification. 
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1.3.4 Target recognition: similarities and specificities 
 
A closer inspection of the various Fic protein structures reveals a common β-hairpin 
element located between helices α2 and α3 (Fig. 15 and 17). In AvrB, this segment forms 
anti-parallel beta-strand hydrogen-bonding interactions with the RIN4 peptide and mutation 
of distinct β-hairpin residues impaired the ability of AvrB to promote immune response in 
plant98 (Fig. 17a). The importance of this element for target recruitment has been confirmed 
by the structure of IbpA-Fic2 in complex with its target protein Cdc42 where a similar β-β 
interaction unit is visible88 (Fig. 17b). Furthermore, the same type of contact is found in the 
crystal of the Shewanella oneidensis Fic protein (PDB code 3EQX) between two neighboring 
molecules90, though, this interaction is of artificial origin. Notably, this β-hairpin is present in 
all Fic structures solved so far, but absent in Doc (Fig. 15), which might further confirm that 
Doc harbors another enzymatic function. 
Target recognition via sequence-independent main chain-main chain hydrogen bonds 
implies the presence of additional structural elements to guide substrate specificity in Fic 
proteins. Consistently, the complex structure of IbpA-Fic2 with Cdc42 reveals a large 
interaction interface between the switch 2 region of the small GTPase and the so-called “arm 
domain” of IbpA88 (Fig. 17b). An equivalent peripheral region is found in VopS Fic protein 
that is likely to confer the same specificity towards the small Rho GTPases87,88. Similarly, in 
AvrB, the Fic core β-hairpin structure is extended into a five-stranded antiparallel beta sheet 
connected to three α-helices. This domain, referred to as upper lobe, provides a large surface 
for RIN4 binding98,101 (Fig. 17a). Apart from the Fic proteins of Shewanella oneidensis and 
Bacteriodes thetaiotaomicron that have large helical extensions at the N- and C-termini to 
possibly recognize targets, these additional satellite domains are not present in the remaining 
Fic proteins with known crystal structures. However, beside the four-helix bundle Fic core 
domain that, for catalytic reason, forms a rigid entity, the peripheral segments that regroup the 
helices α1, α6-α7 and α’ are found in diverse dispositions in the different Fic structures (Fig. 
15). These components, together with further loop extensions are probably relevant for target 
specificity. 
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1.3.5 Catalytic mechanism 
 
Considering its analogy with phosphorylation, two scenarios were proposed for the Fic-
mediated adenylylation in terms of mechanism, both relying on the central active site 
histidine87-89. The first is a ping-pong mechanism involving a high-energy adenylylated 
enzyme intermediate. In this scenario, the histidine is first modified before subsequent 
transfer of the AMP moiety onto the target protein. The second implies the formation of a 
ternary complex between the Fic protein and its two substrates. In this case, the histidine will 
serve as a general base to abstract a proton from the hydroxyl side chain of the target residue. 
The activated hydroxyl group can then performed a nucleophilic attack on the α-phosphate of 
ATP (Fig. 18). 
Support for a histidine modification, which would implicate a ping-pong process, arised 
from the observation that Fic proteins can be auto-adenylylated88,89. The biological meaning 
of this phenomenon is unclear and it remains to be elucidated whether it has any functional 
relevance during adenylylation. 
However, initial velocity experiments achieved on VopS strongly reject the ping-pong 
mechanism and argue for a ternary complex formation87. Additionally, steady-state kinetic 
experiments showed that mutation of the histidine does not entirely eliminate the 
adenylylation activity but significantly reduce it by nine orders of magnitude87. This residual 
activity of the point mutant was also confirmed by in vitro adenylylation assays19. Finally, 
Cdc42 was found adenylylated in the co-crystal obtained with the active site histidine to 
alanine mutant of IbpA-Fic288. 
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Figure 18: Mechanism of Fic-mediated adenylylation. A ternary complex is formed between Fic, ATP 
and the target protein (Tyr). The Fic histidine is ideally positioned to abstract a proton from the target 
hydroxyl group. The activated oxygen acts as a nucleophile, attacking the α-phosphorous of ATP and 
expelling pyrophosphate. 
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1.4 Bartonella: a suitable model for structure/function analysis of the FIC 
domain 
 
1.4.1 General introduction 
 
Bartonella species are gram-negative facultative intracellular pathogens that belong to 
the α2 subgroup of the proteobacteria and are closely related to the genera Brucella and 
Agrobacterium. Up to now, more than twenty species have been identified and ten have their 
genomes sequenced.  
Bartonella species appear to have a specific mammalian species as a host, with B. 
bacilliformis and B. quintana being adapted to human. B. bacilliformis is highly virulent in its 
human reservoir host where it causes Carrion’s disease which is characterized by severe 
hemolytic anemia during the acute phase of the infection102. Except for the acute infection 
phase of B. bacilliformis, bartonellae are typically considered as stealth pathogens in the sense 
that they circumvent host immune responses to establish long-term persistence. In most cases, 
infection of the reservoir hosts only results in mild symptoms103. 
The hallmark of such a reservoir host infection is a chronic intraerythrocytic 
bacteremia, which appears to be a specific adaptation to the mode of transmission by blood-
sucking arthropods. Blood-sucking arthropods vectors, such as fleas, body lice and ticks 
transmit the bacteria from its reservoir to new incidental hosts (e.g. from zoonotic pathogens 
to humans) where it usually causes only benign symptoms. However, upon infection of 
immunocompromised patients, Bartonella can lead to more severe symptoms including tumor 
angiogenesis or meningitis and is therefore considered as an opportunistic pathogen.  
 
1.4.2 Type IV secretion system and Bartonella evolution 
 
A phylogenetic analysis based on four housekeeping genes and core genes of the 
available Bartonellae genomes allowed the classification of the species into four different 
lineages104 (Fig. 19). This analysis placed B. bacilliformis as the sole representative of an 
ancestral lineage (lineage 1) from which most of the other species have evolved by radial 
speciation. The diversification of these species from a B. bacilliformis-like ancestor has likely 
arisen after horizontal acquisition of three different type IV secretion systems (T4SSs) that 
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facilitated adaptation to distinct mammalian reservoirs104,105 (Fig. 19). Species of lineage 2, 
which exclusively are adapted to ruminant hosts, only harbor the so-called VirB-homologous 
(Vbh) T4SS. In contrast, lineages 3 and 4 harbor the translocator VirB/D4 T4SS which 
presumably has been acquired via HGT in an common ancestor. the most species rich lineage, 
lineage 4, harbors a third T4SS, the Trw (Fig. 19) involved in the attachement to erythrocytes. 
The VirB-like (VirB or Vbh) T4SS is conserved in all Bartonella species of lineage 4 
and presumably enable the bacteria to fine-tune the interactions with their respective 
mammalian hosts via translocation of a cocktail of different effector proteins. The effector 
proteins can be translocated into endothelial cells where they subvert cellular functions - a 
process likely essential for establishing a chronic infection106. 
The Trw system, that is only present in a sub-branch of the modern lineage, does not 
translocate any substrates into host cells and functions as an adherence factor mediating the 
invasion of erythrocytes106. 
In the following paragraphs, I will focus on the VirB-like T4SS and the current 
knowledge about the roles of the effector proteins in host subversion. 
 
 
 
 
 
 
 
Introduction 
 
 38 
 
Figure 19: Phylogeny of Bartonella. The phylogenetic tree is based on a maximum-likelihood 
analysis using an alignment of 478 genes from the core genome of the ten sequenced Bartonella 
species (bold and underlined) and Brucella abortus. Additional Bartonella species have been added 
using the sequences of four housekeeping genes. The primary mammalian host as well as key 
virulence factors are indicated for each species. The deadly human pathogen B. bacilliformis forms a 
solely deep-branching ancestral lineage. All modern species harbor a type IV secretion system as a 
key innovation allowing the exploration of new niches. The Vbh and Trw T4SSs are characteristics of 
lineage 2 and 4 respectively. (Taken from Harms & Dehio107). 
 
 
1.4.3 Versatility of the type IV secretion system 
 
The bacterial T4SS is a multicomponent system, which protrudes the cell envelope and 
is used by many bacteria to secrete or translocate effectors into adjacent cells. It is the most 
versatile family of secretion systems, which serves for the delivery of macromolecules into 
various target cells, e.g., the transfer of DNA into bacteria or the transfer of effector proteins 
into eukaryotic target cells108.  
The exchange of genetic material through horizontal gene transfer plays an important 
role in genome plasticity and enables the bacteria to cope with environmental changes, as 
encountered during infection of the human host. It is also the basis for the spread of antibiotic 
resistance as well as virulence traits109,110.  
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Many bacterial pathogens such as Bordetella pertussis, Legionella pneumophila or 
Bartonella spp. rely on T4SSs for their pathogenicity. They utilize this secretion machinery to 
translocate protein substrates into targeted host cells, thereby modulating a wide range of host 
cell functions111-114.  
 
1.4.4 Typical type IV secretion architecure 
 
Although variations exist, many of the T4SS found in Gram-negative bacteria are 
similar to the well-characterized archetypical VirB/D4 system of A. tumefaciens, which 
comprises twelve proteins, named VirB1 to VirB11 and VirD4. A combination of functional 
and structural analysis on various T4S systems has helped to elucidate the overall architecture 
and details of the secretion mechanism. 14 copies of each VirB7, VirB9 and VirB10 proteins 
form a tight core complex anchored in the two membranes of the Gram-negative bacteria 
(Fig. 20). This core structure creates a channel that spans the entire bacterial cell envelope 
with a 55Å opening at the base of the core complex and a small 10Å opening to the 
extracellular milieu115. This narrow outer membrane pore suggests that large structural 
movements have to take place to allow substrate transfer. Unexpectedly, VirB10 inserts in 
both bacterial membranes and serves as a structural scaffold that bridges inner and outer 
membrane leaflets115-117. Thus, VirB10 may sense conformational changes upon substrate 
binding in the cytosol and propagate the signal to regulate outer membrane channel opening 
and closing. The VirB6 and VirB8 are integral membrane subunits that directly contact the 
substrate during secretion in A. tumefaciens and are likely to form, together with VirB10, the 
inner membrane channel118. VirB4, VirB11 and VirD4 harbor ATPase activity that energize 
substrate secretion and possibly assist the assembly of the machinery119-121. VirD4, also 
named coupling protein (CP), recruits substrates and guide them to specific subunit of the 
channel for secretion108. The extracellular pilus is built up by VirB2 and VirB5 subunits 
where VirB2 is the major component that is thought to form a channel between the donor and 
host cells for substrate transfer and VirB5 might function as an adhesin122,123. 
The roles of VirB1 and VirB3 in this complex are still unclear. But VirB1 seems to be 
essential for T-pilus biogenesis in A. tumefaciens and VirB3 is believed to function 
synergistically with VirB4124,125. 
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Figure 20: Schematic model and structure of the VirB/D4 type IV secretion system. (a) The 
experimentally predicted (i.e. copurification, immunoprecipitation) locations of the VirB/D4 subunits. 
(b) Structures of the T4SS components solved to date. The atomic structures are shown in ribbon. The 
cryo-electron microscopy picture of the T4SS core complex comprising VirB7-9-10 subunits is 
displayed as a cut-out volume (in grey). The crystal structure of the outer membrane complex is 
composed of the full-length VirB7 (green), the C-terminal domain of VirB9 (yellow), and the C-
terminal domain of VirB10 (red). (Taken from Waksman & Fronzes126). 
 
 
 
1.4.5 Bartonella-specific VirB/D4 type IV secretion systems and associated effectors 
 
The horizontal acquisition of the VirB type IV secretion system (T4SS) was shown to 
play a central role for the host adaptation of Bartonella species104. This machinery is present 
in lineages 3 and 4 and is dedicated to the translocation of an arsenal of effector proteins to 
manipulate host cell signaling pathways during infection111,112,127. Bartonella effector proteins 
(Beps) display a modular architecture consisting of a variable N-terminal moiety and a 
conserved translocation signal at the C-terminus that is formed by the BID (Bep intracelluar 
delivery) domain and a positively charged C-tail. Both components constitute a bipartite 
signal recognized by the VirD4 coupling protein for efficient VirB-dependent protein 
transfer112. The N-terminal domain is highly diverse among Beps. It can be composed of, 
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additional BID domains that have acquired functions within the host, tandem-repeated 
tyrosine-phosphorylation motifs, or FIC domains. 
A phylogenetic analysis inferred from the different sequences of the bep genes allowed 
classification of orthologous Beps from lineage 3 and lineage 4 in different clusters (clades 1 
to 10 for lineage 3 and clades A to I for lineage 4) (Fig. 21). These clades evolved 
independently by duplications, diversification and reshuffling from a single ancestral Bep 
with a FIC-BID domain topology105. 
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Figure 21: Domain architecture of Bartonella effector proteins. Domain architecture for (a) lineage 3 
and (b) lineage 4. FIC and BID domains are displayed in orange and violet, respectively. The FIC 
motif (HxFx[D/E]GNGRxxR) is depicted. Motifs differing from the consensus sequence are indicated 
with the conserved and divergent residues in red and black, respectively. The far majority of FIC 
domains harbor degenerated FIC active site motifs, suggesting diverse functionalities. (Adapted from 
Engel et al.105). 
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Among the various Bartonella spp., B. henselae is the best characterized member and 
the role of the VirB/D4 T4SS and the translocated effectors in B. henselae pathogenesis has 
been highly investigated in our laboratory. B. henselae causes an asymptomatic bacteremia in 
its feline reservoir host and can be incidentally transmitted to human by a bite / scratch of a 
cat or by indirect bite of cat fleas leading to Cat scratch Disease (CSD). In immunocompetent 
patients, the disease manifests by a benign lymphadenopathy in the proximal region of the 
bite / scratch and resolves spontaneously within 2-4 months128. In contrast, infection of 
immunocompromised patients leads to angioproliferative disorders such as bacillary 
angiomatosis or bacillary peliosis hepatitis that is characterized by vasoproliferative tumors 
through direct or indirect effects on endothelial cells129,130. 
Detailed in vitro studies using Primary Human Umbilical Vein Endothelial Cells 
(HUVEC) as an in vitro infection model131,132 demonstrate that the VirB/D4 T4SS is an 
essential virulence determinant for vascular endothelial cell subversion126,127. B. henselae 
harbors a set of seven effectors, named BepA to BepG, which are encoded together with the 
VirB/D4 genes in a pathogenicity island (PAI)112. While BepA, B and C adopt the original 
FIC-BID domain architecture, the others display additional N-terminal BID domain (BepG), 
tyrosine-phosphorylation motifs (BepD) or a composite of both (BepE and BepF) (Fig. 21b). 
A wide array of VirB/D4 effector-dependent phenotypes have been found such as, 
massive cytoskeletal rearrangements133-135, inhibition of cell apoptosis111,136 and induction of 
proinflammatory phenotype by activation of NF-κB111. The peculiar role of the effectors in 
these processes has been scrutinized. BepA is targeted to the endothelial cell plasma 
membrane where it inhibits apoptosis via a rise in the cytosolic concentration of the second 
messenger cAMP136. Furthermore, it promotes sprout formation in an in vitro angiogenesis 
assay137. Interestingly, the BID domain is sufficient to trigger these cellular phenotypes 
additional to its secretion signal function. No phenotypes have so far been associated with 
BepB and BepE. The combined action of BepC and BepF can mediate F-actin-dependent 
bacterial uptake through invasome formation, similarly to BepG133-135. BepD possesses a 
weak pro-angiogenic activity and becomes phosphorylated after translocation into host 
cells137,138, but the cellular effects of tyrosine-phosphorylation sites remain to be defined. 
Remarkably, almost all phenotypes elicited by B. henselae effector proteins are solely 
dependent on the BID domains and no contribution of any FIC modules has been 
conclusively demonstrated in vivo and in vitro. 
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1.4.6 The Vbh T4SS: evolutionary link between conjugation machinery and host-
interacting T4SS 
 
The VirB homologous (Vbh) T4SS is characteristic of lineage 2 that strictly comprises 
ruminant-infecting species (Fig. 19). Comparative analyses with the VirB T4SS revealed that 
homologous genes of all VirB T4SS subunits are conserved in this ruminant-adapted species 
including the coupling protein-encoding gene. However, a remarkable divergence in gene 
content of the downstream located effector region is evident. Indeed, the vbh locus displays 
all genetic features (origin of transfer (oriT), and traC and traD involved in the processing of 
the oriT during conjugation) that make Vbh T4SS a functional conjugation system. It only 
contains one single bep gene, named vbhT, with the FIC-BID domain architecture as found 
for many effector proteins of the VirB T4SS (Fig. 21). Thus, Vbh T4SS appears to display an 
evolutionary link between conjugation machineries and T4SSs adopted for host interaction139. 
 
 
1.4.7 Bartonella: a tremendous playground to explore FIC domain structure/function 
 
Twelve out of the seventeen Bep clades of the Bartonella lineages 3 and 4 contain FIC 
domains. In total, they represent 55 proteins that harbor FIC domains with disparate active 
site motifs (Fig. 21). Owing to the omnipresence of FIC, Bartonella is an ideal model not only 
to examine the biological importance of FIC-mediated adenylylation during bacterial 
pathogenesis but also to explore new functions adopted by FIC domain with degenerated 
active site motif during evolution. 
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The FIC domain is widely spread in all kingdoms of life and regulates fundamental 
pathways in bacteria to higher organisms by adenylylation of target proteins. Only recently, 
the domain was functionally characterized, yet little is known about the catalytic mechanism. 
A major breakthrough to understanding FIC-mediated AMP transfer arose from the crystal 
structure of IbpA-Fic2 in complex with the adenylylated form of the small Rho-GTPase 
Cdc4288. This snapshot of a Fic protein with an end product of the enzymatic reaction 
provided structural insight into the determinant of target recognition. However, to decipher 
the FIC-catalyzed adenylylation in its entirety, details of ATP binding mode in the FIC active 
site is indispensible. 
Apart from catalysis, the regulation of Fic-mediated adenylylation is the second 
prominent question of biological relevance that needs to be addressed. The function of the Fic 
domains have been discovered in the context of bacterial effector proteins that hijack cellular 
processes of the host upon infection. However, the vast majority of Fic proteins found in the 
genomes of various prokaryotes do not have any apparent link to host interaction and the 
potentially lethal activity carried by these proteins should be tightly regulated. 
During my PhD, I tried to unravel the structural elements and mechanisms governing 
catalysis and regulation of the Fic AMP transferase family. To this end I applied X-ray 
crystallography and biochemical techniques and, focussed mainly on FIC domains from 
Bartonella species with occasionally taking resort to Fic proteins from Shewanella oneidensis 
and Neisseria meningitidis.  
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3.1 Research article I 
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Abstract: Numerous bacterial pathogens subvert cellular functions of eukaryotic host cells by the
injection of effector proteins via dedicated secretion systems. The type IV secretion system (T4SS)
effector protein BepA from Bartonella henselae is composed of an N-terminal Fic domain and a
C-terminal Bartonella intracellular delivery domain, the latter being responsible for T4SS-mediated
translocation into host cells. A proteolysis resistant fragment (residues 10–302) that includes the
Fic domain shows autoadenylylation activity and adenylyl transfer onto Hela cell extract proteins
as demonstrated by autoradiography on incubation with a-[32P]-ATP. Its crystal structure,
determined to 2.9-A˚ resolution by the SeMet-SAD method, exhibits the canonical Fic fold including
the HPFxxGNGRxxR signature motif with several elaborations in loop regions and an additional
b-rich domain at the C-terminus. On crystal soaking with ATP/Mg21, additional electron density
indicated the presence of a PPi/Mg
21 moiety, the side product of the adenylylation reaction, in the
anion binding nest of the signature motif. On the basis of this information and that of the recent
structure of IbpA(Fic2) in complex with the eukaryotic target protein Cdc42, we present a detailed
model for the ternary complex of Fic with the two substrates, ATP/Mg21 and target tyrosine. The
model is consistent with an in-line nucleophilic attack of the deprotonated side-chain hydroxyl
group onto the a-phosphorus of the nucleotide to accomplish AMP transfer. Furthermore, a
general, sequence-independent mechanism of target positioning through antiparallel b-strand
interactions between enzyme and target is suggested.
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Introduction
Adenylylation, that is, AMP-transfer from an ATP
substrate onto a target molecule, is a common pro-
cess in biology. This enzymatic reaction occurs
during nucleotide polymerization and on priming
carboxylate substrates for further chemical modifi-
cation as, for example, catalyzed by acyl-CoA syn-
thetase.1 However, proteins also can become post-
translationally modified by attaching the AMP
moiety onto various types of side-chains. In this
way, a lysyl side-chain is transiently adenylylated
in polynucleotide ligase, followed by adenylyl trans-
fer onto the substrate.2 Glutamine synthetase
adenylyl transferase controls the activity of an im-
portant metabolic enzyme by tyrosyl modification.3
A related protein from the pathogen Legionella,
DrrA, adenylylates the membrane traffic regulator
Rab1b on translocation into eukaryotic host cells.4
Only recently, the Fic (filamentation induced by
cAMP) domain (Pfam 24.05) found in almost all
kingdoms of life and annotated in currently more
than 2000 sequences has been recognized to cata-
lyze adenylyl transfer onto specific protein hydroxyl
side-chains of interacting target proteins. This has
been demonstrated for two bacterial effector pro-
teins carrying a Fic domain, VopS of Vibrio para-
haemolyticus, and IbpA of Histophilus somni, which
on translocation into mammalian host cells inacti-
vate small GTPases of the Rho-family by adenylyla-
tion of conserved threonine or tyrosine residues,
respectively, resulting in a collapse of the cellular
actin cytoskeleton.6,7
Fic-domain containing effector proteins are also
encoded by Bartonella henselae.8 This pathogen
translocates via a dedicated protein secretion sys-
tem, the type IV secretion system VirB, seven effec-
tor proteins known as BepA-BepG into human endo-
thelial cells.9 The resulting cellular changes include
rearrangements of the actin cytoskeleton, the inhibi-
tion of programmed cell death (apoptosis), the acti-
vation of a proangiogenic process, and the initiation
of an inflammatory response.10 All seven Beps show
one or several Bartonella intracellular delivery
(BID) domains in the C-terminal part that are re-
sponsible for protein delivery into host cells,9
whereas the N-terminal part of the homologous
BepA, BepB, and BepC proteins comprise a Fic do-
main (see also Fig. 1, top). The BID domain of BepA
mediates inhibition of apoptosis,11 whereas the pre-
cise function of the N-terminal Fic domain is yet
unknown. Here, we present the crystal structure of
the BepA Fic domain in complex with pyrophos-
phate, the side product of the adenylylation reaction.
Combined with other published structural informa-
tion,12 the structure of a generic ternary substrate
complex is inferred and a detailed catalytic mecha-
nism of the adenylyl transfer onto the target
hydroxyl group is proposed.
Results and Discussion
Crystal structure of a BepA fragment
comprising the Fic domain
An N-terminal His6-tagged construct of full-length
BepA (64 kDa) was expressed in E. coli and was
found to be proteolytically truncated at the C-termi-
nus to yield a fragment (BepAtr) with a mass of
about 40 kDa as evidenced by size-exclusion chroma-
tography and anti-His Western blot. Removal of the
His-tag, which proved essential for crystallization,
was achieved by proteolytic treatment with throm-
bin. The two molecules of the asymmetric unit form
a weak, probably nonphysiological, symmetric dimer
(Supporting Information Fig. S1). Figure 1 shows
the overall structure of BepAtr with residues 12–302
well defined by electron density except for residues
106–111 of a loop close to the signature motif (flap)
and a few side-chains. The structure can be grouped
in an N-terminal, predominantly a-helical part (12–
245), and the remaining C-terminal end exhibiting
the OB (oligonucleotide/oligosaccharide binding)-fold
(Supporting Information Fig. S2). Residues 62–177
[helices a2–a5, see also Fig. 2(A)] are classified as
Fic domain in the Pfam database.5 There is a small
Figure 1. Crystal structure of BepAtr (residues 12–302) and
scheme of the BepA sequence (top). The following color
code is used throughout: red, core of Fic domain as
defined by Pfam5; blue, peptide segment (103–105) in
extended conformation that has been shown to interact
with target protein/peptide in structural homologs IbpA,12
AvrB,19 and SO246613; light-grey, part of the flap that is not
resolved by electron density (106–111, light-grey); yellow,
HPFxxGNG signature motif; gold, OB-fold (see also
Supporting Information Fig. S2); magenta, remainder of
structure. Secondary structure elements are numbered
sequentially, a, a-helices, g, 310-helices, and b, b-strands.
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b-sheet (b1/b2) inserted into the a2–a3 loop that is
not part of the Fic profile. The Fic core structure is
flanked N-terminally by a1 and irregular loop struc-
ture. C-terminally it is followed by a three helix
bundle (a6–a8) and b3 that is an extension of the
b-sheet of the OB-fold domain.
Figure 2(A) shows that the H159PFxxGNG sig-
nature motif of the Fic profile locates to the a4–a5
loop and the following N-cap of helix a5. A chloride
ion is bound to the N-cap in both chains of the asym-
metric unit. The N165 side-chain forms two H-bonds
with the backbone amide and carbonyl group of the
phenylalanine residue [F161, see also Fig. 3(A)] and
may thus be critical for defining the exact geometry
of the loop. The phenylalanine side-chain is tucked
away in the hydrophobic core of the domain.
Structural comparisons
Several structures of Fic proteins have been deter-
mined by structural genomics initiatives (PDB codes:
2f6s, 2g03, 3cuc, and 3eqx13). BepAtr exhibit close
structural resemblance with these proteins (Z-scores
11–13 as determined by Dali,14 see also Supporting
Information Figs. S3 and S4) showing the same
arrangement for helices a1 to a7. Helix a8 is packed
peripherally, together with b3, onto a6 and a7 and
connects to the OB-domain (Fig. 1). In the Fic proteins
and in BepA, an extended HPFxxGNGRxxR motif is
strictly obeyed (Supporting Information Fig. S4a).
More distant structural homologs are the type III
effectors AvrB and VopS, and the Doc toxin (Support-
ing Information Figs. S3 and S4) that give moderate
Z-scores of 8, 5, and 6, respectively. Interestingly, in
BepAtr as in Doc toxin, a helix, that runs antiparallely
to a5 and a1 is missing. This leaves a groove in the
structure that is taken up by the Phd antitoxin in the
Doc/Phd complex.15 Notably, there is no overall signif-
icant sequence similarity of AvrB and Doc with BepA
and the sequences of the signature loop are degener-
ated (Supporting Information Fig. S4). Still these seg-
ments show the canonical conformation (Supporting
Information Fig. S3). A thorough structural compari-
son of all these structural homologs of BepA has
appeared recently.16 The recently reported structure
of the Fic2 domain of IbpA12 [Fig. 2(B)] also exhibits
significant (Z ¼ 8) similarity with BepA and the other
Fic proteins (Supporting Information Fig. S4B).
BepAtr/PPi/Mg
21 product complex
At the time the BepAtr structure was solved, there
was no clue about the molecular function of Fic
domains. However, the N-cap of a5 (residues 165–167)
together with the preceding residue G164 appeared
well suited for polyanion binding. In fact, the three
backbone amide nitrogens of residues G164, N165, and
G166 form a well-defined so-called anion binding
‘‘nest’’ of type LR17 as noted before for the Doc pro-
tein.15 Therefore, BepAtr crystals were used to test
for nucleotide binding. On soaking of crystals with
ATP/Mg2þ, additional electron density was found
near the anion binding nest of the signature motif
[Fig. 3(A)]. The density was modeled satisfactorily
with a PPi/Mg
2þ. Crystallographic statistics are given
in Tables I and II. Although one of the phosphates
occupies the 164–166 nest, the other interacts with
backbone amide 167. Both phosphate moieties and
Figure 2. Structural comparison of (A) BepAtr (PDB code: 2vy3) with a chloride ion bound to the N-cap of helix a5 and (B)
IbpA(Fic2, H3717A) in complex with Cdc42 (green) that has its modified AMP-Y32 residue bound to the Fic active site (PDB
code: 3n3v12). Same color code as in Figure 1, view rotated by 90 about the vertical direction. Important residues are
labeled. The OB-domain of BepAtr has been removed for clarity.
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the carboxylic side-chain of E163 coordinate the diva-
lent cation. The site is probably not fully occupied as
indicated by elevated B-factors of the ligand.
Only when it was reported that the Fic domain of
VopS exhibits adenylylation activity,6 it became clear
that the observed moiety may represent the side-
product of this reaction. In absence of a protein target,
ATP may either have been hydrolyzed between the a-
and b-phosphate or the AMP moiety may have been
transferred to H159 with subsequent partial hydroly-
sis. Indeed, additional density at the imidazole side-
chain [Fig. 3(A)] seems to corroborate later scenario.
For further studies and to avoid the problems
associated with the uncontrolled processing of BepA
that hampered crystal reproduction, a tailored C-
terminally His-tagged construct comprising residues
10–303 of BepA (BepA10-303) was expressed and crys-
tallized (Supporting Information Tables S1 and S2).
Unfortunately, on soaking of various ATP analogs, no
additional density was found. The high salt concen-
tration of the crystallization condition (0.5M NaCl
and 1.5M (NH4)2SO4) probably hindered nucleotide
binding. Instead, as in the native BepAtr crystals, pu-
tative sulphate ions were found within the anion nest
164–166 and the following residue 167 [Fig. 3(A)].
BepA-catalyzed adenylylation
On incubation with a-[32P]-ATP radioactivity was
transferred onto the BepA10-303 fragment [Fig. 4(A)].
This autoadenylylation was dependent on the pres-
ence of the histidine of the signature motif as evi-
denced by the negative result obtained with the
H159A point mutant, which was properly folded as
demonstrated by its crystal structure (not shown).
Autoadenylation also occurred with the shortened
fragment BepA10-218 [Fig. 4(B)] that was designed to
probe the activity of the Fic domain without helix a8
and the following OB-fold. Thus, the activity resides
within the canonical Fic fold. Furthermore, the ac-
tivity was not base-specific. The guanyl- and cytosyl-
nucleotides were incorporated with virtually equal
efficiency as ATP [Fig. 4(B)]. In the presence of
Figure 3. Structural details of BepA. (A) Signature loop
(yellow) with bound PPi/Mg
2þ and corresponding Fo–Fc
map (with H159 side-chain and PPi/Mg
2þ omitted for
phasing) contoured at 3.5r. The structure was obtained by
soaking a BepAtr crystal overnight in 10 mM ATP and 5 mM
MgCl2. Also shown, in the background, are the two sulfate
anions of the BepA10-303 structure (D-chain) bound to two
mutually exclusive positions at the N-cap of helix a5, after
superposition of the two protein structures. Note the
nonmodeled elongation of the electron density of the H159
side-chain (see main text). (B) Putative target docking site
of BepA10-303, view from the top of Figure 1 with helix a6
running horizontally at the bottom of this figure. Full atom
representation with fold cartoon superimposed. The
main-chain atoms of the ‘‘target dock’’ in extended
conformation [blue in Figs. 1 and 2(A)] of the flap (b2–a4
loop) are shown in ball-and-stick representation. Note, that
main-chain amide and carbonyl groups 103 and 105 are
fully exposed. The large pocket next to the ‘‘target dock’’ in
the middle of the figure accommodates the modified
AMP-Tyr side-chain in IbpA(Fic 2), see Figure 2(B). Also
shown are the sulfate anions, as in panel (B).
Table I. Crystallographic Data
BepAtr
a
BepA10–303
bSeMet ATP/Mgþþ
Wavelength (A˚) 0.97935 0.90000 1.0001
Resolution (A˚) 2.9 3.0 3.20
Outer resolution
shell (A˚)
3.06–2.90 3.16–3.00 3.37–3.20
Space group P212121 P212121 H32
a (A˚) 73.3 72.9 230
b (A˚) 84.4 82.9 230
c (A˚) 126.7 126.7 309
Rmerge(%) 10.3 (26.1) 9.8 (33.2) 9.3 (42.1)
Redundancy 5.6 (2.7) 3.4 (3.1) 2.8 (2.6)
I/ 12.8 (1.9) 6.3 (2.3) 7.3 (2.3)
Completeness (%) 92 (68) 94 (92) 96 (94)
Anomalous
completeness (%)
92 (52) – –
Data in brackets refer to the outer resolution shell.
a Full-length BepA GSHMLEM1–S544 proteolytically trun-
cated at C-terminal end during expression/purification.
b Designed BepA fragment MN10–A303HHHHHH.
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HeLa cell extract, adenylyl transfer onto target pro-
teins was evident through the appearance of two
additional bands corresponding to sizes of about 40
and 50 kDa on the autoradiograph [Fig. 4(A)].
Because of the different apparent molecular weight
from Rho-family GTPases representing the only
known protein substrates of Fic domain-containing
proteins6,7 these proteins likely represent novel Fic
domain substrates. Their identification is underway,
but beyond the scope of this study.
Model of ternary substrate complex and
enzymatic mechanism
Based on the two known binary Fic domain/product
complex structures, that is, IbpA(Fic2)/AMP-Y32 and
BepAtr/PPi/Mg
2þ [Figs. 2(B) and 3(A), see also Sup-
porting Information Fig. S5], it was possible to
derive a generic model for the Fic/ATP/Mg2þ sub-
strate complex (Fig. 5). For this, we reasoned that
the observed PPi moiety [Fig. 3(A)] most likely maps
the b- and a-phosphate subsites of the ATP substrate
and not the (original) c- and b-sites. The assumption
appears reasonable considering that the nest (a-
phosphate binding subsite) represents a high-affinity
site, which becomes available for PPi binding on dis-
sociation of the adenylyl moiety. Indeed, after super-
position of the protein scaffolds, the PPi phosphate
in the nest and the AMP a-phosphate have a dis-
tance of only 1.3 A˚ (cf. Supporting Information Figs.
S5b and S5c). Thus, for model building, the PPi had
to be simply linked to the adenosine moiety of AMP-
Tyr and, on the other end, extended by an additional
phosphate to yield the triphosphate moiety. Further-
more, the Mg2þ cation was repositioned such that it
became coordinated by the c- and a-phosphates and
the E163 carboxylate. Finally, the conformation of
the R167 side-chain was altered to stabilize the c-
phosphate. Figure 5 shows the resulting model of
the ternary complex.
Both conserved arginines, R167 and R170, are
predicted to be important for ATP substrate binding.
However, in five of the seven known Fic structures
(not counting the distantly related AvrB and Doc)
Figure 4. Autoadenylylation of BepA fragments and AMP
transfer onto HeLa cell extract. BepA variants were
incubated with a mixture of hot (a-[32P]) and cold
nucleosyl-tri-phosphate. (A) BepA10-303 (wild-type and
mutant H159A) incubated with 20-lM ATP , a-[32P]-ATP (10
lCi) in the presence or absence of 150 lg of S100 HeLa
cell lysate. The control (ctrl) was performed in the absence
of BepA. (B) BepA10-218 incubated with 20-lM
nucleosyl-tri-phosphate and a-[32P]-nucleosyl-tri-phosphate
(5 lCi); lane 1: ATP, lane 2: GTP, lane 3: CTP.
Table 2. Model refinement
BepAtr
a
BepA10–303
bSeMet ATP soak
Resolution (A˚) 30.0–2.90 30.0–3.00 30–3.2
No. of unique
reflections
16,307 14,807 46,664
R / Rfree
c (%) 21.3/27.4 21.1/27.2 23.9/27.7
Average B (A˚2) 63 66 81
r.m.s. deviation
from ideal
values
Bond lengthsd (A˚) 0.011 0.012 0.009
Bond anglesd () 1.1 1.3 1.2
r.m.s.d. NCS
related
Ca-positions (A˚)
0.4e 0.4e 0.05–0.2f
Molecules in
asymmetric unit
2 2 8
Protein atoms 4449 4458 17898
Pyrophosphate
atoms
- 9 -
Water molecules 7 7 -
Ion atoms 6 6 90
Residues in
Ramachandran
core (%)
98 % 97 % 96 %
Residues in
disallowed
region (%)
0.4 % 0.5 % 0.9 %
PDB ID 2vy3 2jk8 2vza
b See Table 1.
c Rfree calculated with 5 % of the data that were not used
for refinement.
d r.m.s.d. from ideal stereochemistry.
e For residues 12–101 and 117–302 after separate
superposition.
f r.m.s.d. values for residues 11–101, 117–223, and 239–306
of chain A after individual superpositions on chains B to H,
respectively.
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the arginines are engaged in salt-bridges to carbox-
ylic side-chains of peripheral a-helices. It is tempting
to speculate that on target binding, conformational
changes are induced in the Fic domain that cause
disruption of these salt-bridges. Such a mechanism
would disfavor ATP binding and, thus, futile hydro-
lysis in the absence of a target. Further kinetic stud-
ies are needed to scrutinize this notion. For BepA,
the nucleotide base is predicted to bind to a pocket
that is structurally equivalent to that of IbpA [Fig.
2(B)]. We were not able to identify hydrophilic resi-
dues that would confer base specificity. Indeed the
promiscuity observed in the functional assay [Fig.
4(B)] may indicate that there are no H-bonds formed
between nucleotide base and enzyme.
The accumulated structural information allows
to propose a detailed mechanism for the adenylyla-
tion reaction catalyzed by Fic domains. Thereby, as
proposed before,12,16 the histidine of the motif would
act as a general base for deprotonation of the tyro-
sine hydroxyl group. In the model, the hydroxyl
group of the tyrosine is in-line with the scissile Pa–
O3a phosphoester bond and has distance of 2.8 A˚
from the phosphorus atom. Nucleophilic attack will
generate the penta-coordinated transition state that
is probably stabilized by the divalent cation. This
would be followed by phosphoester bond cleavage to
yield AMP-tyrosine and pyrophosphate, whereby the
PPi leaving group would again be stabilized by the
divalent cation. Nucleotide polymerases, DNA
ligases,2 and carboxylate:adenylyl transferases1,18
operate by the same general mechanism.
Although this mechanism should be representa-
tive for most Fic proteins with adenylyl transfer ac-
tivity, the situation is different in AvrB that seems
to be a kinase.19 Although the modifiable hydroxyl
side-chain of the RIN4 is in a similar position as in
IbpA(Fic2)/Cdc42, the ADP nucleotide shows a bind-
ing mode different to that of ATP in our model.
Although the polyphosphate is still bound to the
anion binding nest, the direction of the polyphos-
phate is essentially reversed. As the Thr166 side-
chain of RIN4 is in a similar position than Y32 of
Cdc42, this implies that the c-phosphate of an ATP
substrate could be transferred onto Thr166 (after
deprotonation by H217,
19 a residue not homologous
to the usual signature histidine, which is absent in
AvrB). Thus, two different but related activities
have evolved based on the Fic fold.
In absence of a target, autoadenylylation of the
Fic domain has been reported for VopS and a eu-
karyotic Fic domain,16 which is also observed for
BepA10-303 and BepA10-218 (Fig. 4). It is well conceiv-
able that hereby, in a side-reaction, the AMP moiety
is transferred onto the active histidine. The orienta-
tion of the imidazole side-chain appears suitable for
an in-line attack of the Ne2 onto the Pa, but the dis-
tance is comparatively large (>4.3 A˚) suggesting
that this would represent an inefficient side-reac-
tion. Autoadenylylation could be the first step in a
ping-pong mechanism for AMP transfer onto a tar-
get. However, consistent with our model, this has
been convincingly disproven for VopS by analysis of
the enzyme kinetics.20
Target recognition
Fic domain proteins exhibit a rather small conserved
core structure. The helical a4/a5 hairpin and the
intervening loop seem to be tailored for ATP/Mg2þ
binding and catalysis of AMP transfer as discussed
above. Helices a2 and a3 of the core pack against
the a4/a5 hairpin by predominantly hydrophobic
interactions with the phenylalanine of the motif
(F161) being part of the hydrophobic core. Although
helix a1 and helices a6 to a8 are present in most Fic
protein structures, they show considerable variation
in location and orientation. Moreover, relative exten-
sions/deletions at the termini or of loop structure are
common and it is self-evident that these may partici-
pate in target recognition and binding as exemplified
by the IbpA(Fic2)/Cdc42 complex structure.12 Fur-
thermore, as speculated in Ref. 12, the variability of
these peripheral structural elements suggests that
Fic structures have evolved to recognize (or rather
hijack) distinct targets.
Figure 5. Model of the ternary complex of BepA(Fic) with
ATP/Mg2þ and the modifiable tyrosine side-chain (light-
green) of the target protein. The model was obtained by
combining structural information of the BepAtr/PPi/Mg
2þ
(2jk8) and the IbpA(Fig2)/cdc42 (3n3v) complexes, see also
Supporting Information Figure S5. The structures of the two
Fic domains were superimposed, the pyrophosphate moiety
of the BepAtr complex extended to a triphosphate and the
cation positioned in a-, c-phosphate bridging location
(guided by the structure of ATP in a myosin kinase
complex, PDB code: 3lmi). Subsequently, the adenosine
moiety of the adenylylated Y32 of the IbpA complex was
linked to the a-phosphate and the energy of the structure
minimized with program REFMAC27.
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Nevertheless, closer inspection of the accumu-
lated structural information about Fic proteins (Sup-
porting Information Fig. S3) reveals a common fea-
ture that may be pertinent for target positioning. All
known structures (except for Doc) reveal a b-hairpin
or loop structure [‘‘flap’’ in Figs. 1 and 2(A)] preced-
ing helix a3. It is found in various orientations (Sup-
porting Information Fig. S3; in BepAtr it is partly
disordered), but may, on substrate (ATP and/or pro-
tein target) binding, close down onto the active site
as commonly observed for kinases to prevent futile
ATP hydrolysis. The N-terminal part of the flap may
be involved, however, in another important function.
This segment, which shows extended backbone con-
formation in all Fic structures [Supporting Informa-
tion Fig. S3, see also Fig. 3(C)], has been observed
in two cases to form intermolecular antiparallel b-
strand interactions with a cognate eukaryotic target
protein (IbpA(Fic2)/Cdc4212 and AvrB/RIN4-peptide
complexes19). Furthermore, in SO2466, this segment
form an artifactual interaction of the same kind
with a neighboring molecule in the crystal.13 While
this ‘‘target dock’’ appears well suited to recognize,
in a sequence independent manner, target segments
in extended conformation, its main role may be to
contribute to the precise positioning of the modifi-
able target residue in the active site of the Fic do-
main. In fact, residues Y32 of Cdc42 and T166 of
RIN4 are directly preceding the target dock
(residues 33–35 and 167–169, respectively). Such
coupling of sequence independent b-strand recogni-
tion and productive binding of the susceptible part
of the target has also been observed in serine
proteinases.21
Materials and Methods
Protein expression and crystallization
Full-length BepA with an N-terminal His6-tag and a
thrombin cleavage site was overexpressed in E. coli
strain BL21 (DE3). Purification was performed on a
Ni-NTA column (Qiagen AG, Switzerland). The His6-
tag was cleaved using bovine thrombin (Amersham)
at 4C for 6 h. Uncleaved material was removed by
using a second Ni-NTA column. Subsequently, ben-
zamidine sepharose beads (GE Healthcare) were
used to remove thrombin from the sample. Pooled
fractions were dialyzed against 20 mM TrisHCl (pH
8.0), 500 mM NaCl, and 2 mM b-mercaptoethanol
(buffer A) at 4C, concentrated and loaded onto a
Superdex 75 HR 26/60 (GE Healthcare) column. The
protein that turned out to be proteolytically cleaved
at the C-terminal end was designated BepAtr. The
elution volume indicated monomeric protein. Seleno-
methionine-substituted BepA was expressed using
the metabolic inhibition pathway22 and purified the
same way as native BepA. Crystals of wild-type and
Se-Met protein were obtained by mixing 1-lL
protein (17 mg/mL) in buffer A with 1.5-lL 22%
polyethylene glycol 4000, 0.1M tris pH 8.7, 5 mM
NiCl2 reservoir solution.
A BepA construct comprising residues 10–303
and a C-terminal His6 tag (BepA10-303) was
expressed and crystallized by mixing 1-lL protein
(27 mg/mL, in 20 mM Tris pH 8.0, 0.5M NaCl, and 2
mM b-mercaptoethanol) with 1 lL of 1.5M
(NH4)2SO4, 0.1M Tris pH 8.5, and 0.1M Li2SO4.
Crystal structure determination
Diffraction data were collected at the Swiss Light
Source, Paul Scherrer Institute, Villigen, Switzer-
land and were processed with MOSFLM/SCALA23;
details are given in Table I. SHELXD24 was used to
identify 18 selenium sites of the Se-Met-substituted
crystal from the Bijvoet differences determined at
the wavelength of the X-ray absorption peak. Phase
refinement was performed by SHARP/SOLOMON25
and was followed by twofold averaging and phase
extension using DM.26 The model was build at the
interactive graphics and refined by using
REFMAC27 imposing noncrystallographic twofold
symmetry restraints on most of the chain. The
resulting model encompasses residues 11–302 with
the segment 106–111 and several side-chains unde-
fined by electron density. The refinement statistics
is given in Table II.
Activity assay
BepA variants (500 pmol in 20 mM Tris pH 7.5, 100
mM NaCl) were incubated with a mixture of hot (a-
[32P]) and cold nucleosyl-tri-phosphate for 30 min at
30C. The reaction was stopped by the addition of
the SDS sample buffer. Samples were boiled for
5 min at 95C, subjected to SDS-PAGE and analyzed
by autoradiography. S100 HeLa cell lysate was pre-
pared as in Ref. 28.
Conclusions and Outlook
The structure of BepAtr and accompanying data
allowed us to derive a generic model for the Fic/ATP/
Mg2þ substrate complex and to propose a detailed
mechanism for the adenylylation reaction catalyzed
by Fic domains. The identification of the proteins
adenylylated by BepAtr in Hela cell extracts will es-
tablish a novel class of Fic target proteins different
from the known Rho-family GTPases. A subsequent
structure/function analysis of the BepA/target com-
plex may allow to prove the proposed adenylylation
mechanism and, moreover, will address a putative
role of the OB fold in target recognition. Together,
these data will enhance our understanding of the
molecular function of the Fic domain and, moreover,
shed light on the role of the BepA effector protein in
subverting endothelial cell functions during chronic
B. henselae infection.
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Accession codes
The atomic coordinates and structure factors have
been deposited in the Protein Data Bank under
accession numbers 2vy3 (BepAtr), 2jk8 (BepAtr/PPi/
Mg2þ), and 2vza (BepA10-303).
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Fig. S1. Crystal structure of BepAtr/PPi/Mg2+ complex (2jk8). As for the isomorphous native BepAtr 
crystal (2vy3), the asymmetric unit contains two molecules arranged to a 2-fold symmetric dimer. 
The two chains show a rmsd of 0.69 Å for 275 Cα positions after superposition. The dimer is 
stabilized by a putative nickel ion that is tetrahedrally coordinated by residues H45, K49, 
H231’ (the prime indicates a residue of the adjacent monomer) and a water molecule. Due to the 
local two-fold symmetry, this interaction occurs twice. In addition, there is a second nickel binding 
site in each monomer found near the N-terminus coordinated by residues H17, H18 and two water 
molecules. The X-ray fluorescent spectrum confirmed the enrichment of nickel within the crystal 
(data not shown). The blue subunit carries a PPi/Mg2+  moiety bound to the signature loop 
(magenta), whereas the other has a chloride ion bound to the same location.
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Fig. S2. OB-fold of (a) residues 250 - 302 of BepAtr (2vy3) and (b) of a Rho Transcription 
Termination Factor (2a8v), for comparison. Note, that the C-terminal strand β5 has no equivalent in 
BepAtr.
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Fig. S3. Gallery of protein structures with Fic fold.  Color code as in Fig. 1 of main text. PDB codes 
are indicated.  
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(a)
(b)
Fig. S4. (a) Structural similarity Z-scores as determined by Dali1 for BepAtr compared to all other 
Fic domain proteins. Also shown are the sequences of the active loop. (b) Sequence and structure 
similarity of proteins with Fic fold as determined by the PDBeFold server2.
protein PDB-code Z-score                          signature motif
BepA   2vy3    - 1.....H159 PFREGNGRTQR..... 544
 2f6s 13.5 1.....H96  PFLEGNGRATR..... 177
 2g03 13.4 1.....H107 PFLEGNGRSTR..... 191
 3cuc 11.7 1.....H192 PFEDGNGRIAR..... 479
SO2466 3eqx 11.5 1.....H198 PFIDGNGRTGR..... 372
AvrB 1nh1  8.0 1.....M262 PDQRGSAAKAE..... 321
IbpA 3n3u  8.0 1.....H3717PFAEGNGRMAR.....4095
Doc 3dd7  5.8 1.....Y66  IFNDANKRTAL..... 126
VopS  3let  4.7 1.....H348 GFTDGNGRMGR..... 387 
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Fig. S5. Fic/ATP/Mg2+ substrate model and experimental Fic/product structures. (a) BepA(Fic)/
ATP/Mg2+ model with the substrate phosphates occupying binding sub-sites 1 (anion binding LR 
nest), 2, and 3. (b) BepA(Fic) in complex with PPi/Mg2+ (2jk8) with phosphates bound to sub-sites 
1 and 2.  (c) Fic2 domain of IbpA(H3717A) in complex with AMP-Y32 of cdc42 (green) with 
phosphate bound to the sub-site 1, PDB-code 3n3v.  
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Adenylylation control by intra- or intermolecular
active-site obstruction in Fic proteins
Philipp Engel1{*, Arnaud Goepfert1,2*, Fre´de´ric V. Stanger1,2, Alexander Harms1, Alexander Schmidt3, Tilman Schirmer2
& Christoph Dehio1
Fic proteins that are defined by the ubiquitous FIC (filamentation
induced by cyclic AMP) domain are known to catalyse adenylyla-
tion (also called AMPylation); that is, the transfer of AMP onto a
target protein. In mammalian cells, adenylylation of small
GTPases through Fic proteins injected by pathogenic bacteria
can cause collapse of the actin cytoskeleton and cell death1,2. It is
unknown how this potentially deleterious adenylylation activity is
regulated in the widespread Fic proteins that are found in all
domains of life and that are thought to have critical roles in
intrinsic signalling processes. Here we show that FIC-domain-
mediated adenylylation is controlled by a conserved mechanism
of ATP-binding-site obstruction that involves an inhibitory
a-helix (ainh) with a conserved (S/T)XXXE(G/N) motif, and that
in this mechanism the invariable glutamate competes with ATP
c-phosphate binding. Consistent with this, FIC-domain-mediated
growth arrest of bacteria by the VbhT toxin of Bartonella schoen-
buchensis is intermolecularly repressed by the VbhA antitoxin
through tight binding of its ainh to the FIC domain of VbhT, as
shown by structure and function analysis. Furthermore, structural
comparisons with other bacterial Fic proteins, such as Fic of
Neisseria meningitidis and of Shewanella oneidensis, show that ainh
frequently constitutes an amino-terminal or carboxy-terminal
extension to the FIC domain, respectively, partially obstructing
the ATP binding site in an intramolecular manner. After mutation
of the inhibitory motif in various Fic proteins, including the human
homologue FICD (also known as HYPE), adenylylation activity is
considerably boosted, consistentwith the anticipated relief of inhibi-
tion. Structural homology modelling of all annotated Fic proteins
indicates that inhibition by ainh is universal and conserved through
evolution, as the inhibitorymotif is present in 90%of all putatively
adenylylation-active FIC domains, including examples from all
domains of life and from viruses. Future studies should reveal how
intrinsic or extrinsic factors modulate adenylylation activity by
weakening the interaction of ainh with the FIC active site.
In two Fic proteins, IbpA and VopS, that are translocated by patho-
genic bacteria into host cells, the ubiquitous FIC domain has been
shown to catalyse adenylylation1–4. The crystal structure of the effector
domain IbpA(FIC2) in complexwith its adenylylated host target Cdc42
has been reported5 and a catalytic mechanism has been proposed5,6.
IbpA- or VopS-mediated adenylylation of Rho-family GTPases
abolishes downstream signalling in human cells and, thus, causes actin
cytoskeleton collapse and cell death1,2. By contrast, overexpression of a
human Fic protein with similar target specificity, HYPE, had only a
marginal effect1. This suggests that the potentially deleterious adenyly-
lation activity is tightly regulated in HYPE and probably in most of the
almost 3,000 Fic proteins that are proposed to have important roles in
intrinsic signalling processes in bacteria, archaea and eukaryotes.
VbhT is a bacterial Fic protein of the mammalian pathogen
B. schoenbuchensis7,8. It is composed of an N-terminal FIC domain
and a C-terminal BID domain (Fig. 1a). The BID domain facilitates
protein translocation intomammalian or bacterial target cells through
a type IV secretion systemor conjugationmachinery9, respectively, but
the target cell and functional role of VbhT are unknown. VbhT arrests
growth when expressed in Escherichia coli (Fig. 1c and Supplementary
Fig. 1a). Growth arrest is repressed by mutation of histidine to alanine
(VbhT(H136A)) in the conserved FIC motif HXFX(D/E)GNGRXXR.
Inother Fic proteins, this signaturemotif has been shown tobe essential
for target protein adenylylation activity1,2,10, therefore suggesting that
toxicity is related to adenylylation of endogenous proteins. Indeed,
wild-type VbhT, but not VbhT(H136A), catalysed in vitro adenylyla-
tion of a putative E. coli target protein of approximately 80 kilodaltons
(kDa) (Fig. 1d). Furthermore, E. coli cells showed filamentation after
expression of wild-type VbhT, but not of VbhT(H136A) (Supplemen-
tary Fig. 2). A similar phenotype has been described for what is thought
to be a hyperactive mutant of the E. coli Fic protein11. Co-expression of
VbhT with VbhA, encoded by the small open reading frame vbhA
*These authors contributed equally to this work.
1Focal Area Infection Biology, Biozentrum, University of Basel, CH-4056 Basel, Switzerland. 2Core ProgramStructural Biology and Biophysics, Biozentrum, University of Basel, CH-4056 Basel, Switzerland.
3ProteomicsCoreFacility,Biozentrum,University ofBasel, CH-4056Basel, Switzerland. {Presentaddress:Departmentof EcologyandEvolutionaryBiology,YaleUniversity,NewHaven,CT06520-8106,USA.
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Figure 1 | The small protein VbhA represses the toxic effect (growth arrest)
that is mediated by the adenylylation activity of VbhT in E. coli. a, Genetic
organization of the type-IV-secretion-system-associated locus of B.
schoenbuchensis, which is composed of the overlapping vbhA and vbhT genes.
The FIC and BID domains that are encoded by vbhT are shown in different
colours. Protein translations of the regions encoding the conserved motif of
VbhA and the FIC motif of VbhT are depicted. b, Protein alignment of VbhA
and a subset of the 158 homologues that are encoded upstream of fic loci in
different bacteria (see also Supplementary Fig. 4). The most conserved region
shows a (S/T)XX(I/L)EG consensus. Sequence accessions and strain
designations are given in Supplementary Fig. 4. c, Growth of E. coli on lysogeny
broth (LB) plates after IPTG-induced expression of different VbhT and VbhA
constructs. Expression ofVbhT shows a toxic effect, whereas bacterial growth is
not affectedwhenVbhT(H136A) is expressed orwhenVbhT andVbhA are co-
expressed (VbhT–VbhA). All E. coli strains revealed normal growth without
induction. Growth curve experiments in LB gave analogous results
(Supplementary Fig. 1). d, Adenylylation assay with crude cell lysates of E. coli
ectopically expressing the same constructs as in panel c.
2 F E B R U A R Y 2 0 1 2 | V O L 4 8 2 | N A T U R E | 1 0 7
Macmillan Publishers Limited. All rights reserved©2012 69
immediately upstream of vbhT (Fig. 1a), completely repressed VbhT
toxicity, as shown by wild-type-like bacterial growth, normal cell
morphology, and inhibition of VbhT-dependent adenylylation (Fig. 1
and Supplementary Figs 1a and 2). We also observed VbhT-mediated
toxicity and its repression by VbhA in B. schoenbuchensis, the natural
carrier of this toxin and antitoxin, and in the related species Bartonella
henselae (Supplementary Fig. 3).
The inhibitory action of VbhA on the VbhT toxin, and the genetic
organization of the respective genes in an operon are reminiscent of
toxin–antitoxin modules that are found in many bacterial genomes,
often associated withmobile genetic elements12. A comprehensive ana-
lysis of the upstream region of FIC-domain-encoding genes (PFAM
pf02661) identified 158 bacterial vbhA homologues that probably
function as antitoxins. Although the sequences are rather diverse, a
central (S/T)XX(I/L)EG motif is conspicuous (Fig. 1b and Sup-
plementary Fig. 4). The high-resolution (1.5 A˚) crystal structure of
VbhA in complex with the FIC domain of VbhT (VbhT(FIC)) (Sup-
plementary Table 1) shows that VbhA is folded into three anti-parallel
helices that tightly embrace VbhT(FIC) (Fig. 2a) with the N-terminal
helix (ainh), adopting a location that is analogous but distinct to that of
the antitoxin Phd in its complex with Doc13 (Supplementary Fig. 5).
Doc is a Fic protein with a degenerate, probably adenylylation-
incompetent FIC motif14 that may have adopted another toxic activity
(Supplementary Information, section 1). The VbhA antitoxin motif
locates to the C-terminal part of ainh and is positioned close to the
putative ATP-binding site10 at the N-cap of the helix that follows the
active loop of VbhT(FIC). This suggests that the antitoxin competes
with ATP binding. VbhA residues Ser 20 and Glu 24 of the inhibitory
motif form a hydrogen bond and a salt bridge, respectively, with the
conserved Arg147 of VbhT following the active loop.
Intriguingly, structural comparisonwith other bacterial Fic proteins
of known fold (Fic proteins from S. oneidensis (SoFic)14,15 and from
N. meningitidis (NmFic)14 (Fig. 2b, c), and from Bacteroides theataio-
taomicron (BtFic)14 and from Helicobacter pylori (HpFic)14 (Sup-
plementary Fig. 6)) reveals that a structural equivalent of ainh can be
part of theFICdomain fold itself.Moreover, theseproteins also showthe
SXXXE(G/N) inhibitory motifs that are, with respect to the FIC active
site, arranged exactly as in the VbhA-VbhT(FIC) complex. Along the
polypeptide chain, however, these ainh occur at two distinct locations
either in the N-terminal part (SoFic and BtFic) or at the C terminus
(NmFic and HpFic). Thus, Fic proteins containing ainh can be grouped
into three classes (Fig. 2d) depending on whether ainh is provided by an
interacting antitoxin (class I) or whether it is part of the FIC fold as an
N-terminal helix (class II) or a C-terminal helix (class III).
To investigate the distribution of class II and class III Fic proteins, we
predicted the structures of all PFAM FIC domain entries by homology
modelling (Supplementary Information, section 1). Including the class I
proteins that are identified above, two-thirds of all Fic proteins were
classified (Fig. 2e and Supplementary Table 2), with a strong dominance
of class II, the class to which human HYPE belongs (Supplementary
Tables 3 and 4). The proportion of classified Fic proteins increases to
90% when considering only adenylylation-competent Fic proteins that
are defined by compliance with the HXFX(D/E)GNGRXXR motif
(Supplementary Text). This suggests co-evolution of catalytic and
inhibitory function. The inhibition motifs that are derived from Psi-
Blast (class I) and structural predictions (classes II and III) are shown in
Fig. 2f with the overall consensus being (S/T)XXXE(G/N). The strict
conservation of the glutamate is striking and indicates that the observed
ionic interaction with the second arginine of the conserved FIC motif
(Figs 2a–c) is crucial for inhibition. Phylogenetic distribution of class I
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Figure 2 | Structures and classification of Fic proteins according to the
position of the inhibitory motif along the polypeptide chain. Structures are
shown in cartoon (FIC core as defined by PFAM, red; active site loop with
histidine, yellow; inhibitory helix (ainh) with SXXXE(G/N) motif, green) with
important residues in full. a, Complex of VbhT(FIC) with antitoxin VbhA
(green).b, SoFic (from S. oneidensis, PDB code 3EQX)withC-terminal domain
omitted. c, NmFic (from N. meningitidis, PDB code 2G03). d, Linear
organization ofmotifs in the proteins presented in panels a–c. e, Distribution of
the three Fic protein classes for the entire family in the PFAM database (left)
and the subset of Fic proteins with the conserved FIC motif HXFX[(D/
E)GNGRXXR that is likely to convey adenylylation activity (right; see also
Supplementary Information, section 1). f, Sequence profiles for the inhibition
site of the three Fic protein classes.
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and class III Fic proteins indicates that each is of monophyletic origin
(Supplementary Fig. 7). Fic proteins with a degenerate FIC motif are
dispersed over the tree, with the exception of the large cluster of Doc-
like toxins. This suggests that there is recurrent degeneration of the
conserved FIC motif with concomitant loss of adenylylation activity.
Consistent with this, deterioration of the FIC motif seems to correlate
with the absence of a recognizable inhibitory motif (Supplementary
Fig. 7). Fic proteins with a degenerate FIC motif may display catalytic
activities different from adenylylation, such as phosphocholination, as
reported for the Legionella pneumophila effector AnkX16.
Owing to our discovery of the prevalence of the inhibitory motif in
Fic proteins, we carried out a detailed analysis of its functional and
structural role. For this, NmFic (class III, Fig. 2c)was chosen, as it is the
smallest active Fic family protein with known crystallization condition
(Supplementary Table 1). As reported before6, NmFic exhibits in vitro
auto-adenylylation activity (Fig. 3d). The acceptor site was traced to
Y183 of ainh by mass spectrometry (Supplementary Information,
section 1, and Supplementary Fig. 8). On the basis of the location of
Y183 relative to the active site, auto-adenylylation is probably cata-
lysed intermolecularly after partial unfolding or detachment of ainh.
Addition of E. coli lysate to NmFic did not reveal additional bands on
the autoradiograph, and this indicated that there are no NmFic targets
inE. coli or that the activity ofNmFic is inhibited. The latterwas shown
to be correct as mutation of the inhibitory motif (S182A/E186A,
NmFic(SE/AA)) resulted in transfer of radioactivity onto an ,80-kDa
E. coli protein and enhanced auto-adenylylation with an additional
acceptor site (Y188; Fig. 3d and Supplementary Fig. 9). Deletion of the
entire ainh helix (NmFic(D8)) led to similar target protein adenylylation,
proving that the activity resides in the FIC domain core. However, only
weak auto-adenylylation was apparent owing to the lack of the acceptor
tyrosines in this deletion mutant (Fig. 3d and Supplementary Fig. 8c).
To investigate the inhibitorymechanism, crystals ofNmFic proteins
were soaked with the non-hydrolysable ATP analogue adenylyl
imidodiphosphate (AMPPNP) (Supplementary Table 1). TheNmFic–
AMPPNP structure revealed nucleotide binding but with the c-
phosphate disordered (Fig. 3a). Notably, the orientation of the a-
phosphate seems to be non-productive, as the position that is in line
with the scissile Pa-O3a bond is occluded by H107 and N113 (Sup-
plementary Fig. 10a and Supplementary Movie). To reveal the situ-
ation in an inhibition-relievedmutant, the structure ofNmFic(SE/AA)
was determined to 3.0 A˚ (Supplementary Fig. 11). Electron density was
lacking forainh, indicating disorder, whereas the nucleotide conforma-
tion was well defined. In the NmFic(D8)–AMPPNP structure, the
same nucleotide conformation was observed (Fig. 3b) and, owing to
its high resolution (1.7 A˚), the structural basis for the observed relief of
inhibition in these mutants became evident. Whereas the adenosine
moiety adopts the same position as in the wild-type, the c-phosphate
of the nucleotide is bound to R118, occupying the same position as the
carboxylate of the inhibitory E186 in the wild type. As a consequence,
the a-phosphate is found to be re-oriented, and the new orientation
permits in line attack of a target side chain onto the a-phosphorus to
accomplish AMP transfer (Fig. 3c, Supplementary Fig. 10 and Sup-
plementary Movie).
The exact role of the inhibitory glutamate was investigated further
by mutagenesis of Fic proteins from the three regulatory classes. In
wild-type NmFic, Ca and Cb of the glutamate are close to the position
that is attained by the c-phosphate position in NmFic(D8) (Fig. 3c).
Still, an E to G single point mutant may provide sufficient space and
main-chain flexibility to allow c-phosphate binding. Indeed, similar to
NmFic(D8)and NmFic(SE/AA), the mutant NmFic(E186G) resulted
in growth inhibition of E. coli (Supplementary Fig. 1b). Likewise, co-
expression of VbhT(FIC) and VbhA(E24G), as representatives for
class I, caused E. coli growth defects (Supplementary Fig. 1a). We also
included SoFic, a bacterial class II protein, in this analysis. Consistent
with the effects of E to G single point mutants in NmFic and VbhA,
mutant SoFic(E73G) revealed a negative effect on E. coli growth
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Figure 3 | Structure and function of wild-type and mutant NmFic reveals a
general inhibition mechanism corroborated by HYPE protein analysis.
a, Active site of NmFic with bound ATP analogue AMPPNP. The c-phosphate
seems to be disordered and has not beenmodelled. b, Active site of NmFic(D8)
with boundAMPPNP andMg21. The c-phosphate occupies the position taken
by E186 of the SXXXEGmotif in the wild-type (as shown in a). Also shown are
2Fo2 Fc maps that are contoured at 1.2s and cover the ligands. c, Surface
representation of the active site of NmFic(D8) with modifiable Y32 (yellow) of
the Cdc42 switch1 loop (green) in a position that is obtained from a
superposition of the active site loops of NmFic over the IbpA(FIC2)–Cdc42
complex5. d, Autoradiography of an SDS gel after incubation of wild-type and
mutantNmFicwith [a-32P]ATP in the presence or absence of E. coli lysate. The
mutants, but not the wild-type, catalyse AMP transfer onto E. coli target
proteins. e, Scheme of a general inhibitionmechanism for Fic proteins. The ainh
helix (green) with the (S/T)XXXE(G/N) motif prevents productive ATP
binding. It is only after dissociation of the helix that the ATP c-phosphate
attains the position close to a conserved arginine (indicated by ‘‘R’’) of the FIC
motif. This is accompanied by reorientation of the a-phosphate to allow in-line
attack of the target hydroxyl side chain after proton transfer to the active
histidine as proposed before5. f, g, Autoradiography after incubation of
HYPE(FIC) with a-32P-ATP in the presence or absence of Cdc42 (f) or GST-
tagged Rac1 (GST–Rac1) (g). HYPE(FIC/E234G) shows enhanced auto-
adenylylation and target adenylylation. HYPE(FIC)* denotes a degradation
product of HYPE(FIC).
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(Supplementary Fig. 1c) and strongly enhanced auto-adenylylation
(Supplementary Fig. 12). A similar marked effect on auto-adenylyla-
tion was observed after mutation of the corresponding residue in
human HYPE (HYPE(FIC/E234G)), another class II protein (Fig. 3f,
g). It is known that HYPE catalyses Cdc42 and Rac1 adenylylation1,4.
The rather low adenylylation activity of wild-type HYPE on these
substrates is markedly enhanced in the HYPE(FIC/E234G) mutant
(Fig. 3f, g), demonstrating that the relief of inhibition by ainh enhances
not only auto-adenylylation but also AMP transfer onto bona fide
protein targets.
From this study a general mechanism for the inhibition of the FIC-
domain-mediated adenylylation has emerged that invokes a glutamate
finger from ainh to inter- or intramolecularly block part of the ATP
binding site (Fig. 3e). Dissociation of the toxin–antitoxin complex
(class I) or intramolecular loosening of the contact between ainh and
the FIC domain active site (classes II and III) allows ordered binding of
the entire ATP moiety with the a-phosphate in an orientation that is
productive for accepting an incoming target hydroxyl side chain.
Class I proteins might exert functions similar to the classical
bacterial toxin–antitoxin modules12, whereas class II and III Fic
proteins seem to regulate intrinsic cellular functions that are related
to physiological adaptation and cell homeostasis. Conservation of class
II Fic proteins in all three kingdoms of life (Supplementary Table 2)
emphasizes the important role of the regulatorymechanismsdescribed
here. How the adenylylation activity is activated by weakening the
interaction of ainh with the FIC active site in class II and class III Fic
proteins is one of many important questions for future research. We
also anticipate our study to be a starting point for rational approaches
to modulate the adenylylation activities of Fic proteins—approaches
that should aid in elucidating the diverse biological functions of these
widespread signalling proteins.
METHODS SUMMARY
Toxicity experiments were performed with E. coli strain MG1655, which encodes
an IPTG (isopropyl-b-D-thiogalactoside)-inducible T7 polymerase (strain
AB472). Protein expression was controlled by the addition of either 100mM
IPTG (induction) or 1% glucose (repression). A PSI-BLAST search for homolo-
gues with VbhA of B. schoenbuchensis was conducted to identify Fic proteins
belonging to class I. Class II and class III proteins were classified by structure
predictions using the program HHpred17. We analysed all 2,189 proteins of the
FIC PFAM family (pf02661, release 24). Adenylylation assays were carried out
using bacterial crude cell lysates for VbhT constructs or purified proteins for
NmFic, SoFic and HYPE constructs. For structure determination, VbhA and
VbhT(FIC) were co-expressed in the BL21(DE3) strain of E. coli, and NmFic,
SoFic(D8) and NmFic(SE/AA) in the BL21-AI strain of E. coli. VbhA-
VbhT(FIC) andNmFic were purified by affinity chromatography followed by size
exclusion chromatography. An additional anion exchange chromatography step
was performed forNmFic(D8)andNmFic(SE/AA).Diffraction datawere collected
at beamline X06SA of the Swiss Light Source. For NmFic(D8)andNmFic(SE/AA),
we obtained phases by molecular replacement using the NmFic structure (PDB
code 2G03) as a search model. The VbhA–VbhT(FIC) complex was solved by
molecular replacement using a fragment of BepA (PDB code 2JK8).
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Identification of VbhA homologues. VbhA of B. schoenbuchensis was queried
against a database composed of translated open reading frames (.10 amino acids)
identified in the 500-bp upstream region of all fic loci (PFAM release 24, 2,189
proteins). Nine rounds of Psi-Blast were performed and hits with an E-value,1
manually validated.
E. coli toxicity tests and cell filamentation. E. coli AB472, a derivative of
MG1655, was transformed with VbhT-expressing plasmids and always handled
in LB containing 1% glucose. A single colony was picked, resuspended in 20ml of
LB and plated on LB plates containing 100mM IPTG (induction) or 1% glucose
(repression). Plates were incubated overnight at 37 uC. Growth curves were
acquired by measuring optical density of liquid cultures in LB containing 100
mM IPTG that had been inoculated from overnight cultures of single colonies
and were grown at 30 uC with continuous shaking. Cell filamentation was visua-
lized by co-transformation of plasmid pC10E that constitutively expresses GFP
and examined using fluorescence microscopy.
Conjugation experiments for VbhT toxicity tests in Bartonella. Plasmids were
introduced into Bartonella strains by conjugation from E. coli using three-parental
mating. Bartonella strains were grown for 36–48 h at 35 uC with 5% CO2 on
Columbia base agar plates supplemented with 5% defibrinated sheep blood and
100mgml21 streptomycin. E. coli b2150 that harbours helper plasmid pRK2013,
and E. coli b2150 that contains the VbhT-expressing plasmid were grown over-
night at 37 uC in LB supplemented with 50mgml21 kanamycin or 30mgml21
chloramphenicol, respectively, and both media were also supplemented with dia-
minopimelic acid (DAP) and 1% glucose. After 16 h of incubation, E. coli strains
were diluted 1:50 in fresh LB medium and grown to a opticial density (OD) at
595 nm (OD595nm) of 0.4–0.8. Subsequently, each E. coli strain was diluted to
OD595nm of 0.25, washed once and resuspended in supplemented M199
medium (containing 10% FCS and 1% glucose). Bartonella strains were collected
in 1ml and resuspended in 60ml of M199 (OD595nm 5 1). Each Bartonella sus-
pension wasmixed with 20ml of E. coli b2150 that harbours pRK2013 and 20ml of
E. coli b2150 that harbours the VbhT-expressing plasmid. The conjugation mix
was distributed on a conjugation filter on a columbia blood agar (CBA) plate
supplemented with 150ml DAP and 150ml 1% glucose. After 6 h of incubation
under Bartonella growth conditions as described before, the bacteria were washed
off the filter with 1ml supplemented M199. Dilutions of bacterial suspensions
were plated on lysogeny broth agar (LA) supplemented with DAP, 1% glucose and
30mgml21 chloramphenicol for selecting donors, on CBA supplemented with
1.2mgml21 chloramphenicol for selecting transconjugants, and on CBA supple-
mented with 100mgml21 streptomycin for selecting recipients. Agar plates were
incubated under Bartonella growth conditions and colony-forming units were
counted after 1 day for donors and after 7 days for recipients and transconjugants.
In vitro adenylylation assay. Adenylylation activity of VbhT was assessed in an
assay using lysates of ectopically expressing E. coli. Bacterial pellets were resus-
pended in reaction buffer (50mMTris-HClpH8.0, 150mMNaCl, 0.1mMEGTA,
15mMMgCl2, 140mgml
21 RNase A and protease inhibitor cocktail (Roche)) and
lysed by sonication. After clearing lysates by centrifugation, supernatants were
used for experimentation or stored at220 uC.
Adenylylation reactions were prepared by supplementing 15ml supernatant
from expression cultures with 10mCi [a-32P]ATP (Hartmann Analytic) and
25ml blank E. coli supernatant. Adenylylation activity of NmFic and SoFic con-
structs was assessed by incubating 60mg purified protein with 10mCi [a-32P]ATP
(Hartmann Analytic) and 25ml blank E. coli supernatant. Reactions were incu-
bated for 1 h at 30 uC, resolved by SDS–PAGE, and adenylylation was probed by
autoradiography. ForHYPE(FIC) assays, 15 ng of pure proteinwas incubatedwith
1.6mg of purified GTPases.
Protein expression and purification. pFVS0011 vector (encoding VbhA and
VbhT(FIC)) was transformed into E.coli BL21 (DE3). E. coli cultures were grown
at 37 uC in LB medium supplemented with 50mg ml21 of kanamycin to an
OD595nm of 0.6 before induction with 0.3mM IPTG for 16 h at 23 uC. Vectors
pFVS0015 (carrying the NmFic gene), pFVS0016 (encoding NmFic(D8)),
pFVS0037 (encoding NmFic(SE/AA)) were transformed into BL21-AI cells.
Cells were incubated overnight in 750ml LBmedium that was supplemented with
50mgml21 kanamycin and 1% glucose at 23 uC at 200 r.p.m. until OD595nm of 2 was
reached. Bacterial pellets were resuspended in terrific broth medium containing
50mgml21 kanamycin to obtain anOD595nm of approximately 1. Protein expression
was induced at 23 uC with 0.1% arabinose and 0.5mM IPTG for 23h at 200 r.p.m.
Plasmids harbouring HYPE(FIC) and SoFic constructs were transformed in E. coli
Rosetta (DE3) cells and BL21-AI cells, respectively. The proteins were expressed as
described for NmFic.
Cells containing overexpressed VbhA–VbhT(FIC) and NmFic were resus-
pended in lysis buffer containing 20mM Tris (pH7.5), 250mM NaCl and
25mM imidazole and disrupted using French press. Cell debris was pelleted by
ultracentrifugation and the supernatant was applied to a His-Trap column (GE
Healthcare). The stable complex was eluted with a gradient of elution buffer
containing 20mM Tris (pH7.5), 250mM NaCl and 500mM imidazole. The
protein was then concentrated and injected on a Superdex 75 16/60 gel filtration
column (GE Healthcare) equilibrated with 10mM Tris (pH7.5) and 100mM
NaCl. The pure proteins were concentrated to 6mgml21 for VbhA–VbhT(FIC)
and 53mgml21 for NmFic.
The same purification protocol was used for NmFic(D8) and NmFic (SE/AA),
but with an additional intermediate purification step. After affinity purification,
the proteins were adjusted to 20mM Tris (pH8.5), 25mM NaCl, applied to a
Resource-Q anion exchange column (Amersham Biosciences) and eluted with a
linear gradient of NaCl. Peak fractions were concentrated and further purified by
gel filtration chromatography. Purified proteins in 10mM Tris (pH 7.8), 100mM
NaCl were concentrated to 30mgml21 for NmFic(D8) and 51mgml21 for
NmFic(SE/AA). SoFic and SoFic(E73G) were purified as described previously15.
HYPE(FIC), HYPE(FIC/H295A) and HYPE(FIC/E234G) were purified in the
same way as NmFic. GST-tagged Cdc42 and Rac1 were expressed and purified
as described previously18,19.
Crystallization. All crystals were obtained at 20 uC (except for NmFic crystals,
which were obtained at 4 uC) using the hanging-drop vapour diffusion method
after mixing 1ml protein solution with 1ml reservoir solution. VbhA–VbhT(FIC)
andNmFic(SE/AA) crystallized in 23% (w/v) PEG 3350 and 0.2M di-ammonium
tartrate, and were cryoprotected with 25% (w/v) PEG 3350, 0.2M di-ammonium
tartrate and 10%glycerol. NmFic crystallized in 5% 2-propanol, 0.1MMESpH6.0
and 0.1MCa-acetate, and was transferred into 8% 2-propanol, 0.1MMES pH 6.0,
0.1M Mg-acetate and 15% glycerol, then into 30% glycerol for cryoprotection.
NmFic(D8) crystallized with 44% (v/v) PEG 600, 0.1 M Na-citrate pH5.6. No
cryoprotection was needed for data collection. In each case, the substrate analogue
complex was produced by crystal soaking for 2 h with 10mM AMPPNP, 10mM
MgCl2.
Structure determination. Statistics of data collection and refinement are given in
Supplementary Table 1.Diffraction datawere collected at beamlineX06SA (PXIII)
of the Swiss Light Source (l5 1.0 A˚) at 100K on aMAR CCD detector, processed
using MOSFLM20, and scaled with SCALA21. The structures were determined by
molecular replacement (PHASER22) using a BepA fragment (PDB code 2JK810,
residues 30–194) or the uncomplexed NmFic structure (PDB code 2G03, unpub-
lished, Midwest Center for Structural Genomics) as models for structure solution
of VbhA–VbhT(FIC) and the different NmFic proteins, respectively. A structure
solution of wild-type andmutant NmFic in complex with AMPPNP was straight-
forward, whereas a weak solution (RFZ5 5.1, TFZ5 3.6) with poor phasing
power was obtained for VbhA–VbhT(FIC). The partial model lacking VbhA
was refined by rigid-body refinement using REFMAC5 (ref. 23) with three bodies
to an Rfree of 52%. Model extension using the module AutoBuild of the PHENIX
package24 yielded an almost complete model (R/Rfree5 30.8%/35.2%). The
remainder of the molecule was traced manually with COOT25 and then by full
refinement using PHENIX24. TheRamachandran plot showed thatmore than 99%
of the residues are in favoured regions of the four structures. The figures were
generated with Dino (http://www.dino3d.org).
Prediction of inhibition motif in Fic proteins. All Fic proteins (PFAM release
24, 2,189 proteins) were subjected to a profile-to-profile comparison with
sequences from the PDB using HHpred17. HHpred builds an alignment of homo-
logues for each query sequence by using iterations of PSI-BLAST searches against
the non-redundant database. Secondary structures are then predicted on the PSI-
BLAST alignment using PSIPRED26. On the basis of this data, a profile Hidden
MarkovModel (HMM) is generated. Each query profile is compared with the pre-
computedHMMs of the proteins in the PDB to identify structural homologues. In
terms of query profiles, the PDB profiles include secondary structure information
derived from their three-dimensional structure. We analysed the pairwise profile
alignments of each Fic proteinwith the eight different Fic familymembers deposited
in the PDB. A Fic protein was predicted to belong to class II or class III if the
templates’ inhibitory motifs were aligned to a corresponding query sequence in
the profile alignments (see Supplementary Information, section 1).
Phylogenetic analysis of Fic proteins. Phylogenetic trees of the Fic family were
inferred with FastTree 2 (ref. 27) and RAxML 7.0.4 (ref. 28). Trees were built on
the amino acid alignment provided by the PFAMdatabase.Unaligned overhanging
ends were trimmed off and identical sequences were reduced to one representative.
We used local support values based on the Shimodaira–Hasegawa test to estimate
the reliabilityof the tree inferredwith FastTree2. TheRaxML treewas inferredusing
the PROTMIXWAGF model and 25 rate categories.
Liquid chromatography–mass spectrometry analysis. 2.5mM of purified
NmFic, NmFic(D8) or NmFic(SE/AA) were incubated in reaction buffer
(10mM Tris, pH8, 100mM NaCl) in the presence or absence of 50mM ATP
and 50mM MgCl2 for 1 h. Proteins were reduced in 5mM TCEP, alkylated in
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10mM iodacetamid and digested with sequencing grade trypsin (Promega). The
generated peptides were purified with C18 Microspin columns (Harvard
Apparatus) and analysed using liquid chromatography–mass spectrometry
(LC–MS) or MS on an easy nano-LC system coupled to an LTQ-Orbitrap-
Velos mass spectrometer (both from Thermo-Fisher Scientific), as recently
described29 using a linear gradient from 95% solvent A (0.15% formic acid, 2%
acetonitrile) and 5% solvent B (98% acetonitrile, 0.15% formic acid) to 35% solvent
B over 40min. The data acquisition mode was set to obtain one high-resolution
MS scan in the Fourier Transform (FT) part of the mass spectrometer at a reso-
lution of 60,000 (full width at half maximum) andMS–MS scans in the linear ion
trap of the 20 most intense ions. The resulting MS2 scans were searched against a
N.meningitidis protein database containing the target protein sequence, including
NmFic and NmFic(SE/AA) sequences, that was obtained from EBI (http://www.
ebi.ac.uk) using the SEQUEST search algorithm provided in the Proteome
Discoverer software package (Thermo-Fisher Scientific). In silico trypsin digestion
was performed after lysine and arginine (unless followed by proline), with a tol-
erance of twomissed cleavages in fully tryptic peptides. Database searchparameters
were set to allow phosphoadenosine modification (1329.05252Da) of threonine
and tyrosine residues as variable modification and carboxyamidomethylation
(157.021464Da) of cysteine residues as fixed modification. The fragment mass
tolerance was set to 0.8Da and the precursor mass tolerance to 15 p.p.m.
Strain construction. For toxicity experiments, the vbhT wild-type gene
(FN645515) from B. schoenbuchensis R1 was cloned into pRSF-Duet1
(pPE0017, His6-tagged vbhT). VbhT(H136A) (pPE0034) was constructed by
introducing a two-base-pair point mutation in the FIC motif of vbhT of
pPE0017, as described elsewhere30. Plasmid co-expressing VbhT and VbhA
(VbhT/VbhA) was constructed by cloning vbhA (FN645515) amplified from B.
schoenbuchensisR1 into pRSF-Duet1 (pPE0020,HA-tagged vbhA). vbhTwas then
cloned into pPE0020, resulting in pPE0021. To construct VbhT-expressing plasmids
for Bartonella, vbhT from B. schoenbuchensis R1 was cloned into vector pMMB206
(ref. 31) (pVbhT, HA-tagged vbhT). pVbhT(H136A) was constructed from pVbhT
as described before.
The in-frame deletion of the complete vbhA/vbhT operon in B. schoenbuchensis
(Bsch DvbhA/vbhT) was generated as described previously by a two-step gene
replacement procedure9. The mutagenesis vector pPE3005 was constructed by
ligating a cassettewith the flanking regions of the in-framedeletion into pTR10009.
For protein purification, the full-length vbhA gene and part of the vbhT gene
encoding the FIC domain (vbhT(FIC)), amino acid residues 1–198, His6-tagged)
were amplified from plasmid pPE0021 and cloned into the pRSF-Duet1 vector
(pFVS0011). VbhA(E24G)/VbhT(FIC) expression plasmid (pFVS0065) was
generated by introducing a two-base-pairmutation in pFVS0011. TheNmFic gene
was amplified with an N-terminal His6-tag from N. meningitidis from coding
region of amino acid residues 11–191 and from coding region of amino acid
residues 11–167 to generate plasmids expressing NmFic (pFVS0015) and
NmFic(D8) (pFVS0016), respectively. The S182A/E186A double mutant
construct (NmFic(SE/AA)) was generated by introducing two subsequent point
mutations in pFVS0015. The E186G mutant construct (NmFic(E186G)) was
generated by the same approach. The SoFic gene was amplified from plasmid
(ASU biodesign institute, Clone ID SoCD00104192) and cloned with an
N-terminal His6-tag into pRSF-Duet1 (pFVS0040). The SoFic(E73G) plasmid
(pFVS0058) was generated by introducing a two-base-pair point mutation in
pFVS0040. GST–HYPE(E234G) (pFVS0064) was generated by introducing point
mutations in the plasmid containing GST–HYPE. From these plasmids, shorter
constructs (HYPE(FIC), HYPE(FIC/E234G) and HYPE(FIC/H295A)) only
carrying the FIC domain of HYPE (from amino acids 187 to 437) were generated.
For the expression of human Cdc42 and Rac1, the Cdc42–Q61L and Rac1–Q61L
coding sequences were amplified from plasmid pRK5myc L61 Cdc4232 and
pRK5FLAG L61 Rac1 (ref. 32) and cloned into pGex6p1 with an N-terminal
GST-tag, resulting in pAH088 and pAH060, respectively. The wild-type variants
ofCdc42 andRac1were generated from themutant constructs through polymerase
chain reaction (PCR)-based site-directed mutagenesis30 (resulting in pAH059 and
pAH071). All primers and the resulting vectors are summarized in Supplementary
Tables 5 and 6.
18. Self, A. J. & Hall, A. Purification of recombinant Rho/Rac/G25K from Escherichia
coli. Methods Enzymol. 256, 3–10 (1995).
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(2007).
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(1997).
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1. Supplementary Text 
1.1 Defining an adenylylation competent FIC signature motif 
Based on sequence conservation, previous mutagenesis results, and the structure of the 
competent NmFic(8)/AMPPNP complex (Supplementary Fig. 10b), we have defined the 
HxFx[D/E]GNGRxxR profile as the crucial core motif for catalytically active Fic proteins 
with respect to adenylylation. The histidine residue (H) has been shown in several studies1,2 to 
be essential for activity and probably acts as a general base for deprotonation of the target 
side-chain hydroxyl group2,3. The phenylalanine (F) is part of the hydrophobic core and 
important for correct positioning of the active loop. It remains unclear whether other 
hydrophobic residues could replace the phenylalanine. Strikingly, all Fic proteins so far 
shown to exhibit adenylylation activity harbour a phenylalanine at this position. The 
carboxylic side-chain of the aspartic/glutamic acid (D/E) probably coordinates the divalent 
cation (Mg2+ or Mn2+) that is required for activity (data not shown). However, in the 
competent substrate complex structure (Supplementary Fig. 10b) it is partly disordered. As 
predicted before2 and confirmed by the competent AMPPNP complex structure 
(Supplementary Fig. 10b), the three backbone amide nitrogens of GNG are involved in - and 
- phosphate binding. No other residue than a glycine is allowed for the two G positions, 
since side-chains would clash with the core of the protein or the ATP substrate, respectively. 
The asparagine side-chain is involved in positioning of the -phosphate and establishes two 
H-bonds with the backbone amide and carbonyl group of the active site phenylalanine 
residue. Finally, the two arginines are forming a salt-bridge with the - and -phosphate, 
respectively (Supplementary Fig. 10b).  For all residues of the motif, single point mutants 
have been constructed except for the first glycine and first arginine that showed reduced or 
negligible auto-adenylylation and/or target adenylylation1-5, thereby highlighting the 
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importance of these conserved residues. Thus, based on current structural and biochemical 
knowledge, we can assume that Fic proteins with a motif conforming to the consensus 
HxFx[D/E]GNGRxxR are likely to represent AMP transferases. In contrast, proteins 
divergent from this motif have most probably lost adenylylation activity. 
 
1.2 Prediction and analysis of the three regulatory classes of Fic proteins 
While class I proteins were identified by Psi-Blast for the detection of VbhA-homologous 
peptides encoded in the upstream region of fic loci, we used a structure based approach to 
detect class II and class III Fic proteins. The program HHpred predicts structures of distant 
homologs from proteins deposited in structure databases6. The analysis is based on a profile-
to-profile comparison of Hidden Markov Models (HMMs) generated from Psi-Blast and 
secondary structure predictions (see Online Methods). We conducted an HHpred analysis for 
each protein in the FIC family (PFAM release 24, 2,189 proteins) using the protein structure 
database PDB. The PDB contains structures of FIC domains from eight different proteins: (i) 
3dd7, DocH66Y of prophage P1 in complex with the C-terminal domain of Phd; (ii) 2jk8, 
BepA of Bartonella henselae, a type IV secretion system effector protein; (iii) 3n3u, IbpA of 
Histophilus somni, a protein secreted into host cells; (iv) 3let, VopS of Vibrio 
parahaemolyticus, a Type III secretion system effector protein; (v) 2f6s, Fic protein of 
Helicobacter pylori (HpFic); (vi) 2g03, Fic protein of Neisseria meningitidis (NmFic); (vii) 
3eqx, Fic protein of Shewanella oneidensis (SoFic); (viii) 3cuc, Fic protein of Bacteroides 
thetaiotaomicron (BtFic). For all Fic proteins analyzed with HHpred, we detected significant 
structural homology with these eight FIC domain structures in the PDB. Based on the 
corresponding HHpred alignments, we validated each Fic protein for the presence of an N-
terminal (class II) or C-terminal (class III) inhibition motif. Fic proteins were predicted to fall 
into one of these two classes, if the structural alignments with the two structural prototypes of 
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a class (for class II, SoFic and BtFic; for class III, NmFic and HpFic ) included the region 
comprising their inhibition motif. The segment of the query sequence aligning with the 
inhibition motifs of a given class was then identified as the putative inhibition motif of the 
query protein. Only proteins for which both alignments predicted the same inhibition motif 
were categorized into the corresponding class. 
Supplementary Tables 4a-e show that for most proteins, predicted to fall into one of 
the two classes, the corresponding template structures resulted in the highest homology scores 
among the eight Fic proteins in our HHpred analysis. Further, the inhibition motifs 
independently predicted from the two template structures, turned out to be the same for most 
Fic proteins. Finally, only four proteins were identified to belong to more than one of the 
three classes. Altogether, this demonstrates the high specificity of our analysis for the 
prediction of these regulatory features.  
Strikingly, the consensus sequence of all motifs from class I, II, and III converges 
towards the general inhibition motif [S/T]xxxE[G/N]. The glutamate (E24 of VbhA), thereby, 
displays the most conserved amino acid, which is consistent with the presented mechanism of 
inhibition (Fig. 3).  
As mentioned in the main text, in comparison to the entire family, the total number of 
proteins predicted to fall into one of the three regulatory classes is significantly increased in 
the subset of Fic proteins harbouring the adenylylation-competent FIC motif 
HxFx[D/E]GNGRxxR (see Supplementary Text 1.1). Thus, the inhibition motif seems to be a 
specific feature of proteins with adenylylation activity and indicates co-evolution of these two 
functional features. In contrast to this general trend, the relative number of class I proteins 
(regulated by an antitoxin-like protein) decreases in the subset of Fic proteins with a 
conserved FIC motif. This can be explained by the fact that a significant fraction of class I 
comprises proteins from E. coli and related species which harbour a serine instead of an 
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asparagine and a leucine instead of arginine (1st position) in the active loop. It remains to be 
elucidated whether HxFx[D/E]GSGLxxR either can still mediate adenylylation or has evolved 
another activity which is regulated by a similar mechanism as adenylylation. 
Interestingly, class I and III are restricted to bacteria (which present 90% of all Fic 
proteins), while in archaea and eukaryotes only class II inhibition motifs were predicted 
(Supplementary Table 2). Most of the metazoan Fic proteins including the human homolog 
HYPE as well as some of the fungal Fic proteins are predicted to contain a class II regulatory 
motif suggesting that this regulatory mechanism of adenylylation activity is conserved in all 
domains of life. 
 
1.3 Prediction of regulatory classes for selected Fic proteins 
The classification based on the presence/absence of an inhibition motif is listed in 
Supplementary Table 3 for a subset of Fic proteins which were previously studied. For VopS, 
the effector protein of Vibrio parahaemolyticus, our analysis did not predict an inhibition 
motif. This is in agreement with the 3D structure of VopS3, which does not reveal any 
regulatory helix positioned next to the FIC active site.  
In case of the second bacterial virulence factor for which adenylylation activity in 
eukaryotic host cells was described, IbpA4, our analysis predicted an N-terminal inhibition 
motif (class II). However, the 3D structure of IbpA does not show this predicted inhibition 
motif to be located in the active center of the FIC domain1. Thus, our prediction for IbpA may 
be a false positive. Both VopS and IbpA are translocated into eukaryotic host cells, where 
they adenylylate proteins of the Rho family GTPases. This leads to the collapse of the actin 
cytoskeleton and subsequently to cell death4,5. In general, effector proteins of bacterial 
pathogens that aim at killing or dramatically subverting the cells of their eukaryotic hosts (e.g. 
79
SUPPLEMENTARY INFORMATION
6  |  W W W. N A T U R E . C O M / N A T U R E
RESEARCH
immune cells) by adenylylation of cellular targets might not need to be regulated. Further, due 
to their specificity for eukaryotic targets, they may not be toxic for the bacterium before 
translocation and would thus not require an inhibited state.  
However, for effector proteins of Bartonella, our Psi-Blast analysis identified 
homologs of VbhA located upstream of the effector gene loci. In contrast to VopS and IbpA, 
the effector proteins of Bartonella seem to have a much more subtle effect on host cells7. It 
remains to be elucidated whether for Bartonella effector proteins co-translocation of a VbhA-
homolog into host cells allows regulation of adenylylation activity. 
Like the bacterial virulence factors IbpA or VopS, the human Fic protein HYPE, was 
shown to adenylylate the GTPases RhoA, Rac1, and Cdc424. The conserved N-terminal 
inhibition motif identified for HYPE and other mammalian Fic proteins might explain why 
HYPE, in contrast to IbpA or VopS, did not show any cytotoxic effect on mammalian cells4. 
Thus, the here-identified regulatory mechanism might be essential for the tight regulation of 
mammalian Fic proteins and their integration into key signaling pathways of mammals.  
Doc proteins share the same structural fold as Fic proteins and are thus grouped into 
the FIC PFAM family (which is also referred to as Fic/Doc family). They constitute the toxins 
of toxin-antitoxin modules homologous to the post-segregational killing system Doc/Phd of 
Bacteriophage P18. In our phylogenetic analysis (Supplementary Fig. 7), Doc proteins form a 
separate cluster clearly distinct from the remaining Fic proteins. Furthermore, their core motif 
(Supplementary Table 3) is highly divergent from the adenylylation competent motif as 
defined above (see Supplementary Text 1.1). Consistently, our HHpred and Psi-Blast analyses 
did not identify any adenylylation-inhibiting motif for Doc-related proteins. Nevertheless, 
Doc activity is inhibited by the antitoxin Phd which binds in a similar way as VbhA to VbhT 
(Supplementary Fig. 5). Doc-mediated toxicity on bacteria results from binding to the 30S 
ribosomal subunit, but the exact underlying mechanism of Doc-mediated toxicity remains 
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elusive and adenylylation activity has not been reported9. Still, inhibition of Doc toxicity by 
mutation of the histidine in the central motif of the FIC domain indicates its involvement in 
mediating the toxic effect10.  For Doc as well as for other Fic proteins carrying a motif 
divergent from the adenylylation-competent consensus profile, the FIC domain could mediate 
other enzymatic activities11. Catalytic versatility of the FIC domain fold would further explain 
why this protein family is so abundant in a wide range of organisms. 
 
1.4 Mass spectrometry (MS) results for the identification of the auto-
adenylylation site of NmFic 
In order to specifically pinpoint the location of the adenylylation in the FIC domain and to 
verify the results obtained for the adenylylation assay (Fig. 3d), a mass spectrometric analysis 
of the trypsinized NmFic protein samples was performed. As apparent from Supplementary 
Fig. 8a, the majority of the adenylylation could be identified at position Y6 in the displayed 
peptide sequence. Additional conformation was obtained by the identification of the same 
adenylylation site on the same peptide containing the C-terminal glycine as consequence of 
incomplete proteolysis (Supplementary Fig. 8b). However, due to the close proximity of the 
tyrosine residues, it cannot be excluded that Y7 or Y8 are also modified. Comparative 
analysis of the NmFic and NmFic(8) mutant clearly indicates a strong increase in 
adenylylation for this domain (Supplementary Fig. 8c). Notably, we covered the whole 
protein sequence by MS analysis and could only identify adenylylation at the C-terminal 
tyrosine residues of this protein, indicating exclusive adenylylation of this protein at these 
sites and confirming the results obtained in Fig. 3d. 
 MS analysis of the NmFic(SE/AA) mutant revealed a higher degree of adenylylation, 
which is indicated by the identification of more and multiple adenylylated peptide species 
(Supplementary Fig. 9), again, confirming the observations made in Fig. 3d. 
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2. Supplementary Figures 
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Supplementary Figure 1. Growth curves of E. coli MG1655 expressing different 
constructs of (a) VbhA-VbhT, (b) NmFic, or (c) SoFic. Cultures were inoculated with 5 μl 
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of an overnight culture and induced with 100 μM IPTG. Bacterial growth was measured by 
monitoring the optical density at 600 nm every 30 minutes. All experiments were carried out 
in quadruplicates. 
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Supplementary Figure 2. Cell filamentation of E. coli upon expression of VbhT is 
repressed by co-expression of VbhA. Fluorescence microscopy of E. coli harbouring a GFP-
reporter plasmid (pC10E) in addition to the same VbhA-VbhT-expression plasmids as 
presented in Fig. 1c (scale bar, 5 μm). Cell filamentation of E. coli observed upon VbhT 
expression is not evident for VbhT(H136A) or VbhA-VbhT. 
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Supplementary Figure 3. Conjugation of VbhT expression plasmids into Bartonella 
schoenbuchensis and Bartonella henselae reveals toxicity of VbhT in the absence of 
vbhA. Conjugation frequencies are given by the number of transconjugants per recipient as 
determined by dilution plating and counting of colony forming units on media selective for 
either transconjugants or recipients. Conjugation of a plasmid expressing VbhT wild-type 
(pVbhT) into B. schoenbuchensis wild-type (Bsch wt) resulted in a conjugation frequency of 
about 10-5. In contrast, conjugation of the same plasmid into B. schoenbuchensis harbouring a 
deletion of the complete vbhA-vbhT operon (Bsch vbhA-vbhT) or into B. henselae wild-type 
(Bhe wt), which does not encode vbhA, gave no transconjugants in four and three independent 
experiments, respectively. This resulted in conjugation frequencies < 10-7 (when taking the 
detection threshold in our experiments into account). The inability to conjugate the plasmid 
into these strains was dependent on a functional FIC motif: a plasmid expressing VbhT with 
an adenylylation-deficient FIC motif (pVbhT(H136A)) could be conjugated into Bsch vbhA-
vbhT and Bhe wt with a similar frequency as into Bsch wt. 
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Supplementary Figure 4. Protein alignment of translated ORFs with homology to VbhA 
encoded in the upstream region of fic gene loci. We used Psi-Blast to query the VbhA 
protein sequence against all translated ORFs (>10 aa) found in the 500 bp upstream of loci 
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encoding Fic proteins. In total, this analysis identified 158 ORFs with homology to VbhA. 
127 ORFs are overlapping with the corresponding fic gene, together constituting putative 
operons. From the remaining 31 ORFs, 20 are less than 100 bp away from the annotated start 
codon of the fic gene. In the depicted alignment, sequences identical to each other were 
reduced to one representative resulting in 87 aligned sequences including VbhA. Overhanging 
ends were trimmed. Start and end positions of the aligned sequences are indicated. The 
consensus sequence logo is depicted on top of the alignment indicating the conserved central 
motif. The alignment was generated with MUSCLE12 (implemented in Geneious v5.3.6) and 
manually curated. Shading of amino acids indicates degree of conservation. Sequences used 
in the alignment of Fig. 1b are highlighted in red color. 
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Supplementary Figure 5. Comparison of FIC domain folds and FIC/antitoxin 
interactions. a, VbhA-VbhT(FIC) from B. schoenbuchensis. The VbhT(FIC) structure is 
highly similar to that of BepA(FIC)2 (rmsd of 1.6 Å for 169  C-positions, panel c). b, 
Doc/Phd from Bacteriophage P113, PDB code 3dd7). c, BepA(FIC) from B. henselae2. 
Representations of the structures as in Fig. 2.
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Supplementary Figure 6. Fic protein structures BtFic (BT2513 from Bacteroides 
thetaiotaomicron, PDB code 3CUC) (a) and HpFic (HP1159 from Helicobacter pylori, 
PDB code 2F6S) (b). Structures are shown in cartoon representation as in Fig. 2 (Fic core as 
defined by PFAM, red; active site loop with histidine, yellow; inhibitory helix (inh) with C-
terminal SxxxEG motif, green; termini labeled with N and C) with important residues in 
full. Note that BtFic and HpFic are class II and III Fic proteins, respectively, and are close 
structural homologs of SoFic(Fig. 2b) and NmFic (Fig. 2c).  
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Supplementary Figure 7. Phylogenetic trees of Fic proteins. a, Approximately-maximum-likelihood tree inferred with FastTree2. 
Local support values were calculated as implemented in FastTree214 using the Shimodaira-Hasegawa test. Circles indicate branches 
with local support values > 0.9. b, Maximum-likelihood tree inferred with RAxML15 using the PROTMIXWAG model. Dark and light 
grey coloring on the inner circle indicates the presence (conserved) or absence (degenerate) of the adenylylation competent motif, 
respectively. The outer circle depicts the class assigned to each Fic protein conforming the coloring of Fig. 2e. The large cluster of Doc-
like proteins lacking the conserved FIC motif is indicated. An interactive version of the tree with species and accession number labels 
for each leaf can be accessed via the following link http://itol.embl.de/shared/Engel2011. 
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Supplementary Figure 8. LC-MS/MS analysis of adenylylated NmFic protein. a, 
MS/MS-spectrum of the fully cleaved peptide GIEQSYYYEGYEK at a charge state of 3 
using CID. The identified adenylylation sites are underlined in the peptide sequence and 
indicated in red. All correctly assigned y- and b- fragment ions are indicated in blue and red, 
respectively, unassigned fragment ions are shown in gray. b, MS/MS-spectrum of the 
incompletely cleaved peptide GIEQSYYYEGYEKG showing the same modification. c, 
Extracted ion chromatograms of the fully cleaved peptide displayed in panel a for the 
different samples analyzed. 
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Supplementary Figure 9. LC-MS/MS analysis of adenylylated NmFic(SE/AA) protein. 
Four MS/MS-spectra are displayed showing the most significant adenylylated peptide 
sequences identified in the NmFic(SE/AA) mutant. The identified adenylylation sites are 
underlined in the peptide sequence and indicated in red. All correctly assigned y- and b- 
fragment ions are indicated in blue and red, respectively, unassigned fragment ions are shown 
in gray. 
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Supplementary Figure 10. AMPPNP binding to NmFic and NmFic(8). The stereoviews 
of NmFic (a) and NmFic(8) (b) show the detailed interactions of the nucleotide with the Fic 
active site with H-bonds marked by stippled lines in aquamarine. The structure represenations 
show similar views as in Figs 3a and b, but with the N-terminal end of helix 5 shown in full 
to visualize the capping interactions of the - and -phosphate with the helix. Additionally, 
the position that would have to be adopted by a target hydroxyl group for productive 
nucleophilic attack inline with the scissile P-O3 bond is indicated by a small red sphere 
(marked X) with the X - P distance set to 3.0 Å. (c) Superposition of NmFic (gray carbons) 
and NmFic(8) (orange carbons). 
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Supplementary Figure 11. Crystal structure of NmFic(SE/AA). The schematic cartoon of 
chain A is shown in the same representation as in Fig. 2a. Note that (as in all other 15 
molecules of the asymmetric unit) helix inh which follows 7 is disordered as evidenced by 
missing electron density. The AMPPNP substrate analog, however, is fully resolved and 
found in the same conformation and orientation as in the corresponding 
NmFic(8)/AMPPNP structure (Fig. 3b). The ligand has been omitted from phasing. The 
2Fo-Fc density map is shown in grey (1.2 ), the Fo-Fc map in green (3.0 ). 
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Supplementary Figure 12. Autoradiography of an SDS-gel after incubation of SoFic and 
SoFic(E73G) with -32P-ATP in the presence or absence of E. coli lysate. Auto-
adenylylation is drastically increased in the SoFic(E73G) mutant. SoFic* indicates a 
truncated version of SoFic as evidenced by mass spectrometry. No target bands are revealed 
upon incubation with E. coli lysate. It is conceivable that the target is a small, unresolved 
peptide or DNA. 
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3. Supplementary Tables 
Supplementary Table 1. Data collection and refinement statistics. 
 
 VbhA-VbhT(FIC) NmFic NmFic(8) NmFic(SE/AA) 
Data collection     
Space group C2 P6422 P21 P21 
Cell dimensions       
    a, b, c (Å) 106.34, 40.37, 73.79 148.96, 148.96, 75.80 73.94, 65.03, 75.99 110.31, 136.92, 114.66 
    , ,   (°)  90.00, 121.40, 90.00 90.00, 90.00, 120.00 90.00, 107.08, 90.00 90.00, 100.26, 90.00 
Resolution (Å) 45.21-1.50(1.58-1.50) * 65.35-2.15(2.27-2.15) * 37.03-1.7(1.79-1.70) * 87.07-3.02(3.19-3.02) * 
Rsym or Rmerge 6.3(23.8) 9.3(46.9) 6.9(37.3) 11.2(35.2) 
I/I 9.1(2.0) 18.5(4.0) 9.8(2.6) 6.9(2.2) 
Completeness (%) 96.2(74.8) 99.1(93.9) 97.7(95.4) 89.0(43.1) 
Redundancy 3.8(2.0) 13.6(8.8) 4.0(3.5) 3.8(2.1) 
     
Refinement     
Resolution (Å) 15.0-1.50 15.0-2.15 15.0-1.7 15.0-3.02 
No. reflections 41,211(4,622) 27,218(3,678) 73,865(10,470) 58,488(4,120) 
Rwork/ Rfree 18.0/21.5 18.8/21.3 15.9/19.7 22.2/24.8 
No. atoms     
    Protein 2173 1681 5076 21120 
    Ligand/ion 2 TAR 1 ANP 4 ANP, 4 MG, 4 P6G 16 ANP 
    Water 255 189 424 - 
B-factors     
    Protein 22.1 37.2 18.4 66.4 
    Ligand/ion 22.2 44.8 34.6 36.5 
    Water 31.1 47.8 24.4 - 
R.m.s deviations     
    Bond lengths (Å)  0.012 0.012 0.010 0.009 
    Bond angles (º) 1.3 1.2 1.3 1.1 
*Highest resolution shell is shown in parenthesis.  
 
 
Supplementary Table 2. Distribution of Fic proteins from different domains of life in the three regulatory classes I to III. 

 Data analyzed Distribution of Fic proteins into the different regulatory classes I to III  
    class I
d class IIe class IIIf no class class I and II  class I and III  class II and III  
Domain Dataseta Proteinsb Domainsc # % # % # % # % # % # % # %
All 
FIC family 
  
   



   	 
  
  
  
conserved FIC motif    
 		 

 	          
Bacteria 
FIC family  	 
	  	 
    
  
  
  
conserved FIC motif 

 
 
 		 
	 	          
Archaea 
FIC family 	 	        
      
conserved FIC motif                
Eukaryota 
FIC family 
 
   
           
conserved FIC motif 	 	   
    
 		      
Viruses 
FIC family 
 
        	      
conserved FIC motif 	 	    
    
      
Unclassg 
FIC family      
          
conserved FIC motif                
Otherg 
FIC family          
      
conserved FIC motif                
a we analyzed the entire FIC PFAM family (PFAM release 24) as well as a subset of Fic proteins harbouring an adenylylation-competent core motif (conserved FIC motif, 
HxFx[D/E]GNGRxxR), 
bnumber of proteins analyzed,  
cnumber of domains analyzed; two proteins harbour two FIC domains, 
dclass I, antitoxin-like ORF harbouring inhibition motif, 
eclass II, N-terminal inhibition motif, 
fclass III, C-terminal inhibition motif, 
g”Unclass” stands for unclassified Fic proteins, “Other” comprises three Fic proteins from plasmid sequences sampled from the environment 
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Supplementary Table 3. Prediction of class I, class II, and class III inhibition motifs for selected Fic proteins. 
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       2 -3,   0 -53   / .//   . .0,   4 2, - /.2 3 -0- 1 -34
	$!&
(45/1-) 	
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 - /35 
 1 ..2   2 .,5   4 4- 3 -5/ . /22 / .5.
 
(13./3) 	
   $"     - 2-2 
 . .42 
 0 -3-   2 -12   4 14 3 -1, 1 -25 / .3,
#
(332.,) 	
   $"     . .4/ 	 - 05. 	 1 .-2   2 -5/   4 33 3 -4, 0 .0. / .25

('.3//--) 	     $"   2 -1,   0 -5/   - /2/  . //4  4 2- / .-4 3 -0/ 1 -3-
	!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(
.341/) 	     $"   3 -01   0 -43   . /-2  - /04  4 2/ / .,4 2 -04 1 -3-
aprotein name and genbank accession 
bgrey shading indicates conserved FIC motif (HxFx[D/E]GNGRxxR) 
cbased on Psi-Blast and HHpred analysis, class I: antitoxin-like ORF harbouring inhibition motif; class II: N-terminal inhibition motif; class III: C-terminal inhibition motif 
dresults of the HHpred alignments with each of the eight template structures from the FIC family, the rank of each alignment, the alignment score, and the presence of an 
inhibition motif for class II and class III are indicated. 
eaccession of the antitoxin-like ORF: YP_034061  
fin the IbpA xtal structure (3n3u) the identified motif locates to a loop preceding a helix 6 that is roughly in the position of a canonical inh (see Supplementary Text) 
gaccession of the antitoxin-like ORF: NP_417821 



Supplementary Table 4. Classification of all PFAM FIC domain-containing proteins according to the presence of an antitoxin or an intrinsic
inhibition motif. Due to its bulkiness, the table is provided as an extra file in Excel format on http://www.nature.com/nature. 
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Supplementary Table 5. List of primers used in this study.
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Supplementary Table 6. List of plasmids constructed in this study. 
 
 
$  $#"%!  ##$&$( #'
"1128 -
2. "&%2 "#595 "#596
"1131 -
3. "&%2 "#631 "#62:
"1132 -
2.;-
3. "&%2 , ,
"1145 	$247-
2. "&%2 "#	227 "#	238
"2129 	, "

317-". "#611 "#612
"2142 	,-	247. "

317-"-	247.. "#	227 "#	238
"4116 ,%! # % "2111 "#637 "#628
"1122 -
2.;2,2:9-
3. "&%2 "#148 "#112
"1123 2,2:9-
3. "&%2 "#148 "#112
"1126 22,2:2-
3. "&%2 "#118 "#119
"1127 22,278<9-
3. "&%2 "#118 "#11:
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Abstract
The ubiquitous FIC domain is evolutionarily conserved from bacteria to human and has been shown to catalyze AMP
transfer onto protein side-chain hydroxyl groups. Recently, it was predicted that most catalytically competent Fic proteins
are inhibited by the presence of an inhibitory helix ainh that is provided by a cognate anti-toxin (class I), or is part of the N-
or C-terminal part of the Fic protein itself (classes II and III). In vitro, inhibition is relieved by mutation of a conserved
glutamate of ainh to glycine. For the class III bacterial Fic protein NmFic from Neisseria meningitidis, the inhibitory
mechanism has been elucidated. Here, we extend above study by including bacterial class I and II Fic proteins VbhT from
Bartonella schoenbuchensis and SoFic from Shewanella oneidensis, respectively, and the respective E-.G mutants.
Comparative enzymatic and crystallographic analyses show that, in all three classes, the ATP substrate binds to the wild-
type FIC domains, but with the a-phosphate in disparate and non-competent orientations. In the E-.G mutants, however,
the tri-phosphate moiety is found reorganized to the same tightly bound structure through a unique set of hydrogen bonds
with Fic signature motif residues. The c-phosphate adopts the location that is taken by the inhibitory glutamate in wild-type
resulting in an a-phosphate orientation that can be attacked in-line by a target side-chain hydroxyl group. The latter is
properly registered to the Fic active center by main-chain b-interactions with the b-hairpin flap. These data indicate that the
active site motif and the exposed edge of the flap are both required to form an adenylylation-competent Fic protein.
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Introduction
Adenylyl transferases (ATases) utilize adenosine triphosphate
(ATP) to covalently modify proteins, nucleic acids, or small
molecules with adenosine monophosphate (AMP), a reaction
known as adenylylation or AMPylation. The ubiquitous FIC
domain (pfam 02661) found in proteins of all domains of life and
viruses has only recently been shown to confer ATase activity.
Thus, the bacterial T3SS effector protein VopS from Vibrio
parahaemolyticus and the surface antigen IbpA from Histophilus somni
covalently attach the bulky AMP moiety onto a specific threonine
or tyrosine, respectively, of the switch I region of Rho family
GTPases [1,2]. This abrogates binding of downstream effectors
and results in actin cytoskeleton collapse and concomitant cell
detachment and death. Mutational and bioinformatics analysis
indicated that Fic proteins containing a strictly conserved
HxFx(D/E)GNGRxxR signature motif in the active center
typically display adenylylation activity [1,2,3,4,5], while Fic
proteins with an active center deviating from this consensus are
considered to have adopted different activities. Indeed, the host-
targeted effector protein AnkX of Legionella pneumophila exhibiting
an HxFxDANGRxxV signature motif displays phosphocholina-
tion activity towards the GTPase Rab1 [6].
The FIC domain is structurally characterized by a conserved
central core of four helices (a2 to a5) that is flanked by three
helices (a1, a6 and a7) found in diverse dispositions in different Fic
proteins [3,7]. Helices a4 and a5 are joined by a loop that together
with the N-terminal cap of helix a5 forms the active center
represented by a signature motif with the consensus sequence
HxFx(D/E)GNGRxxR. The catalytic mechanism of adenylylation
was deduced from the crystal structure of the second FIC domain
of IbpA in complex with the adenylylated Cdc42 target [4] and
from biochemical studies [5] and shown to involve nucleophilic
attack of the target side-chain hydroxyl onto the ATP a-
phosphate. The triphosphate binding site at the anionic nest at
the N-terminus of helix a5 was characterized by the crystal
structure of BepA from Bartonella henselae in complex with
pyrophosphate, the side product of the reaction [3]. An ATP
substrate complex structure was obtained recently for the Fic
protein of Neisseria meningitidis [8] corroborating the catalytic
mechanism. The histidine of the signature motif is critical for
deprotonation of the incoming target hydroxyl group [5], whereas
the phenylylanine is part of the hydrophobic core of the domain.
The remaining residues of the motif are involved in ATP/Mg2+
binding and loop stabilization [3,8].
We recently demonstrated that the Fic protein VbhT from
Bartonella schoenbuchensis causes bacterial growth arrest when
overexpressed in Bartonella or E. coli and that this effect can be
repressed by co-expression with the anti-toxin VbhA, a small
protein encoded upstream of VbhT [8]. As shown by structure
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analysis, VbhA forms a tight complex with the FIC domain of
VbhT with the conserved glutamate (Einh) from the inhibitory
helix ainh partly obstructing the ATP binding site, which gave a
first clue regarding the inhibitory mechanism mediated by VbhA
binding.
Exhaustive bioinformatic analysis coupled with homology
modeling revealed that the (S/T)xxxE(G/N) signature motif of
ainh is not only found in several other putative anti-toxin sequences
coded immediately upstream of Fic proteins, but is often part of
the FIC domain itself either preceding helix a1 or immediately
following helix a7 [8]. Thus, a classification system was introduced
grouping the Fic proteins for which an anti-toxin with an
inhibitory helix ainh had been found into class I and those with
an equivalent of ainh in the N- or C-terminal part of the Fic
protein into classes II and III, respectively. Indeed, 90% of the Fic
proteins with the canonical FIC signature motif could be classified
accordingly, suggesting that all these enzymes are inhibited in their
enzymatic activity.
The physiological stimulus or condition for relief of ainh-
mediated inhibition is not yet known. For T4SS Fic proteins of
class I (such as VbhT or BepA [9]), however, it appears likely that,
for injection into host cells, the Fic protein has to unfold and will
be translocated without the antitoxin. For class II and III proteins,
detachment, unfolding, or proteolytic cleavage of the ainh helix
may cause relief of inhibition. In fact, a truncation mutant of the
class III Fic protein from N. meningitidis (NmFic) lacking the entire
C-terminal ainh helix showed strong ATase activity and allowed to
study the catalytic and inhibitory mechanism in detail [8]. A more
subtle means to relieve inhibition, which is applicable to Fic
proteins of all three classes, is the replacement of the inhibitory
glutamate by glycine. In vivo, such E-.G mutations showed a
detrimental effect on bacterial growth [8]. For the human HYPE
protein (class II), the corresponding mutant protein catalyzed
in vitro AMP transfer to the small GTPases Rac1 and Cdc42,
whereas only marginal effect was seen with the wild-type proteins
[8].
Here, we assayed in a systematic approach Fic representatives of
the three Fic classes and their E-.G mutants for in vitro
adenylylation showing that the mutation causes inhibition relief
across the Fic classes. Binding of ATP substrate or AMPPNP
substrate analog to the wild-type and the E-.G mutant proteins
was studied by protein crystallography to reveal the inhibitory
mechanism and to get further insight into catalysis. This yielded a
consistent molecular mechanism that most likely applies to most
adenylylation competent Fic proteins irrespective of class.
Materials and Methods
Cloning
The full-length vbhA gene and part of the vbhT gene (amino acid
residues 1–248, His6-tagged) were amplified from plasmid
pPE0021 and cloned into the pRSF-Duet1 vector leading to
plasmid pAG0077 (VbhA/VbhT(FIC)). The full-length vbhA gene
and part of the vbhT gene encoding the FIC domain (amino acid
residues 1–198, His6-tagged) were PCR-amplified from plasmid
pPE0021 and cloned into the pRSF-Duet1 vector (pFVS0011). A
two-base pair mutation is then introduced in pFVS0011 to obtain
plasmid pFVS0065 (VbhAE24G/VbhT(FIC)). The fic gene of
Neisseria meningitidis was PCR-amplified with an N-terminal
His6-tag from Neisseria meningitidis from coding region of amino
acid residues 11–191 to generate plasmid expressing NmFic
(pFVS0015). The E186G mutant construct (NmFicE186G,
pFVS0059) was generated by introducing a two-base pair
mutation in pFVS0015. The fic gene of Shewanella oneidensis was
PCR-amplified from plasmid (ASU biodesign institute, Clone ID
SoCD00104192) and cloned with an N-terminal His6-tag into
pRSF-Duet1 (pFVS0040). The SoFicE73G plasmid (pFVS0058)
was generated by introducing a two-base pair point mutation in
pFVS0040.
Protein Expression and Purification
Vectors pAG0077 (VbhA/VbhT(FIC)), pFVS0040 (SoFic) and
pFVS0015 (NmFic) were transformed into E.coli BL21 (DE3). E.
coli cultures were grown at 37uC in LB medium supplemented with
50 mg/ml of kanamycin to an OD595 of 0.6 before induction with
0.3 mM IPTG for 16 h at 23uC. Vectors pFVS0065 (VbhAE24G/
VbhT(FIC)), pFVS0059 (NmFicE186G), pFVS0058 (SoFicE73G)
were transformed into BL21-AI cells. Cells were incubated in
750 ml LB medium supplemented with 50 mg/ml kanamycin and
1% glucose at 37uC at 200 rpm until an OD595 value of 1.5 was
reached. Bacterial pellets were resuspended in 1 L of Terrific
Broth media containing 50 mg/ml21 kanamycin. Protein expres-
sion was induced at 23uC with 0.1% arabinose and 0.1 mM IPTG
for 23 h at 200 rpm.
Cells containing overexpressed VbhA/VbhT(FIC) and NmFic
were resuspended in lysis buffer containing 20 mM Tris (pH 7.5),
250 mM NaCl, and 25 mM imidazole and disrupted using French
press. Cell debris were pelleted by ultracentrifugation and the
supernatant was applied to a His-Trap column (GE Healthcare).
The proteins were eluted with a gradient of elution buffer
containing 20 mM Tris (pH 7.5), 250 mM NaCl, and 500 mM
imidazole. The proteins were then concentrated and injected on a
Superdex 75 16/60 gel filtration column (GE Healthcare)
equilibrated with 10 mM Tris (pH 7.6) and 100 mM NaCl. The
pure proteins were concentrated to 3.7 mg/ml for VbhA/
VbhT(FIC) and 30 mg/ml for NmFic.
The same purification protocol as described above was used for
VbhAE24G/VbhT(FIC) and NmFicE186G with an additional
intermediate purification step. After affinity purification, the
proteins were adjusted to 20 mM Tris (pH 8.5), 25 mM NaCl,
applied to a Resource-Q anion exchange column (Amersham
Biosciences), and eluted with a linear gradient of 1 M NaCl. Peak
fractions were concentrated and further purified by gel filtration
chromatography. Purified proteins in 10 mM Tris (pH 7.6),
100 mM NaCl were concentrated to 4.1 mg/ml for VbhAE24G/
VbhT(FIC) and 33 mg/ml for NmFicE186G. Cells containing
overexpressed SoFic and SoFicE73G were resuspended in lysis
buffer containing 50 mM HEPES (pH 8.0), 50 mM NaCl, 1 mM
TCEP, 10% glycerol and 10 mM Imidazole and disrupted using
French press. Cell debris were pelleted by ultracentrifugation and
the supernatant was applied to a His-Trap column (GE
Healthcare). The proteins were eluted with a gradient of elution
buffer containing 50 mM HEPES (pH 8.0), 50 mM NaCl, 1 mM
TCEP, 10% glycerol and 300 mM imidazole. The proteins were
then concentrated and injected on a Superdex 75 16/60 gel
filtration column (GE Healthcare) equilibrated with 20 mM
HEPES (pH 8.0), 200 mM NaCl and 1 mM TCEP. The pure
proteins were concentrated to 21.8 mg/ml for SoFic and 12 mg/
ml for SoFicE73G.
Protein Crystallization
For crystallization, the hanging-drop vapor diffusion method
was used with 1 ml protein solution mixed with 1 ml reservoir
solution. The VbhA/VbhT(FIC) and VbhAE24G/VbhT(FIC)
complexes were concentrated to 3.7 mg/ml and 4.1 mg/ml,
respectively, and crystallized at 20uC using a reservoir solution
composed of 15% (w/v) PEG 4000, 0.1 MMES pH 6.5. Whereas,
the wild-type crystal was soaked with 5 mM ATP, and 5 mM
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MgCl2, the mutant was co-crystallized with 10 mM ATP, and
10 mM MgCl2. For data collection, crystals were transferred to
reservoir solutions supplemented with 20% glycerol and flash
frozen in liquid nitrogen. SoFic and SoFicE73G were concentrated
to 21.8 mg/ml and 12 mg/ml, respectively, and co-crystallized
with either 5 mM ATP or 5 mM AMPPNP and supplemented
with 5 mM MgCl2 in a solution composed of 21% (w/v) PEG
3350 and 0.2 M NaF pH 7.1 at 4uC. For data collection, crystals
of the protein-ligand complex were cryoprotected by transfer to a
reservoir solution supplemented with 15% (v/v) PEG 200 and
flash cooled in liquid nitrogen. For crystallization of NmFicE186G
(33 mg/ml), a reservoir solution composed of 4 M potassium
formate, 0.1 M Bis-Tris propane pH 9.0, 2% (w/v) PEG MME
2000 was used. Crystals were soaked with 5 mM AMPPNP and
5 mM MgCl2 and then cryoprotected with 20% glycerol prior
flash-cooling in liquid nitrogen.
Data Collection, Structure Determination, and
Refinement
Diffraction data were collected at the Swiss Light Source at
100 K and processed using XDS [10]. The structures were solved
by molecular replacement using the apo structures of VbhA/
VbhT(FIC) (PDB code 3SHG), SoFic (PDB code 3EQX) or
NmFic (PDB code 2G03) as search models using Phaser [11].
Several rounds of iterative model building and refinement were
performed using Coot [12] and PHENIX [13] or REFMAC5
[14], respectively. 5% of the data were excluded from refinement
and used for cross-validation. The geometry of the final model was
assessed using MolProbity [15] showing .99% of the residues in
the core and allowed regions of the Ramachandran plot. Data
collections and refinement statistics are summarized in Table 1.
The atomic coordinates and structure factors of VbhA/
VbhT(FIC)/ATP, VbhAE24G/VbhT(FIC)/ATP, SoFic/ATP, So-
FicE73G/AMPPNP, and NmFicE186G/AMPPNP have been de-
posited in the Protein Data Bank under accession codes 3ZC7,
3ZCB, 3ZCN, 3ZEC and 3ZLM, respectively. The figures were
generated with Dino (A. Philippsen unpublished, http://www.
dino3d.org).
In vitro Adenylylation Assay
Adenylylation activity of VbhA/VbhT(FIC), SoFic and NmFic
constructs was assessed by incubating 125 ng, 1.25 mg and 2.5 mg
of purified protein, respectively, with 10 mCi a-32P-ATP (Hart-
mann Analytic) in a buffer containing 50 mM Tris pH 8.0,
150 mM NaCl, 0.1 mM EGTA, 15 mM MgCl2, and protease
inhibitor cocktail (Roche). Reactions were incubated for 1 h at
30uC, resolved by SDS–PAGE, and subjected to autoradiography.
Results
Constitutive Inhibition is Relieved by Truncation of the
Inhibitory Glutamate in All Three Fic Classes
For the comparative structure/function study on the inhibitory
mechanism of Fic proteins from the various classes we chose as
representatives the FIC domain of VbhT (residues 1 to 198) from
Bartonella schoenbuchensis in complex with its cognate antitoxin
VbhA (VbhA/VbhT(FIC); class I), Fic protein SO_4266 from
Shewanella oneidensis (SoFic; class II) and Fic protein NMB0255
from Neisseria meningitidis (NmFic; class III).
Auto-adenylylation is a convenient read-out to assess adenylyla-
tion activity of Fic proteins. It does not require the presence of a
physiological protein target that may, in fact, not yet been known
as in the case of SoFic. Autoradiographies of SDS-PAGE gels after
incubation with a-32P-ATP (Fig. 1) show that auto-adenylylation is
virtually absent in the wild-type Fic proteins of all three classes, i.e.
for VbhA/VbhT(FIC), SoFic, and NmFic (see also ref. 8), but is
drastically boosted in the respective E-.G mutants suggesting a
common inhibitory mechanism.
ATP Binds to Wild-type Fic Proteins in Disparate and
Catalytically Incompetent Conformations
Fig. 2 shows the high-resolution structures of VbhA/VbhT(FIC)
(class I) and SoFic (class II), both in complex with ATP. Whereas
VbhA/VbhT(FIC) crystallized isomorphously to the unliganded
wild-type crystals ([8], PDB code 3SHG), SoFic yielded crystals of
monoclinic space group, i.e. distinct to the orthorhombic form of
the apo structure ([16], PDB code 3EQX). In the two structures
the nucleotide is clearly visible, albeit with elevated B-factors
(40 A˚2) in VbhA/VbhT(FIC). Only marginal structural changes
are induced upon substrate binding (rms deviations between the
Ca-positions of apo and complex form of 0.4 A˚ and 0.8 A˚ for
VbhA/VbhT(FIC) and SoFic, respectively).
In both structures the ATP substrate is found at analogous sites
(Fig. 2) with the base filling a pocket formed by a4, a6, and the b-
hairpin flap, the ribose 39-hydroxyl H-bonded to the conserved
glutamate of ainh, and the triphosphate moiety interacting with the
anionic nest formed by the N-terminus of a5. The same binding
mode has been observed for class III NmFic [8]. In all three
structures, also the ribose 29-hydroxyl is forming an H-bond, but
to non-homologous protein side-chains. Similarly, the binding sub-
site for the base is not conserved on the residue level. However, in
each case, hydrophobic residues are contributed by helix a6 and
by the flap. A weak H-bond is formed between the adenine N3
and N133 in VbhT(FIC). A homologous interaction (with N104) is
found in NmFic [8].
Most relevant for catalysis is the orientation of the a-phosphate
that has to be accessible for nucleophilic attack by the target side-
chain hydroxyl group. In VbhA/VbhT(FIC) and SoFic, as in
NmFic [8], the position that is in-line with the scissile Pa-O3a
bond is not accessible for an attacking group (Fig. 2). Such a group
positioned there would severely clash with atoms of the enzyme.
Thus, in Fic proteins of all three classes, catalytically non-
competent orientation of the a-phosphate appears to be the reason
for the lack of adenylylation activity.
Interestingly, while the a-phosphate is locked in a secured
position in each of the structures, it shows distinct orientations
among the three proteins that can be traced back to differences in
the binding mode of the b- and c-phosphates (Fig. 2C). Though
interacting with the same protein groups (anionic nest; histidine,
asparagine, and first arginine of the signature motif), the detailed
H-bonding patterns are different (e.g. the main chain amide of the
second glycine of the motif interacts with the bridging O3b in
VbhA/VbhT(FIC), and with the non-bridging O1b in SoFic).
It seems that during convergent evolution of ainh-mediated
adenylylation inhibition in the different Fic protein classes no strict
constraints for the ATP binding mode were operational apart from
the requirement for a non-competent orientation for the reacting
phosphate.
Truncation of the Inhibitory Glutamate Allows the ATP
Substrate to Bind in a Catalysis Competent Conformation
Relief of Fic protein inhibition was achieved previously by
expression of VbhT without its cognate antitoxin VbhA or by
replacing in NmFic the SxxxE inhibition motif by AxxxA or –
most drastically - by deleting the entire ainh [8]. The conserved
glutamate of ainh, Einh, was identified to be crucial for the
inhibitory effect, since mere truncation of its side-chain (E-.G
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mutation) rendered recombinantly overexpressed Fic proteins of
all three classes toxic to E. coli [8].
In vitro, the mutation has a drastic effect in that auto-
adenylylation is boosted in all three representative Fic proteins
(Fig. 1). This opens the door for studying the action of any active
Fic protein in vivo, even without knowing the physiological stimulus
for inhibition relief.
To reveal the underlying inhibition relief mechanism, crystal
structures of the three mutant proteins in complex with ATP or
AMPPNP were determined to high resolution. Although, in
solution the mutants show auto-adenylylation, no such modifica-
tion is observed in the crystal structures. For NmFicE186G this is
not surprising, since the complex structure has been obtained by
soaking and auto-adenylylation would require partial unfolding of
ainh carrying the modifiable tyrosine (Y183) [8]. The VbhAE24G/
VbhT(FIC) and SoFicE73G complexes were co-crystallized. Since
we do not see adenylylated residues, the extend of modifications
may be either minor, locate to flexible loops or only the
unmodified fraction may have crystallized. Figs. 3A–C show that
in all three cases, the nucleotide is well resolved and, in contrast to
Table 1. Data collection and refinement statistics.
Protein VbhA/VbhT(FIC) VbhAE24G/VbhT(FIC) SoFic SoFicE73G NmFicE186G
Ligand ATP ATP ATP AMPPNP AMPPNP
PDB code 3ZC7 3ZCB 3ZCN 3ZEC 3ZLM
Data collection
Wavelength (A˚) 1.000 0.979 0.979 0.979 1.000
Detector MAR225 CCD PILATUS 2M MAR225 CCD MAR225 CCD PILATUS 2M
Space group C2 C2 P21 P212121 P6422
Cell dimensions
a, b, c (A˚) 106.5, 40.6, 73.7 106.5, 40.3, 73.9 37.8, 164.9, 70.2 71.3, 80.6, 141.8 149.1, 149.1, 76.4
a b c (u) 90.0, 121.6, 90.0 90.0, 121.4, 90.0 90.0, 94.4, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 120.0
Resolution (A˚) 45.422.1 (2.222.1) 45.421.9 (2.121.9) 35.521.7 (1.821.7) 42.722.2 (2.322.2) 49.322.0 (2.122.0)
Rsym or Rmerge (%) 8.5 (33.8) 5.7 (33.4) 4.4 (41.3) 10.5 (52.8) 6.3 (72.7)
CC(1/2) (%) 99.8 (93.6) 99.9 (93.1) 99.9 (87.1) 99.8 (90.3) 100.0 (97.9)
I/s 18.9 (5.7) 14.5 (3.4) 22.9 (3.4) 17.6 (4.5) 31.1 (5.7)
Completeness (%) 99.2 (92.3) 99.2 (97.0) 99.5 (96.7) 100.0 (100.0) 99.9 (100.0)
Multiplicity 5.4 (4.9) 3.6 (3.6) 3.9 (3.4) 7.4 (7.5) 21.4 (22.6)
Refinement
Resolution (A˚) 15.022.10 30.021.94 15.021.70 15.022.20 30.022.00
No. reflections 15,769 (2,342) 18,923 (1,355) 93,100 (2,837) 42,085 (3,956) 32,490 (2,338)
Rwork/Rfree [%] 16.6/23.0 19.4/23.4 16.7/20.2 16.5/21.1 18.2/19.9
Mol./a.u 1 1 2 2 1
No. atoms
Protein 2172 2011 5961 5984 1458
Ligand/ion 1 ATP 1 ATP, 1 MG 2 ATP 2 ANP, 1 MG 1 ANP, 1 MG
Water 226 134 981 695 135
Average B (A˚2)
Protein 22.0 25.0 21.9 20.7 45.9
Ligand/ion 39.7 27.5/11.4 21.9 12.9/28.9 40.1/64.8
Water 28.4 32.1 33.7 28.0 49.3
R.m.s deviations
Bond lengths (A˚) 0.007 0.011 0.008 0.009 0.010
Bond angles (u) 1.0 1.3 1.2 1.2 1.2
Values for the highest resolution shell are shown in brackets.
doi:10.1371/journal.pone.0064901.t001
Figure 1. AMP transfer catalyzed by Fic proteins and their
inhibition-relieved variants. Autoradiography of VbhA/VbhT(FIC),
SoFic and NmFic (wt, wild type; E/G, E-.G mutant) after incubation with
radioactively labeled a-32P-ATP.
doi:10.1371/journal.pone.0064901.g001
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Figure 2. Crystal structures of wild-type Fic proteins representing classes I to II in complex with ATP substrate. (A) VbhA/VbhT(FIC), (B)
SoFic. Structures are shown in cartoon representation (red, FIC core as defined by PFAM; yellow, active site loop and N-terminal end of helix a5; dark-
green, inhibitory helix ainh). In (A), the fold of the antitoxin is shown in dark-green and steel-blue. Selected residues are shown in full with the
inhibitory glutamate (E24 or E73, respectively) colored in dark. The 2Fo-Fc simulated annealing omit maps covering the ligand are contoured at 1.1 s.
In both structures, the orientation of the a-phosphate prevents nucleophilic attack of a putative target side-chain hydroxyl onto the ATP substrate,
since the position inline with the scissile Pa-O3a bond (magenta star) is unattainable. C) Stereo view of the superposition of the ATP nucleotides
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the wild-type complexes, shows a unique conformation and
relative position within the binding site (Fig. 3D).
While the base and ribose moieties interact with the mutant in
the same way as with the wild-type proteins (compare with Fig. 2,
see also Fig. 3a in [8] for NmFic), the triphosphate has adopted a
strongly curved conformation with the terminal c-phosphate
approaching closely the ribose moiety and forming a tight salt-
bridge with the second arginine of the FIC motif (R(2): R147,
R209, or R118, respectively).
The position and orientation of the triphosphate is defined by a
multitude of specific interactions (Fig. 3A–C). In all structures, the
a- and b-phosphate moieties form four H-bonds with the four
exposed backbone amide groups of the compound anion binding
nest [17] at the N-terminal end of helix a5. In addition, the first
arginine of the signature motif (R(1): R144, R206, or R115,
respectively) forms a salt-bridge with the b-phosphate involving
two H-bonds and the asparagine of the motif (N142, N204, or
N113, respectively) interacts with a non-bridging oxygen of the a-
phosphate.
In all the structures, a magnesium ion is present albeit with high
B-factor for NmFicE186G (63 A˚
2). The metal bridges the a- and b-
phosphate and is coordinated in addition by the conserved D/E
residue of the Fic signature motif in VbhAE24G/VbhT(FIC) and
SoFicE73G (E140, D202, respectively). It is particularly well
resolved in the former structure where three well-defined water
molecules complete its octahedral coordination shell (Fig. 3A).
Interestingly, the divalent cation is observed only in the
adenylylation competent complexes, but not in the wild-type
complexes. Indeed, magnesium is indispensable for Fic mediated
ATase activity (data not shown) and is probably important for fine-
tuning of the a- and b-phosphate orientation within the compound
anion binding nest and for stabilization of the transition state.
Overall, the three structures display a unique mode of ATP
binding that can be attained only in the mutants, since the c-
phosphate effectively adopts the position that is taken by the
inhibitory glutamate in the wild-type proteins (Fig. 4). Most
relevantly, the reorganization of the triphosphate in the binding
site results in a a-phosphate orientation that is now prone for in-
line attack by an incoming target side-chain (Fig. 3D). Clearly, the
conservation of this binding mode across the FIC classes shows
that it is essential for FIC function.
shown in panel A and B with AMPPNP from the complex structure of the class III NmFic protein (PDB 3S6A [8]) within the active site of the VbhA/
VbhT(FIC) complex (same as in panel A). The nucleotides of the various complexes are distinguished by their colors (white for the ATP bound to
VbhA/VbhT(FIC), green for the ATP bound to SoFic, and blue for the AMPPNP of the NmFic complex. Note that the AMPPNP c-phosphate in NmFic is
found disordered [8] and therefore not shown. The residues of the HxFx(D/E)GNGRxxR Fic signature motif are labeled, the two glycine and the two
arginine residues are distinguished by a "1" or "2" in brackets. The phenylalanine (not shown) is part of the hydrophobic core. The inhibitory
glutamate from ainh is labeled as Einh.
doi:10.1371/journal.pone.0064901.g002
Figure 3. Crystal structures of E-.Gmutated Fic proteins representing classes I to III in complex with substrate or substrate analog.
A, VbhAE24G/VbhT(FIC) in complex with ATP/Mg
2+; B, SoFicE73G, C, NmFicE186G, both in complex with AMPPNP/Mg
2+. Representation as in Fig. 2 with
magnesium ions shown as magenta spheres. The 2Fo-Fc simulated annealing omit maps covering the nucleotide/Mg2+ ligands are contoured at 1.1
s. D, Stereo view of the superposition of the ligand structures shown in panels B and C onto the VbhAE24G/VbhT(FIC) complex (same as in panel A).
Note that the nucleotides of the various complexes are distinguished by their carbon color (VbhAE24G/VbhT(FIC) ATP in green, SoFicE73G AMPPNP in
orange and NmFicE186G AMPPNP in pink). The residues of the HxFx(D/E)GNGRxxR signature motif are labeled as in Fig. 2C with the phenylalanine not
shown. Also shown is the modifiable hydroxyl side-chain Y32 of Cdc42 (blue) after superposition of the IbpA(FIC2)/Cdc42 complex [4] onto VbhAE24G/
VbhT(FIC). For the superposition, only the Fic active site loops were used. The a-phosphate moieties appear well-suited for in-line attack of the target
hydroxyl group (broken line in magenta).
doi:10.1371/journal.pone.0064901.g003
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Target Registration to the FIC Active Site
The conservation of the FIC active site and the ATP substrate
binding mode prompts for a precise alignment of the incoming
side-chain hydroxyl with the scissile Pa-O3a bond. The beta-
hairpin flap partly covering the active site appears to represent a
"target dock" that ensures this precise positioning of the target
backbone stretch immediately following the modifiable hydroxyl
side-chain and thus registers the side-chain to the active site as has
been proposed before (2). This was deduced mainly from the only
known Fic protein/target complex structure IbpA(FIC)/Cdc42 [4]
where the AMPylated Y32 of Cdc42 is part of a segment (switch 1
loop) in extended conformation and complements inter-molecu-
larly the b-hairpin of the flap (Fig. 5A).
This notion is further corroborated by the structure of the wild-
type VbhA/VbhT(FIC) complex presented here that revealed
additional density close to the flap above the active site (Fig. 5B).
This was interpreted as a four residue peptide in extended
conformation that is associated antiparallely to the edge of the
two-stranded b-hairpin of the flap via three main chain-main
chain H-bonds. Location and side-chain densities are consistent
with the peptide representing residues 203 to 206 of a symmetry
mate (note that the ordered part of the VbhT(FIC) construct ends
with residue F197). Very similarly, peptide density is present at an
equivalent location in the A-chain of SoFicE73G and could be
attributed to the N-terminus (residues 0 to 3) of a symmetry related
B-chain as also reported for the isomorphous crystal structure of
wild-type SoFic (Fig. 5C) [16].
Figure 4. Comparison of triphosphate nucleotide structures as bound to wild-type and E-.Gmutated Fic proteins from class I to III.
Stereo views of the ligand structures after superposition of the FIC domains (not shown). Also shown is the inhibitory glutamate of the wild-type
structures. A, ATP as bound to VbhA/VbhT wild-type (white) and the E24G mutant (dark green). B, ATP and AMPPNP as bound to SoFic wild-type
(green) and the E73G mutant (orange), respectively. C, AMPPNP as bound to NmFic (blue) and the E186G mutant (pink). Note that the AMPPNP c-
phosphate in NmFic is found disordered [8] and therefore not shown.
doi:10.1371/journal.pone.0064901.g004
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Comparison of Figures 5A–C suggests that a tyrosine instead of
the valine in position 203 of the symmetry related VbhT(FIC)
chain or of the tryptophan in position 3 of the symmetry related
SoFic chain would indeed be well poised to attack the ATP a-
phosphate. Furthermore, it has been shown for IbpA that the side-
chains of the target dock residues Leu3668 and Lys3670 form a
hydrophobic clamp that fix the target tyrosine side-chain (Fig. 5C)
[4]. Side-chains of residues I83 and K85 in VbhT(FIC) and
residues T143 and L145 in SoFic, that hold the valine and
tryptophan, respectively, may in a similar way clamp down the
modifiable side-chain (Fig. 5A–B). Taken together, these observa-
tions show that the flap has propensity for peptide binding as it is
well known for exposed beta-sheet edges in other proteins
[18,19,20] and ensures productive alignment of the target
hydroxyl side-chain with the bound ATP substrate.
Probably, sequence independent positioning of the backbone
flanking the modifiable target residue confers an evolutionary
advantage. While exposed loops in extended conformation of
many proteins may easily dock to the flap, other parts of the
enzyme would confer target affinity and specificity (as seen in the
IbpA(FIC)/Cdc42 complex [4]) that were free to adopt during
evolution without compromising on the catalytic mechanism.
Notably, peptide registration to the active site via main-chain
interactions is known also for serine proteases [21] and protein
kinases [22,23].
Discussion
The vast majority of Fic proteins are characterized by a
conserved HxF[D/E]GNGRxxR active site motif and catalyses
adenylylation, an enzymatic activity that involves nucleophilic
attack of a target hydroxyl group onto the a-phosphate of ATP.
Productive AMP transfer therefore relies on the proper juxtapo-
sition of the reaction partners. The inhibition-relieved (E-.G)
mutant structures of Fic proteins from the three distinct classes
shed light on the importance of the active site [D/E]GNGRxxR
residues to enable catalytically competent ATP substrate binding.
Indeed, in the three classes, these residues, by way of a large
hydrogen-bonding network, enable a unique mode of ATP
binding to orientate favorably the a-phosphate relative to the
target side-chain hydroxyl group (Fig. 3). The latter is registered to
the FIC active site in-line with the scissile Pa-O3a bond via
sequence-independent main chain-main chain interactions with
the target dock at the edge of the FIC flap (Fig. 5). Thus, the FIC
active site and the target dock are two indivisible structural
elements that have been exposed to high functional constraints to
ensure productive catalysis. Fic proteins with degenerated active
site signature motifs and/or devoid of a flap-like structure are
likely to have adopted new functions.
In Fic proteins of the three inhibition classes, the inhibitory
glutamate plays the same role. It out-competes the c-phosphate for
binding to arginine R(2) of the FIC signature motif (Fig. 4). This
results in an a-phosphate orientation that does not permit an
attack of the incoming target side-chain hydroxyl group.
Interestingly, though the active sites are structurally well
conserved, the nucleotide triphosphates show variation in their
binding to the Fic proteins of the three classes (Fig. 2). This is in
contrast to the uniform binding mode found in the inhibition
relieved mutants (Fig. 3) and shows that the mode of ATP binding
to the inhibited enzyme per se was not under evolutionary
constraints.
Knowledge of the universal catalytic and inhibitory mechanism
of Fic mediated AMP transfer will now pave the way for further
studies towards the physiological roles of Fic proteins and
particularly the identification of their protein targets. It may also
prompt rational structure based design of small molecule inhibitors
targeting the ATP binding pocket or novel peptides that mimic the
inhibitory helix to neutralize bacterial virulence factors which kill
their host via uncontrolled Fic-mediated adenylylation activity.
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Figure 5. Sequence independent registration of peptide or target protein to the FIC flap. The bound peptide/protein segment (blue) and
the target dock (brown) are shown in full. Main chain-main chain H-bonds are depicted as stippled lines. A, Product complex of IbpA(Fic2) with Cdc42
target [4]. Tyrosine 32 from the switch1 region of Cdc42 is adenylylated. B, VbhA/VbhT(FIC) complexed with residues 203 to 206 of a symmetry
related molecule. The 2Fo-Fc simulated annealing omit map covering the residues 203 to 206 is contoured at 1.1 s. Note that the preceding 7
residues are disordered and not shown. C, SoFic complexed with residues 0 to 4 of a symmetry related molecule (PDB 3EQX) [16]. The side-chains of
residues 0, 1 and 4 are disordered and not displayed for clarity reason. Note that Y32 in panel A, V203 in panel B and W3 in panel C are in equivalent
positions.
doi:10.1371/journal.pone.0064901.g005
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3.4.1 Further structural investigations on the B. henselae effector BepA  
3.4.1.1 Introduction 
In Chapter 3.1140 (Research article I), we investigated the mechanism of Fic-catalyzed 
adenylylation based on the complex structure of IbpA-Fic2/Cdc42 and the structure of a 
tailored construct of Bartonella henselae BepA (FIC-OB). It turned out that this construct had 
a pyrophosphate, the side product of the adenylylation reaction bound to the FIC active site 
cavity. From this data, we proposed a catalytic mechanism for the AMP transfer, where we 
modeled the ATP substrate based on the pyrophosphate location and the structure of the 
adenylylated IbpA-Fic2/Cdc42 complex88. But for a complete and unbiased understanding of 
the mechanism the structure of the FIC-ATP complex would be most desirable. To this end, at 
the beginning of my PhD, I extensively attempted to obtain BepA in complex with ATP by 
following experimental procedures developed by Dinesh Palanivelu (Chapter I (Research 
article I)). Soaking and Co-crystallization trials with ATP and non-hydrolyzable ATP 
analogue did not succeed and putative sulphate ions were constantly found within the anion 
binding nest. This is most likely due to the high salt concentration of the crystallization 
condition (1.5M (NH4)2SO4) that prevented nucleotide binding. Therefore, I decided to 
slightly vary the protein buffer and went for a new round of crystallization condition 
screening to hopefully obtain crystals of a BepA/ATP complex. 
 
3.4.1.2 Materials and Methods 
A BepAH159A construct comprising residues 10-303 (Fic-OB) and a C-terminal His6 tag 
was expressed and purified as described in Chapter 3.1140. At the end of the purification step, 
the protein was eluted in 10 mM Tris-HCl (pH 8.0), 100 mM NaCl and 2 mM β-
mercaptoethanol. The protein was then incubated with 5 mM of AMP-CPP (α,β-
Methyleneadenosine 5′-triphosphate, a non-hydrolyzable ATP analog) and 10 mM MgCl2 for 
1hour. 
Crystals were obtained at 20°C using the hanging-drop vapor diffusion method upon 
mixing 1 µl protein solution with 1 µl reservoir solution. The reservoir solution was composed 
of 25% (w/v) PEG 3350 and 0.2 M ammonium sulfate (non- buffered). For data collection, 
crystals were transferred to 25% (w/v) PEG 3350, 0.2 M ammonium sulfate, and 5% v/v PEG 
400 and frozen in liquid nitrogen. Diffraction data were collected on beam-line X06SA 
(PXIII) of the Swiss Light Source (λ = 1.0 Å) at 100 K on a MAR CCD detector, processed 
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using MOSFLM141, and scaled with SCALA142. The structure was solved by molecular 
replacement using Phaser143 with the BepA fragment (PDB code 2VZA) as the search model. 
Several rounds of iterative model building and refinement were performed using Coot144 and 
PHENIX145 respectively. 5% of the data were excluded from refinement and used for cross-
validation. The geometry of the final model was assessed using MolProbity146 with >99% of 
the residues in the core and allowed regions of the ramachandran plot. Data collections and 
refinement statistics are summarized in Table 1. The figure was generated with Dino (A. 
Philippsen unpublished, http://www.dino3d.org). 
 
 
Table 1: Data collection and refinement statistics for BepAH159A (10-303). 
Protein 
Ligand 
BepAH159A (10-303) 
AMP-CPP 
Data collection  
Space group P21 
Cell dimensions    
    a, b, c (Å) 42.3, 50.8, 66.0 
    α, β, γ  (°)  90.0, 96.6, 90.0 
Resolution (Å) 28.0 - 1.8(1.9 - 1.8) * 
Rsym or Rmerge 5.7(30.6) 
I/σI 13.7(4.0) 
Completeness (%) 99.6(99.0) 
Redundancy 3.8(3.8) 
  
Refinement  
Resolution (Å) 15-1.70 
No. reflections 58,005(5,445) 
Rwork/ Rfree 
Average B (Å2) 
24.5/28.8 
30.8 
No. atoms  
    Protein 2334 
    Ligand/ion - 
    Water 266 
R.m.s deviations  
    Bond lengths (Å)  0.020 
    Bond angles (º) 1.6 
                                    * Values for the highest resolution shell are shown in parenthesis.  
 
 Results: Unpublished results 
 
 118
3.4.1.3 Results 
The crystal structure of the BepA construct comprising the FIC-OB module was solved 
at 1.7 Å and yielded a new monoclinic (P21) crystal form compared to the orthorombic 
(P212121) of the structure described in Chapter 3.1140 (Research article I) (PDB 2JK8). 
Comparison of both structures does not reveal major changes and both proteins display the 
same overall topology with a Cα-RMS deviation (RMSD) of 1.1 Å (DaliLite). Whilst electron 
density at the FIC active site is present, neither AMP-CPP nor any obvious molecule from the 
crystallization condition could be unambiguously assigned to it (Fig. 1). At the time of 
writing, the refinement was not completed. The high free R-factor (28.8%) is explained by 
unassigned and yet unidentified strong positive density peaks located in close proximity to 
histidine and glutamate side-chains. Whether these electron density blops represent ions or 
modified histidine is still unclear and will need further investigations. 
 
 
 
Figure 1: Active site of BepA. The 2Fo-Fc map calculated at 1.7 Å resolution and contoured at 1.2 σ 
is shown. The unassigned density is represented by green lines. 
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3.4.1.4 Conclusion 
Although this new structure did not give any further valuable information on the 
putative mechanism of Fic-mediated adenylylation, the higher resolution might be pertinent 
for future structural investigations on Fic BepA and its interactions with the yet unknown 
target protein. 
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3.4.2 The FIC domain of B. rochalimae Bep1 effector protein adenylylates Rac1 and is 
inhibited by BiaA 
 
3.4.2.1 Introduction 
       Bartonella rochalimae belongs to lineage 3 of the Bartonella genus and has been shown 
to infect dogs and foxes. As the other Bartonella species, B. rochalimae utilizes a T4SS to 
translocate an arsenal of effectors (Beps) into host cells and manipulate host cell signaling 
pathways during infection. B. rochalimae species has not been deeply investigated and no 
phenotype has yet been associated with any of the effectors. Nevertheless, Alexander Harms 
(Biozentrum) unambiguously demonstrated that the effector Bep1, which possess the typical 
FIC-BID domain architecture, is capable of transferring AMP onto tyrosine32 from the switch 
I region of Rac1 GTPase that is likely to be the physiological target in the eukaryotic host 
cell147. Surprisingly, Bep1 showed high specificity towards its target since no adenylylation 
has been detected for the closely related Rho subfamily proteins Cdc42 and RhoA. 
Additionally, he could show that BiaA (bep-interacting antitoxin A), the protein encoded 
upstream of Bep1, inhibits Bep1-catalysed adenylylation of Rac1147. Here, I performed 
structural investigations on Bep1 in complex with BiaA to unravel the mechanism of BiaA-
mediated inhibition of Bep1 and initiated biochemical assays that will help in elucidating the 
mode of recognition of Rac1 target. 
 
3.4.2.2 Materials and Methods 
The full-length biaA gene that codes for the small ORF directly upstream of bep1 gene 
and part of the bep1 gene from Bartonella rochalimae encoding the FIC domain (amino acid 
residues 13-229) were PCR-amplified from genomic DNA. The PCR products for biaA and 
the fragment of bep1 were cloned into the pRSF-Duet1 vector. The biaA gene was cloned into 
the multiple cloning site 1 (MCS1) and the vbhT construct with an additional C-terminal His6 
affinity tag in MCS2. 
The pRSF-Duet1 vector containing biaA and the bep1 construct (denominated 
Bep1(FIC)) was transformed into E.coli BL21 (DE3). The construct was expressed and 
purified as described in Chapter 3.2 (Research article II) for VbhA/VbhT(FIC) with the 
difference that 5 mM DTT was additionally used throughout the purification procedure. 
Fractions were pooled and concentrated to 13.6 mg ml-1 for crystallization. 
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A crystal was obtained at 4°C using the hanging-drop vapor diffusion method upon 
mixing 1 µl protein solution with 1 µl reservoir solution. The reservoir solution was composed 
of 0.2 M HEPES (pH 7.5), 2.3 M ammonium sulfate and 2% v/v PEG 400. For data 
collection, crystal was frozen in liquid nitrogen without cryoprotectant. Diffraction data were 
collected on beam-line X06SA (PXIII) of the Swiss Light Source (λ = 1.0 Å) at 100 K on a 
MAR CCD detector. Data were processed and the structure solved as described for BepAH159A 
(10-303) in Chapter 3.4.1, using the VbhA/VbhT(FIC) structure (PDB 3SHG) as the search 
model. Data collections and refinement statistics are summarized in Table 1 
Adenylylation assays were performed as described for HYPEFIC in Chapter 3.2 
(Research article II) by mixing 300 ng of pure Bep1 protein with 1.2 µg GTPases. 
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Table 2. Data collection and refinement statistics for BiaA/Bep1(FIC). 
Protein BiaA/Bep1(FIC)  
Data collection  
Space group P43212 
Cell dimensions    
    a, b, c (Å) 73.1, 73.1, 130.0 
    α, β, γ  (°)  90.0, 90.0, 90.0 
Resolution (Å) 51.7 - 1.7(1.8 - 1.7) * 
Rsym or Rmerge 11.7(47.6) 
I/σI 21.0(3.0) 
Completeness (%) 99.5(96.4) 
Redundancy 18.9(4.7) 
  
Refinement  
Resolution (Å) 15-1.70 
No. reflections 38,495(3,165) 
Rwork/ Rfree 
Average B (Å2) 
16.0/21.0 
25.3 
No. atoms  
    Protein 2164 
    Ligand/ion - 
    Water 266 
R.m.s deviations  
    Bond lengths (Å)  0.010 
    Bond angles (º) 0.9 
                    * Values for the highest resolution shell are shown in parenthesis.  
 
3.4.2.3 Results 
The FIC domain is sufficient to adenylylate Rac1. Alexander Harms (Biozentrum, Basel) 
showed that full-length Bep1 is able to specifically adenylylate Rac1. To test whether the FIC 
domain on its own has the potential to adenylylate this particular GTPase, the enzymatic 
activity of Bep1(FIC) was assayed in-vitro using α-32P-ATP and Rac1 or Cdc42 as substrates 
(Fig. 1). Bep1(FIC) affords efficient transfer of AMP onto Rac1 and the activity is repressed 
by mutation of histidine to alanine (Bep1(FIC/H158A)) in the conserved FIC motif 
HxFx[D/E]GNGRxxR. Interestingly, the constitutively active form (Rac1 Q61L) does not get 
adenylylated and suggests that Bep1(FIC) exclusively interacts with wild-type GDP-bound 
form of the GTPase. However, it cannot be excluded that the Q61L point mutant that prevents 
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endogenous and GAP-stimulated GTPase activity of Rac1 might artificially impede 
Bep1(FIC) binding. Finally, the absence of radioactive signal on Cdc42 infers that structural 
element(s) responsible for the specificity towards Rac1 are confined to the FIC domain. 
 
 
 
 
Figure 1: Bep1(FIC) specifically adenylylates Rac1. Autoradiography of an SDS-gel after incubation 
of wild-type and catalytic histidine mutant of Bep1(FIC) with α-32P-ATP in presence of wild-type or 
constitutively active (Q61L) Rac1 (a) or Cdc42 (b). Wild-type Bep1(FIC) catalyses adenylylation of 
Rac1 but not Cdc42. Only weak adenylylation is observed for the constitutively active variants of 
Rac1 (Rac1Q61L). 
 
 
 
Comparison of BiaA/Bep1(FIC) and VbhA/VbhT(FIC) reveals high structural and 
functional similarities. The high resolution structure (1.7 Å) of BiaA/Bep1(FIC) from B. 
rochalimae shows high level of structural similarity (RMSD of 1.8 Å) and 30% sequence 
identity with VbhA/VbhT(FIC) (PDB code 3SHG, see Chapter 3.2 (Research article II)) from 
B. schoenbuchensis (Fig. 2). Bep1(FIC) contains all elements characteristic for an 
adenylylation-competent Fic protein. Besides the typical α-helical Fic topology, the protein 
displays the β1-β2 hairpin feature for target positioning along with the highly conserved 
active site motif essential to mediate adenylylation. Noteworthy, superposition of Bep1(FIC) 
with VbhT(FIC) indicates an almost strict conservation of residues involved in ATP 
interaction, suggesting an equivalent substrate binding mode (Fig. 2a and 2d). 
Notwithstanding the similar overall topology, a major structural deviation is evident. 
Bep1(FIC) presents an insertion in the loop preceeding the β1-β2 hairpin. Moreover, the 
hairpin turns out to be elongated (Fig. 2a and 2c).  
Analogously to VbhA, the BiaA antitoxin is folded to three antiparallel helices that 
wind around helix α1 of Bep1(FIC) with the N-terminal helix inserted in the Fic protein core 
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(Fig. 2c). This helix (αinh) harbors the conserved inhibitory motif [S/T]xxxE[G/N] with Thr29 
and Glu33 forming H-bonds with the Bep1(FIC) residue Arg166 (Fig. 2b-d). Thus, Glu33 
intrudes in the Fic active site and may compete for ATP binding. 
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Figure 2: (legend on next page) 
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Figure 2: Structure based sequence alignments of VbhT(FIC) with Bep1(FIC) (a) and VbhA with 
BiaA (b). (a) The two proteins share 30% sequence identity and a strictly conserved Fic motif located 
between helices α4 and α5. The major difference resides between helices α2 and α3 where Bep1(FIC) 
harbors loop extensions (see also panel C). The red triangles highlights residues conserved between 
the two proteins that are involved in ATP binding (see panel d). (b) The two proteins share 30% 
identity and possess the conserved inhibitory motif [S/T]xxE[G/N] with S/T and E highlighted with 
red triangles. (c) Structure comparison of BiaA/Bep1(FIC) (left panel) and VbhA/VbhT (PDB code 
3SHG, right panel). Color code is the following: red, core of Fic domain as defined by Pfam86; yellow, 
HxFxxGNGRxxR signature motif; green, antitoxin; magenta, remainder of structure. BiaA/Bep1(FIC) 
is highly similar to VbhA/VbhT but with further loop extensions around the β-hairpin region situated 
between helices α2 and α3 (colored in grey). (d) Superposition of active-sites from proteins shown in 
panel C that highlights the conservation of residues involved in ATP binding. turquoise, Bep1(FIC); 
grey VbhT; green, BiaA; black, inhibitory glutamate from VbhA. H-bonds are marked by stippled 
grey lines. Residues corresponding to BiaA/Bep1(FIC) are written in turquoise with the equivalents 
from VbhA/VbhT(FIC) in brackets. The location of the glutamate from the inhibitory motif is similar 
in both structures supporting a conserved mechanism of active-site obstruction. 
 
3.4.2.4 Conclusion 
Biochemical analysis performed on Bep1 revealed that the FIC module is sufficient to 
specifically recognize and adenylylate the small Rho GTPase Rac1. Interestingly, Bep1(FIC) 
shows insertions in the vicinity of the β1-β2 hairpin. Expansion in this particular region has 
already been seen in AvrB where it mediates binding to the plant immune response regulator 
RIN498,101. Therefore, these features may represent potential target recognition modules and 
enable Bep1(FIC) to discriminate between small Rho GTPases. Remarkably, these elements 
are also found in the structure of the FIC domain of the B. henselae effector BepA140 (PDB 
2JK8) and might be therefore characteristic of eukaryotic host-interacting Bartonella 
effectors. Furthermore, the elongated β-hairpin forms a cap on the Fic active site and may 
prevent futile ATP hydrolysis140. 
These biochemical findings provide groundwork for future structural investigations on 
the Bep1(FIC)/Rac1 complex structure aiming to decipher the molecular recognition and 
specific interactions of the toxin with its host cell target. 
The complex structure of BiaA/Bep1(FIC) shows high structural homology with the 
putative VbhT/A toxin-antitoxin system of B. schoenbuchensis and suggests a conserved 
mechanism of FIC domain inhibition by active site obstruction. Whereas the plasmid encoded 
VbhA peptide might exert a function similar to the classical bacterial antitoxins, the 
biological role of the chromosomal BiaA is yet unknown and putative functions will be 
discussed in the general discussion Chapter. 
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3.4.3 The FIC domain of VbhT from B. schoenbuchensis might harbor both AMP 
transferase and kinase activity 
 
3.4.3.1 Introduction 
           In Chapter 3.2 (Research article II), we showed that the Fic domain of VbhT from B. 
schoenbuchensis catalyses adenylylation of a 80kDa E. coli target protein148. This 
modification results in bacterial filamentation and growth arrest. The toxic activity of VbhT is 
repressed by the protein VbhA encoded directly upstream the locus for VbhT. VbhA 
possesses a conserved inhibitory motif [S/T]xxE[G/N] in which the glutamate impedes proper 
ATP binding to the FIC active site148. Furthermore, by solving the structure of 
VbhAE24G/VbhT(FIC) in complex with ATP, we structurally demonstrated that mutation of 
this glutamate to glycine relieves inhibition in that it allows competent ATP binding149 
(Chapter 3.3, Research article III). Here, I present a new structure of VbhAE24G/VbhT(FIC) in 
complex with ATP that shows a novel ATP binding mode. 
 
3.4.3.2 Materials and Methods 
The plasmid pFVS0065 containing VbhAE24G/VbhT(FIC) has been cloned, expressed 
and purified as described in Chapter 3.3 (Research article III). 
A crystal was obtained at 20 °C using the hanging-drop vapor diffusion method upon 
mixing 1 µl protein solution with 1 µl reservoir solution. The reservoir solution was composed 
of 12% w/v PEG 4000 and 0.1 M MES (pH 6.5). The protein was then incubated with 10 mM 
ATP and 10 mM MgCl2 for 1 hour. For data collection, the crystal was frozen in liquid 
nitrogen with reservoir buffer supplemented with 20% glycerol as cryoprotectant. Diffraction 
data were collected at beam-line X06SA (PXIII) of the Swiss Light Source (λ = 1.0 Å) at 100 
K on a PILATUS 2M detector, and scaled and integrated with XDS/XSCALE150. The 
structure was refined with the program PHENIX145 using starting phases from the 
VbhAE24G/VbhT(FIC)H136A/AMPPNP structure (see Chapter 3.3, Research article III), from 
which water molecules, magnesium ion and AMPPNP had been removed. The remainder of 
the molecule was traced manually with Coot144 followed by full refinement using PHENIX145. 
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Table 1: Data collection and refinement statistics for VbhAE24G/VbhT(FIC). 
Protein VbhAE24G/VbhT(FIC) 
Data collection  
Space group C2 
Cell dimensions    
    a, b, c (Å) 106.4, 41.5, 74.3 
    α, β, γ  (°)  90.0, 121.7, 90.0 
Resolution (Å) 31.6 - 1.5(1.6 - 1.5) * 
Rsym or Rmerge 4.1(43.5) 
I/σI 18.2(2.7) 
Completeness (%) 98.6(95.2) 
Redundancy 3.6(3.6) 
  
Refinement  
Resolution (Å) 15-1.5 
No. reflections 44,097(4,087) 
Rwork/ Rfree 
Average B (Å2) 
15.1/20.8 
21.6 
No. atoms  
    Protein 1821 
    Ligand/ion 1 ATP, 1MG 
    Water 291 
R.m.s deviations  
    Bond lengths (Å)  0.01 
    Bond angles (º) 1.2 
• Values for the highest resolution shell are shown in parenthesis.  
3.4.3.3 Results 
         The crystal structure of VbhAE24G/VbhT(FIC) in complex with ATP/Mg2+ was solved at 
1.5 Å resolution and is isomorphous to the wild-type VbhA/VbhT(FIC) structure148 (Table 
S1, see Chapter 3.2 (Research article II)). Electron density corresponding to an ATP/Mg2+ 
complex is clearly visible in the active site (Fig. 1a). The divalent cation has a perfect 
octahedral coordination sphere mediated by three water molecules, the carboxyl side-chain of 
a conserved glutamate (E140) from the FIC active site motif and two non-bridging oxygens of 
the β- and γ-phosphates of ATP. Comparison with the previously reported 
VbhAE24G/VbhT(FIC) structure in complex with ATP149 (see Chapter 3.3 (Research article 
III)) reveals striking results (Fig. 1). Whereas the adenosine moiety adopts equivalent position 
in the two structures, the triphosphate is found reoriented (Fig. 1a). The position in the 
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compound nest adopted by the α-phosphate of ATP in the previously reported 
VbhAE24G/VbhT(FIC) structure (Fig. 1b) is taken by the γ-phosphate of ATP in the new 
VbhAE24G/VbhT(FIC) structure (Fig. 1a). In this particular conformation, the ATP α-
phosphorous interacts with the second arginine of the FIC active site motif and is therefore 
not in an adenylylation-competent conformation. On the contrary, the γ-phosphate appears 
well suited to undergo in-line attack induced by the target hydroxyl group, resulting in 
phosphate transfer onto the target (Fig. 1a).  
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Figure 1: ATP can bind in two distinct orientations to the substrate binding site of VbhT(FIC) 
suggesting a dual AMP transferase and kinase activity for VbhT(FIC). ATP is represented in full and 
colored in dark green. Magnesium ion and water molecules are shown as magenta and red spheres, 
respectively. Residues important for ATP/Mg2+ binding are shown in full. The modifiable Y32 of the 
Cdc42 switch I-loop is shown in blue in a position obtained after superposition of the active site loops 
of VbhT(FIC) and the IbpA(FIC2)/Cdc42 complex148. (a) Active site of VbhAE24G/VbhT(FIC) in 
complex with ATP/Mg2+. Also shown is the 2Fo-Fc map contoured at 1.2 σ and covering the ligand. 
The ATP is found oriented such that the γ-phosphate is in an appropriate position allowing in-line 
attack of a target side-chain to accomplish phosphate transfer. 
(b) Active site of VbhAE24G/VbhT(FIC) in complex with ATP/Mg2+ (PDB code: 3ZCB) showing 
adenylylation-competent nucleotide binding149 (see also Chapter 3.3 (Research article III)). 
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3.4.3.4 Conclusion 
The two distinct ATP binding modes suggest that VbhT(FIC) might be a bifunctional enzyme 
that can utilize one active site to post-translationally modify target proteins by either 
adenylylation or phosphorylation. Further biochemical data are needed to support this 
hypothesis. 
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Throughout my PhD, I solved various structures of FIC-domain containing proteins that 
were essential for a thorough structural understanding of their adenylylation activity and 
regulation.  
The vast majority of Fic proteins are characterized by a conserved HxF[D/E]GNGRxxR 
active site motif and catalyses adenylylation, an enzymatic activity that involves nucleophilic 
attack of a target hydroxyl group onto the α-phosphate of ATP. Productive AMP transfer 
therefore relies on the proper juxtaposition of the reaction partners. The active site 
[D/E]GNGRxxR residues are critical to enable catalytically competent ATP substrate binding. 
Indeed, these residues, by a way of a large hydrogen-bonding network, enable a unique mode 
of ATP binding to orientate favorably the α-phosphate relative to the target side-chain 
hydroxyl group. The latter is registered to the FIC active site in-line with the scissile Pα-O3α 
bond via sequence-independent main chain-main chain interactions with the target dock at the 
edge of the FIC flap. Thus, the FIC active site and the target dock are two indivisible 
structural elements that have been exposed to high functional constraints to ensure productive 
catalysis. We believe that this catalytic mechanism (summarized in Figure 1) can be 
generalized and extrapolated to all adenylylation-competent Fic proteins.  
The structure of VbhA/VbhT(FIC) of Bartonella schoenbuchensis brought into light an 
unexpected and widely spread mode of regulation used by adenylylation-competent Fic 
proteins to regulate intrinsic signaling processes. The proteins present an alpha helix (αinh) 
characterized by a conserved [S/T]xxxE[G/N] motif to the FIC active site and perturb ATP 
binding. Intriguingly, αinh can be part of the Fic protein itself as a N- or C-terminal extension 
or provided by an additional antitoxin. Thus, we suggested a tripartite classification scheme to 
group Fic proteins, according to the position of the inhibitory helix along the polypeptide 
chain. Moreover, a detailed analysis of competent and inhibition-relieved states of 
VbhA/VbhT(FIC), Shewanella oneidensis, and Neisseria meningitidis Fic protein structures 
allowed us to propose a general mechanism for inhibition of FIC domain adenylylation 
activity, in which the strictly conserved inhibitory glutamate finger located in helix αinh 
prevents competent ATP binding. Finally, structural homology modeling and biochemical 
assays indicate that this mechanism is conserved from bacteria to higher eukaryotes. 
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Figure 1: (legend on next page) 
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Figure 1: 3D scenario highlighting the common steps of FIC-catalyzed adenylylation. The 
magnesium ion is displayed with a grey ball. Important residues and the ATP are shown in full. The 
structure of NmFic(∆8) from Neisseria meningitidis is used to illustrate the FIC backbone. The target 
is represented by the switch I region of Cdc42. Its position has been obtained after superposition of the 
active site loops of NmFic(∆8) and IbpA-Fic2 from the IbpA-Fic2/Cdc42 complex (PDB code 3N3V). 
Side-chains of the residues involved in FIC-target β-β interactions are omitted. 
Step 1: A ternary complex forms between the Fic protein and its two substrates. The ATP binding site 
is composed of: 1) hydrophobic pocket enclosing the purine ring, 2) The second arginine (Arg2) of the 
fic active site motif and a side-chain hydroxyl group coming from helix α6 that serves as a anchor for 
the nucleotide in the middle of the active site. 3) The compound anion binding nest formed by the 
conserved GNGR residues from the Fic active site motif together with Arg2 and the magnesium ion 
that provide extensive hydrogen-bonding network to interact with the triphosphate moiety and 
orientate the α-phosphate for catalysis. The target dock, through sequence-independent main chain-
main chain hydrogen bonds with the target protein, favorably position the side-chain OH group of the 
target residue (Tyr) with respect to the α-phosphate and the catalytic histidine. 
Step 2: The catalytic histidine function as a general base to deprotonate the hydroxyl group of the 
target residue side-chain and hence activates it for nucleophilic attack on the α-phosphate of the ATP. 
Step 3: The AMP moiety is transferred onto the target. 
Step 4: The adenylylated target is released with concomitant re-positionning of the pyrophosphate 
leaving group in the high-affinity binding nest. The pyrophosphate may stay in the Fic active site 
cavity until a new cycle of adenylylation starts. 
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5.1 FIC: one fold with several functions 
 
The ubiquitous FIC fold is a rigid and versatile α-helical protein scaffold on which 
various extensions and insertions give rise to different proteins and provide a broad range of 
target specificities89. Furthermore, proteins with a FIC fold often have additional domains that 
precede or follow the FIC domain generating additional variability (see Pfam database 
(PF02661)). The fold also displays a high degree of active site flexibility and plasticity. 
Plasticity, i.e., amino acid substitutions, is an essential feature to adopt new functions151. The 
mutated residues are usually found at the wall or vicinity of active sites being part of the 
substrate-binding pocket, and exhibiting high conformational flexibility151,152.  
Active site plasticity is Fic proteins has been nicely exemplified by the work on the 
effector protein AnkX from Legionella pneumophila18. The protein harbors an active site 
(HxFxDANGRxxV) slightly diverging from the consensus HxFx[D/E]GNGRxxR motif that 
is characteristic of adenylylation-competent Fic enzymes. Indeed, substitutions of the first 
glycine and second arginine into alanine and valine, respectively, enable AnkX to bind CDP-
choline at the active site and catalyse phosphocholination. Apart form these two mutations, 
proteins bearing AMP or phosphocholine transferase activity share the same active site 
residues. They most likely utilize a similar anion binding hole made up by residues GNGR 
and ANGR, respectively, to accomodate the phosphorus groups of their respective ATP and 
CDP-choline substrates. In both cases, the phosphate moieties are probably further stabilize 
by a divalent cation coordinated by the common [D/E] amino acid. Remarkably, the two 
reactions occur via different kinetic mechanisms involving the conserved histidine for 
catalysis. Whereas a ternary complex forms between the enzyme and both substrates during 
adenylylation with the histidine serving as a general base, phospho-choline transfer requires a 
ping-pong mechanism where the histidine is first modified before subsequent transfer on the 
target protein87,153. The fact that proteins with activities of AMP and P-choline transfer are 
likely to share the main active site features of phosphate-binding and catalytic histidine may 
suggest that they divergently evolved from a common Fic ancestor with promiscuous 
functions154. 
Doc and AvrB proteins are structurally related to Fic proteins in the sense that they 
harbor the same overall α-helical topology and active site location89 (Chapter 1.2.7). While 
they have been biologically characterized, the molecular mechanisms underlying their 
functions remain unknown95,97. Even though adenylylation activity has not been disproven, 
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the structural variations observed in their active sites may imply that they catalyze other 
reactions or transform other substrates.  
The preliminary structural result obtained in Chapter 3.4.3 on the capacity of the 
VbhT(FIC) protein to recognize the ATP ligand in two distinct orientations is also indicative 
of the prominent structural flexibility of the substrate-binding site. Flexibility in the vicinity 
of the active site may allow Fic proteins to accommodate the same substrate in various 
conformations or probably even different substrates. 
This high active site plasticity observed in the several thousand FIC domains suggests 
that adenylylation and phosphocholination represent only a fraction of the spectrum of 
reactions they can catalyze. Future studies will considerably expand the functional repertoire 
of biochemical strategies employed by this ubiquitous protein to interplay with key signaling 
pathways. 
 
 
5.2 The Rho GTPase master regulators: preferential targets of Fic-
mediated adenylylation 
 
Up to know, all characterized proteins targeted by adenylylation-competent FIC 
domain-containing effectors appear to belong to the Rho GTPases family. Rho proteins are 
master regulators of the cytoskeleton and control a remarkable diversity of cellular functions 
like motility, cell morphology, differentiation and cell division155-157. It is therefore not 
surprising that bacterial Fic-containing effectors, like many virulence factors16,17,158 directly 
target this essential protein to establish successful infection.  
Rho proteins act as molecular switches that cycle between an ‘activated’ GTP-bound 
state allowing binding of downstream effectors and an ‘inactivated’ GDP-bound state. This 
cycle is controlled by three types of proteins: the guanine nucleotide exchange factors (GEFs) 
that catalyze exchange of GDP for GTP to activate the switch159; the GTPase activating 
proteins (GAPs) that stimulate the intrinsic GTPase activity to inactivate the switch160; and 
the guanine nucleotide dissociation inhibitors (GDIs), which mediate the sequestration of Rho 
proteins from membranes161. Fic proteins have been shown to recognize different GTPase 
states. VopS and IbpA are capable of AMP transfer onto the constitutively active form of the 
GTPases thereby preventing interaction with downstream partners, but can also chemically 
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modify the inactive (GDP-bound) state of Rho-GTPases84. Rho proteins are activated or 
inactivated upon binding of GEFs or GAPs, respectively. These two families of Rho GTPase 
modulators mediate a series of interactions with the switch 1 region of Rho GTPases and in 
particular with Tyr32/34 and Thr35/37162,163. It is therefore conceivable that adenylylation of 
one of these two residues will modulate GEF or GAP activities towards GTPases. 
Interestingly, Bep1(FIC) displays high affinity for wild-type Rac1, that is most likely in a 
GDP-bound form, and only negligible interaction with the constitutively active variant 
(Chapter 3.4.2). This may indicate a disparate mode of GTPase regulation. Though we cannot 
exclude that the point mutant that lock GTPases into a constitutively active (Q61L) form, 
alters the conformation of the GTPase, such that it may not be effectively recognized by 
Bep1(FIC). 
Moreover, as proposed by Mattoo et al84, Fic proteins, by covalent modification with an 
AMP moiety, may also differently impair the distribution between the membrane and the 
cytosol of Rho GTPases by perturbing Rho GDIs binding. Such a disruption of complex 
formation between GDIs and Ras-like GTPases has been already observed in the context of L. 
pneumophila infection. The covalent coercion of Rab GTPase by AnkX and DrrA through 
phosphocholine and AMP transfer, respectively, lead to GDI displacement from Rab 
proteins164. 
Thus, besides the role in blocking the binding of downstream effectors, Fic proteins are 
likely to disrupt the spatio-temporal regulation of Rho GTPases. But this hypothesis needs 
further investigations. 
 
Interestingly, in contrast to VopS, IbpA, and PfhB2 that are able to adenylylate all Rho 
family members84, Bep1 from Bartonella rochalimae shows remarkable specificity towards 
Rac1. Thus, upon translocation into the host cell, Bep1 is likely to hijack specific signal 
transduction pathways that are under Rac1 control. The specific contribution of Bep1 in 
Bartonella infection and the associated phenotype(s) are currently under investigation in our 
laboratory. My contribution, as a structural biologist, will be the characterization of the 
structural features allowing Bep1 to distinguish between this proteins that share high structure 
and sequence similarities. 
 
The tendency of Fic proteins to target GTPases may reflect a strong selective pressure 
on the Fic protein to adopt a stable and evolutionarily conserved architecture that specifically 
recognize the highly abundant GTPase fold. GTPases, also commonly named G proteins, 
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belong to the P-loop NTPase superfamily that is defined by the so-called P-loop NTPase 
fold165. This fold is characterized by a highly conserved globular shape, made up by at least 5 
α/β units, with the strands forming a core parallel sheet, and is the most abundant fold in 
proteins encoded in the genomes of most cellular life-forms166. Moreover, the phosphate-
binding loop and the two switch regions that carry the basic functions of nucleotide binding, 
hydrolysis and effector binding are extremely similar among proteins harboring this typical 
architecture. It is therefore well imaginable, that all protein targeted by FIC domain display 
the typical NTPase fold. 
 
 
5.3 Emergence of new targets of Fic-mediated adenylylation 
 
In Chapter 3.1140 (Research article I), I could show that the FIC domain of Bartonella 
henselae T4SS effector BepA can adenylylate two eukaryotic targets in-vitro. The apparent 
size of the proteins detected by in-vitro adenylylation assay clearly excludes them to be small 
Rho GTPases. It therefore highlights for the first time target proteins distinct from this family 
and their detection is currently ongoing. BepA has been shown to inhibit apoptosis upon 
infection of human endothelial cell through elevation of cytosolic cAMP concentration136. 
This phenotype that is triggered by manipulation of host adenylylate cyclases and Gα-subunit 
of heterotrimeric G-proteins has been exclusively associated with the BID domain of 
BepA167. Even though the FIC domain seems not to be implicated in this process, it is 
tempting to speculate that it may contribute to it by slight modulation of G-protein activity. 
Interestingly, the size of the Gs alpha subunit (45 kDa) fits with one of the two bands revealed 
on the in-vitro adenylylation assay performed with the BepA FIC-OB domain (Chapter 3.1 
(Research article I))140. 
The linker region between the FIC and the BID domain adopts an OB-fold like topology 
that was originally named for its oligonucleotide/oligosaccharide binding properties. This fold 
is quite frequent in DNA- and RNA-binding proteins but has also been observed at protein-
protein interfaces and in some cases can even bear a catalytic function168,169. The role of the 
OB domain in Bartonella effector proteins is still unknown. A putative function in target 
recognition analogous to the arm domain of VopS and IbpA might be considered88. However, 
the fact that OB-fold appears to be also present on the relaxases of B. grahamii and B. 
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schoenbuchensis, from which the BID translocation signal originates, and that the OB-fold 
linker region of Bep1 rochalimae does not contribute to Rac1 binding (Chapter 3.4.2), 
suggest that it might rather function independently or in conjunction with the BID domain. 
 
In Chapter 3.2148 (Research article II), we performed in vitro adenylylation assays with 
the FIC domain-containing protein VbhT from B. schoenbuchensis. Incubation of the protein 
with E. coli lysate, revealed a band with an apparent size of 80 kDa that is likely to represent 
a bacterial target for the Fic protein. By a combination of pull-down and mass spectrometry 
experiments, Alexander Harms could demonstrate that this band corresponds to the subunit 
beta of the DNA gyrase (Unpublished results). Strikingly, the β-subunit of DNA gyrase 
harbors a P-loop NTPase domain supporting the hypothesis that Fic proteins are pre-adapted 
to recognize this typical fold170. DNA gyrase is an enzyme that catalyzes the introduction of 
negative supercoils in DNA, an activity that is essential in the process of cell replication171. 
Whereas the catalytic machinery is situated in the subunit alpha, the subunit beta bears an 
ATPase domain that is essential for gyrase function. Interestingly, blockade of the gyrase 
ATPase activity leads to cell filamentation in E. coli172, supporting that the filamentous 
growth phenotype observed for VbhT might result from specific adenylylation of DNA 
gyrase148. Mass spectrometry has traced Y109 to be the modified residue (Alexander Harms, 
Biozentrum Basel, unpublished result). This amino acid is highly conserved among bacterial 
gyrases and is located within the ATP-binding pocket of the ATPase domain. 
From a biological point of view the VbhT toxic activity probably plays a role during the 
conjugation process in Bartonella. Indeed, the VbhA-T operon is tightly associated with the 
plasmid-encoded Vbh T4SS that has been shown to be a functional conjugation machinery 
mediating plasmid transfer between different Bartonella species139. Moreover, adjacent to the 
FIC domain, VbhT harbors a functional BID translocation signal suggesting that it gets co-
translocated with the plasmid DNA during conjugation139. Thus, VbhT may toxify the 
recipient cell during conjugation by adenylylating the gyrase and blocking the replication 
process leading to cell filamentation and growth inhibition. Once the conjugation process is 
completed, the antitoxin encoded on the plasmid will be expressed, detoxifying the recipient 
cell. In case of abortive conjugation, VbhT activity would not be counteracted resulting 
eventually to cell death. Furthermore a blockade of replication might increase the amount of 
freely available bacterial host DNA replication machinery and allow rapid replication of the 
plasmid. The ability of the system to kill or inhibit the growth of recipient cell that does not 
receive a copy of plasmid through gyrase inhibition displays analogy with some post-
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segregational killing (PSK) systems that ensure stable inheritance of plasmids in a 
population173,174. 
 
Intriguingly, the Fic protein from N. meningitidis (NmFic) was also found to 
adenylylate DNA gyrase in vitro, further indicating that Fic proteins are conservative in their 
target specificity (Alexander Harms, Biozentrum Basel, unpublished). However, in vitro 
adenylylation assay revealed additional modified proteins in E. coli148 (Chapter 3.2 (Research 
article II)). These proteins have not been yet identified and it is unclear whether they are 
specific or non-specific targets. But the modification of multiple proteins that may have 
counteracting activities could explain the less severe toxic effect observed in E. coli. 
 
Finally, recent investigations performed by Alexander Harms (Biozentrum, Basel) on 
the Bep2 effector from B. rochalimae also revealed adenylylation of an unknown eukaryotic 
target protein with an apparent size of 50 kDa147. Studies aiming to identify the target and the 
corresponding phenotype are currently underway in our laboratory. 
 
A vast majority of Fic proteins bear adenylylation function to regulate multiple cellular 
functions. However, the activity is hindered in a large portion of Fic proteins by the general 
inhibitory mechanism described in Chapter 3.2 and 3.3148,149 (Research articles II and III). 
This regulation may largely explain the current lack of knowledge about the various 
biological functions mediated by adenylylation-competent Fic proteins. Knowing the easy 
genetic trick to relieve the inhibition opens new avenues for exploring the diverse biological 
roles of Fic-mediated adenylylation in all kingdoms of life.   
 
5.4 Putative roles of Fic-antitoxins associated with host-interacting 
effectors. 
Comparative sequence analysis of the Vbh T4SS of B. schoenbuchensis with the VirB 
loci of Bartonella lineages 3 and 4 showed that the small open reading frame encoded directly 
upstream of vbht and coding for the antitoxin VbhA in the Vbh locus is also present in front 
of fic genes in the virB loci. The exact biological function of these Fic-antitoxins that are 
genetically associated with eukaryotic host-interacting bep effectors remains elusive.  
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In Chapter 3.4.2, I corroborated previous finding made by Alexander Harms147 and 
demonstrated that the B. rochalimae BiaA protein, encoded upstream of Bep1, can inhibit 
Bep1-mediated adenylylation of the eukaryotic Rac1 GTPase. Remarkably, comparison with 
the structure of the VbhA/VbhT(FIC) complex from B.schoenbuchensis shows high 
homology and probably an identical inhibitory mechanism via Fic active site obstruction148. 
The first obvious hypothesis that emerges from this functional and structural data is that BiaA 
tightly associates with the FIC domain and gets translocated into the eukaryotic host where it 
would prevent adenylylation of Rac1. Nevertheless, it remains to be elucidated whether Fic-
antitoxin are injected into the host cell during Bartonella infection. Preliminary experiment 
done by Philipp Engel with a B. henselae mutant devoid of the antitoxin did not affect 
invasome formation during in vitro infection.  
Furthermore, it is assumed that proteins need to unfold or partially unfold in order to be 
translocated through the T4S apparatus108. Protein unfolding would lead to the release of the 
antitoxin from the effector prior secretion, indicative of a role within the bacteria. Thus, the 
antitoxin may still have an ancestral function of FIC inhibition in the bacteria. However, no 
toxic effect of any Bartonella Fic effector on bacterial cells could be detected so far.  
More cryptic functions might be also envisaged, but would require further experimental 
support. The small ORF may act as a chaperone for the FIC domain-containing effector 
proteins, preventing their aggregation or targeting them to the secretion machinery175. 
Interestingly, Fic-antitoxins are characterized by a small size, acidic pI, and amphipathic 
helices that are physical properties characteristics of chaperones175.  
Also, the functional analogy with classical toxin-antitoxin systems may indicate a 
function in transcriptional regulation of fic operons.  
Finally, adenylylation involves consumption of ATP that is a potential danger to the 
bacterial cell. Even in the absence of target, ATP hydrolysis may happen in the course of 
auto-adenylylation. Thus, antitoxin might control Fic activity to prevent futile ATP hydrolysis 
until translocation into host cell. 
All these various aspects are currently being investigated in our laboratory. 
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